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Summary 
This thesis is a description of the effects of Sulphadoxine/Pyrimethamine (SP) 
selection on the genome of Plasmodium Jalciparum. Antimalarial resistance in P. 
Jalciparum to the antifolate combination of SP is conferred by a series of substitutions 
that alter the active sites of the target enzymes dihydrofolate reductase (DHFR) and 
dihydropteroate synthetase (DHPS). 
Different combinations of substitutions result in differing levels of drug insensitivity 
as shown by both in vitro studies and association with treatment failure. In southeast 
Africa, where the samples taken for this study originate, the two most highly resistant 
dhfr and dhps alleles are the triple mutant (N51I+C59R+Sl08N) and the double 
mutant (A437G+K540E) ,respectively. A molecular population genetic analytic 
approach is applied to examine the emergence and spread of SP resistant mutations in 
Africa. We observe that differences in the frequencies of the resistance alleles 
between southeast African populations broadly reflect heterogeneity in drug selection 
history across the region. We find that this exists despite strongly homogenising gene 
flow. 
Selection for a favourable allele can have effects on neutral loci flanking the selected 
site. A selective sweep occurs when neutral flanking loci hitchhike with the selected 
allele as it increases in frequency, reducing genetic diversity along the chromosome 
in the population. The hitchhiking alleles indicate the ancestry of the selected allele 
and has shown that alleles at dhfr and dhps comprised of multiples of mutations have 
emerged rarely in east African parasite populations (Roper et al. 2003). 
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The thesis is the first description of the full extent of the selective sweeps around 
three dhfr and dhps resistance alleles in southeast Africa. The thesis contains analysis 
of the changes that occur to a selective sweep over time and in populations with 
contrasting recombination rates and selection histories. Through use of a 
deterministic model we identify that gene flow plays an important role in establishing 
the frequency of the resistance allele at values greater than l/Ne, the frequency of a de 
novo mutation. 
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Chapter 1 Plasmodium falciparum.D rug Selection and Selective Sweeps 
The apicomplexan parasite, PlasmodiumJalciparum is the most deadly of the four 
human malarias. The World Health Organisation (WHO) estimated that in 1998 P. 
Jalciparum globally caused 273 million clinical attacks per year, with over 90% of 
clinical disease occurring in sub Saharan Africa, of which the majority was in 
children (Greenwood and Mutabingwa 2002). A recently published estimate for the 
year 2002 reported that the number of clinical attacks per year globally was 515 
million clinical attacks (Snow et al. 2005),hig her than estimated by WHO and 
revising the burden of malaria in sub Saharan Africa to 70% of the global total, to 
reflect the under reported burden of malaria in southeast Asian populations 
In addition to the cost in human life, P. Jalciparum malaria through its effect on 
morbidity greatly burdens the economies of African countries. The cost of malaria to 
the annual GDP of African countries is a 1.9% reduction in economic growth to 
below that of the global average outside Africa (2.3 %) (Sachs and Malaney 2002). 
The importance of reducing the malaria burden globally is great. The control of this 
disease and HIV / Aids are arguably the first steps in relieving poverty in developing 
countries. Organisations such as the WHO and Global Fund have recognised this and 
have targeted P. Jalciparum malaria as one of three key infections to control in the 
developing world, putting malaria alongside HIV / Aids and Tuberculosis. 
The focus of this literature review will specifically be on drug resistance in P. 
Jalciparum malaria,conc entrating particularly on the situation in southeast African 
while making some reference to drug resistance globally. 
24 
Plasmodiumfalciparum,D rug Selection and Selective Sweeps 
I Plasmodium Jalciparum basic biology 
a The life cycle 
The definitive host of P. Jalciparum is the female Anopheline mosquito. Blood 
feeding on humans (the intermediary host) by the mosquito releases infective 
sporozoites collected in the mosquito salivary glands into the human bloodstream. 
Once in the bloodstream, the sporozoites move rapidly to infect hepatocytes in the 
liver (Figure 1-1). Here sporozoites multiply through several rounds of cell division 
(schizogony) eventually releasing merozoites into the bloodstream where they infect 
erythrocytes. Here begins erythrocytic schizogony and the parasite numbers increase 
through numerous rounds of multiplication via the trophozoite stage and then mature 
schizonts that rupture, releasing merozoites into the bloodstream, infecting other 
erythrocytes. A subset of merozoites leaves erythrocytic schizogony and 
differentiates into gametocytes. The gametocytes are taken up in a blood meal by a 
female Anopheline mosquito where they further develop into male and female 
gametes that fuse and form a zygote in the insects' stomach lining. The zygote 
develops into the ookinete which moves across the mosquito stomach wall forming a 
sporozoite-filled oocyst. The oocyst bursts, the sporozoites are released into the 
haemocoele and move to the mosquito salivary glands. There the process can begin 
again when the mosquito inoculates these into the bloodstream of another host. 
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In mosqui1o 
gut 
Gametoey1es 
Figure 1-1: The life cycle of Plasmodium Jalciparum between the definitive host, the 
Anopheline mosquito, and the human host. Details of the lifecycle steps can be found 
in the text. Taken from (Miller et al. 1986) 
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b Genetic consequences oj the lifecycle 
The P. Jalciparum genome is comprised of 14 highly A + T rich (>80%) 
chromosomes (Gardner et al. 2002), which are haploid throughout the parasites 
lifecycle in the human host. When the male and female gametes fuse in the mosquito 
gut, the genome becomes diploid and homologous recombination occurs during 
meiosis. Recombination occurs in P. Jalciparum at a high rate; breakpoints are 
estimated to occur at a rate of 1 cM per 17kb as determined by analysis of 
microsatellite genotypes in a genetic cross between two P. Jalciparum strains, Hb3 
and Dd2 (Su et al. 1999). This estimated meiotic recombination rate is 20 times 
higher than that estimated in Drosophila and 40 times higher than in humans 
(Conway et al. 1999). Estimates of the recombination rate in the field in African P. 
Jalciparum populations are similarly high. Linkage disequilibrium in antigen genes 
MSP1 and AMA1 reaches half its maximal value at a distance of about 300 base pairs 
(Conway et al. 1999; Polley and Conway 2001). 
It is important to note that the meiotic recombination rate in a genetic cross is an 
overestimate of recombination in the field because selfing occurs between 
gametocytes of the same genotype. In African parasite populations parasite genetic 
diversity is high, whereas at other locations globally diversity tends to be lower; least 
diverse populations are in South America (Anderson et al. 2000a). This difference in 
genetic diversity limits the opportunities for recombination to occur between different 
genetically distinct parasite lineages. 
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c Transmission intensity 
In areas of high transmission intensity infections tend to be composed of multiple 
genetically distinct parasite lines (Babiker, Ranford-Cartwright, and Walliker 1999). 
These occur either through super-infection of a host who has received multiple 
infectious bites, or through the bite of a mosquito carrying a mixture of genotypes 
within its' inoculating saliva. The multiplicity of an infection is correlated with a 
measure of transmission intensity, known as the entomological inoculation rate (EIR). 
This is a measure of the number of infective bites per individual per annum. In a 
review of 159 distinct sites recorded in sub Saharan Africa, regardless of land use 
type (EIRs are lower in urban areas), annual EIR ranged from 0 to 884, with a mean 
of 121 infected bites per annum (Hay et al. 2000) indicating that malaria transmission 
is both endemic and high. By contrast, in South America and southeast Asia, the 
annual EIR tends to be low, rarely exceeding 5 infective bites per adult per annum 
(reviewed by (Greenwood and Mutabingvva 2002). Malaria in such areas is unstable, 
and rather than endemic in a population, it is prone to epidemics, where the majority 
of disease occurs during short bursts of intense transmission. It is less likely that 
multiple infections occur under these circumstances and the opportunities for 
outcrossing are reduced as a consequence. 
d Transmission intensity and its ' effect on host parasite interactions 
In addition to the effect on genetic diversity, the second effect of high malaria 
transmission is that the development of clinical immunity in the human host occurs 
quicker than in low transmission areas, as an individuals' immune system receives a 
far higher number of challenges (Snow et al. 1997). For an individual living in an 
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area of intense transmission the first few years of childhood are when the risks of 
severe disease and mortality are highest. With age the risk of mortality and severity 
of disease decrease as the individual develops immunity against the disease (Snow et 
al. 1997). Infections in the clinically immune are by definition asymptomatic, 
although attacks of fever and headache are common. However, premunition is not 
sterilising immunity and resolution of infections tends to occur through, or is assisted 
by, use of antimalarial chemotherapy. 
II Antimalarials and P. ja/ciparuHl 
a History of antimalarial usage 
Treating malaria infection has been a concern of humans for centuries and it is 
unsurprising that the earliest antimalarials were isolated from plants. The oldest 
recorded antimalarial was used in China over 2000 years ago. Artemesinin is 
extracted from the Chinese herb quinghao (Artemisia annua) and had been done so 
for over 1500 years before the discovery of Quinine, found in the bark of the 
Peruvian 'fever tree' (Chinchona spp.). Artemesinin is undergoing resurgence of 
interest and its use in Artemesinin-based Combination Therapy (ACT) is the most 
promising future direction of antimalarial treatments. 
Quinine was isolated from the bark of the Chinchona tree in the 19th century 
(Cowman 1997; Talisuna, Bloland, and D'Alessandro 2004). It has provided the 
backbone for much of the development of novel antimalarials since shortly after the 
First World War, as well as current usage as treatment of drug resistant malaria 
infections. It is not in widespread use as a prophylactic or therapeutic antimalarial 
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because of severe side effects of intravascular haemolysis and acute renal failure; 
colloquially called 'black water fever' 
Shortly before the Second World War, breakthroughs were made in the manufacture 
of synthetic quinine analogues known as the 4-aminoquinolones. Of the four 
discovered to have antimalarial activity, chloroquine and amodiaquine were the two 
most useful, having the least contraindications, although amodiaquine is not 
recommended for prophylactic use due to adverse reactions (Cowman 1997). 
Use of the highly schizonticidal compound chloroquine as a drug of choice for 
malaria treatment began in the mid 1940s and it was readily adopted due to its cheap 
manufacture and minimal side effects. The other great benefit of chloroquine is its 
antipyretic activity, as reducing fevers quickly aids the perception of a curative effect 
of the drug whereas other antimalarials that do not have antipyretic action, such as 
sulphadoxine pyrimethamine, the perceived benefit is lessened. This has latterly 
become an issue as anecdotal evidence points to its continued use in populations 
where the prevalence of resistance alleles are high, because the antipyretic benefit 
remains. 
In the 1960s resistance to the 4-aminoquinolones, most importantly chloroquine, 
began to emerge with the earliest reports of chloroquine resistance coming out of 
South America in 1960 followed by Southeast Asia in 1962 reviewed by (Payne 
1989). Resistance to chloroquine then radiated out from these initial foci eventually 
reaching Africa in the 1980s (Figure 1-2). From the temporal distribution of reported 
chloroquine resistance Payne concluded that there was a dispersal of resistance 
through Southeast Asia, spreading outwards to India and eventually East Africa. 
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Figure 1-2: The geographical expansion of chloroquine resistance globally from 
1960 to 1985. Adapted from (Payne 1989) 
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1952 1954 1957 
1958 1960 1961 
1962 1963 
Figure 1-3: A time series of reported in vivo resistance after wide scale prophylactic 
use of pyrimethamine in Africa from 1952 to 1963, collated from (Peters 1970). 
Countries shaded in black represent the first report of pyrimethamine resistance in 
that country. Note the apparent spread of the resistance phenotype in East Africa 
from Sudan to Kenya to Tanzania but in West Africa the pattern is more (cont'd over) 
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disjointed. The explanation for the apparently discontinuous spread of a resistance 
phenotype in West Africa (1957) is either under-reporting or the occurrence of de 
novo mutation 
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The conclusion that spread rather than repeated de novo emergence of resistance in 
each country was later supported by molecular studies of the ancestry of chloroquine 
resistance alleles (Wootton et al. 2002), and this is reviewed below. 
As chloroquine came into widespread usage in the 1940s the chemical company I CI 
began to investigate the potential of pyrimidine derivatives as antimalarials. In 1945 
proguanil was identified as a drug with low toxicity and high activity against avian 
malaria and in the early 1950s pyrimethamine was developed. Early use of 
pyrimethamine quickly led to resistance detected within populations across Africa 
(Figure 1-3) reviewed by (Peters 1970). Notably there is an apparent spread of the 
pyrimethamine resistance phenotype in east Africa from Sudan to Kenya to Tanzania, 
similar to the spread chloroquine resistance out of south east Asia, however it also 
appears that it has emerged de novo independently at several sites, particularly in the 
disjointed distribution of pyrimethamine resistance in West Africa. 
In an attempt to prolong the useful therapeutic life of pyrimethamine, it was 
combined during the 1960s with a sulphonamide, sulphadoxine, in a drug called SP or 
Fansidar, as trademarked by Hoffman LaRoche. Sulphadoxine and Pyrimethamine 
are competitive inhibitors of enzymatic components of the folate biosynthesis 
pathway, dihydropteroate synthase (DHPS; bifunctionally combined with 
hydroxymethylpterin pyrophosphokinase, PPPK-DHPS) and dihydrofolate reductase 
(DHFR; bifunctionally combined with thymidylate synthetase, DHFR-TS) 
respectively. The two inhibitors work synergistically in disrupting folate synthesis 
and the parasites lifecycle. They are sometimes considered to be a single 
'monotherapy' drug rather than a 'combination therapy' because they target the same 
pathway (Sibley et al. 2001), the development of resistance to one of the drugs 
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reversing the synergy. The first reported national use of SP in southeast Africa began 
in Tanzania in 1982 when it was introduced as second-line treatment for use in cases 
of chloroquine failure. As early as 1984 it was the policy of the Muheza district 
hospital to use SP as first line antimalarial (Mutabingwa et al. 2001), although it did 
not become first line antimalarial throughout Tanzania as national policy until 2001. 
KwaZulu Natal in South Africa followed shortly after Muheza, changing policy from 
chloroquine usage to SP in 1988. The first country in Africa to begin using SP as 
first line treatment was Malawi, in 1993. Four years later Kenya, South Africa 
(following KwaZulu Natal) and Botswana followed Malawi in adopting SP as first 
line antimalarial (Bloland et al. 1993; Bloland et al. 1998). 
Resistance to SP was relatively quick to develop, although slower than to 
pyrimethamine alone. The earliest reports of emerging SP resistance in Africa were 
from Muheza district in Tanzania during 1994 and 1995 (Ronn et a1. 1996; Trigg et 
al. 1997). Studies from the region around Muheza reported that SP was highly 
effective during the late 1980s but resistance was present in Magoda village near 
Muheza in 1994 (Ronn et a1. 1996). It was subsequently reported in villages in the 
surrounding area (Jelinek et al. 1997; Trigg et al. 1997; Jelinek et al. 1998). 
b Mechanism of resistance to Sulphadoxine Pyrimethamine 
The mechanism of resistance to sulphadoxine and pyrimethamine was identified 
through association in vitro with a series of substitutions within the active site of the 
target enzymes of the folate biosynthesis pathway, dihydropteroate synthase (DHPS) 
(Brooks et al. 1994; Triglia and Cowman 1994) and dihydrofolate reductase (DHFR) 
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(Cowman et al. 1988; Peterson, Walliker, and Wellems 1988; Snewin et al. 1989) 
respectively. This was demonstrated through laboratory based in vitro sensitivity 
tests and transfection experiments on DHFR (Zolg et al. 1989; Wu, Kirkman, and 
Wellems 1996) and DHPS (Triglia et al. 1997; Wang et al. 1997b; Triglia et al. 
1998). A Ser to Asn substitution at codon 108 of DHFR decreases sensitivity to 
pyrimethamine by a 100 fold (Wu, Kirkman, and Well ems 1996). Additional 
substitutions at codons 51 (N51I), 59 (C59R), and 164 (I164L) progressively increase 
levels of resistance to pyrimethamine (Hyde 1990; Wu, Kirkman, and Well ems 
1996). Isolates containing all four substitutions have been found in South America 
and Southeast Asia but have yet to have been reported in field studies in Africa 
(Wang et al. 1997a; Mutabingwa et al. 2001; Kublin et al. 2002). At DHPS 14 
substitutions at five sites have been characterised world wide of which six have been 
recorded in Africa. The A4370 and K540E mutations are the most frequently 
reported in Africa (Wang et al. 1997a; Wang et al. 1997b; Eberl et al. 2001). 
The role of the point mutations at each locus in conferring resistance to SP in vivo 
has been inferred from studies showing predictive association of particular mutations 
with treatment failure (Omar, Adagu, and Warhurst 2001; Kublin et al. 2002), and 
from over-representation of mutations in recrudescent infections following treatment 
failure (Edoh et al. 1997; Jelinek et al. 1997; Khan et al. 1997; Basco, Tahar, and 
Ringwald 1998; Cortese and Plowe 1998; Curtis, Duraisingh, and Warhurst 1998; 
Jelinek et al. 1999a; Jelinek et al. 1999b; Basco et al. 2000; Doumbo et al. 2000; 
Nzila et al. 2000a). 
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c Folate salvage and dhps enzyme 
The importance of sulphadoxine in killing parasites in vivo has been under some 
doubt, because of the ability of the reported parasite to source folate externally 
(Sibley et al. 2001). Different parasite lines show differing abilities to use exogenous 
folate and some grow almost normally in very high concentrations of sulphadoxine in 
vitro,ind icating that dhps is non essential in the biosynthesis of folate (Wang et al. 
1997b; Wang et al. 1999). The ability of parasites to salvage folate from the host has 
been postulated as the explanation of why in the majority of populations where SP 
resistance occurs, resistance alleles at dhfr are found in higher frequencies than at 
dhps. 
Genetic analysis of folate salvage in P. Jalciparum was performed on the genetic 
cross between a sulphadoxine sensitive parasite strain, Hb3, and a sulphadoxine 
resistant strain, Dd2. It was found that there was complete linkage of the folate 
utilisation phenotype with a 48.6kb region around dhfr on chromosome 4 (Wang et al. 
2004a). Of the 7 putative open reading frames in this region, the strongest candidate 
for the folate salvage phenotype was dhfr. Low level folate reductase activity has 
been detected at dhfr of other systems such as chickens, bacteria and mammals, and it 
is plausible that this extends to P. Jalciparum (Wang et al. 2004a). It is argued, but 
not shown, that different combinations of mutations at dhfi- may affect the ability of a 
parasite to utilise exogenous folate, as it is speculated that as Hb3, which displays 
little folate utilisation effect, is a single S 1 08N mutant, and that the presence of three 
mutations (N51I+C59R+S108N) at dhfr of parasite line Dd2 explains its highly 
efficient folate utilisation effect phenotype (Wang et al. 2004a). 
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In contradiction to the assertion that dhps is non essential, recent transfection studies 
have shown that parasites with truncated forms of dhps are not viable (Wang et al. 
2004b). It was shown that DHPS activity above a low yet critical level is essential for 
viable parasites, regardless of the availability of salvageable folate. Earlier studies 
had assumed that high concentrations of sulphadoxine were completely inhibiting all 
dhps activity with negligible effect on parasite viability because of the folate salvage 
effect. The authors speculate that this contradiction is resolved by considering that 
dhps may be active in more than one compartment in the cell, in which one 
compartment is perhaps less susceptible to sulphadoxine influx (Wang et al. 2004b). 
Analysis of dhps mutant alleles in field populations of P. falciparum have shown that 
positive selection is operating on dhps A437G+K540E double mutant resistance 
alleles during a period of SP firstline use in South African populations (Roper et al. 
2003). 
d Evolution and emergence ofSP resistance 
Compared to chloroquine resistance, SP resistance developed relatively quickly. This 
is thought to be due to the long half life of the drug in the body of treated people, 
wherein a long tail of sub inhibitory plasma concentrations can select for allelic forms 
of the enzymes that do not survive full therapeutic doses, but are mutant stepping 
stones to fully drug insensitive forms of the enzymes (Hastings, Watkins, and White 
2002). For example N51I+S108N dhfr double mutant allele can only survive plasma 
concentrations found in the body 5-7 days after initial dosing with pyrimethamine, 
whereas the sensitive form of the enzyme is inhibited by pyrimethamine 
concentrations present in the plasma for more than 52 days after the initial dosing 
(Watkins et al. 1997). The dhfr N51I+C59R+S 1 08N triple mutant is thought to be of 
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borderline sensitivity to the initial high concentrations of pyrimethamine in the blood 
plasma (Watkins et al. 1997; Hastings, Watkins, and White 2002). 
In addition to the long half life of the drug, the mechanism of resistance to SP is 
simple when compared to chloroquine, requiring only substitutions in the drug target 
to preferentially bind the native substrate rather than the inhibitor. By contrast 
chloroquine targets the polymerisation of toxic haem from digestion of haemoglobin 
to the inert haemozoin and thus resistance occurs through the prevention of 
chloroquine from accumulating in the digestive vacuole of the red blood cell 
(Cowman 1997). 
It has long been assumed that the point mutations that confer resistance to SP occur 
regularly. Indeed, the in vitro mutation rate of codon 108 of dhfr has been calculated 
as 2.5xl0-9 mutationslDHFR gene/infection (Paget-McNicol and Saul 2001). As each 
patent infection contains between 101°_ 1012 parasites, this equates to a mutation 
occurring at d~fr during every infection. Recent studies using flanking markers 
around dhfr and dhps have thrown the ability of these de novo mutations to survive 
into doubt (reviewed below). 
III The effects of strong selection on chromosomal flanking sequence 
Strong positive selection operating on a favourable allele can reduce gene diversity at 
loci flanking the selected gene as the frequency of a favourable allele increases. The 
association of neutral flanking alleles with the selected site is termed 'hitchhiking' 
(Smith and Haigh 1974; Kaplan, Hudson, and Langley 1989). As the hitchhiking 
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flanking sequence surrounding the selected site occurs, hence the term selective 
sweep (Smith and Haigh 1974). 
a Determinant parameters of selective sweeps 
The persistence of a selective sweep in a population and the length of chromosome 
affected are dependant on both the strength of selection and the rate of recombination. 
If selection for a favourable allele is strong and it increases in frequency to fixation 
rapidly, the selective sweep will be large. Conversely if the rate of recombination is 
high the associations between selected site and flanking markers are rapidly broken 
down and the selective sweep is likely to be small. 
There are a range of sizes of selective sweeps reported. In humans the region of 
reduced diversity found around the lactate dehydrogenase extended for more than 1 
Mb (Bersaglieri et al. 2004). In organisms where there are higher rates of 
recombination, selective sweeps are contained to a smaller region of sequence 
flanking the selected site such as the extended haplotype of -88kb in a highly 
recombining region of the genome of Drosophila simulans (Quesada et al. 2003). 
Interpretation of the cause of selection giving rise to ancient selective sweeps is often 
speculative. In organisms with long generation times, such as humans, the formation 
of a selective sweep occurs over a long time, limiting the observations that can be 
made of the changes occurring in genome in real time. Retrospective data can clarify 
the nature, strength and duration of selection occurring for an allele in some cases. 
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By contrast the selective sweeps that arise due to therapeutic drug selection in malaria 
parasites occur in a defined period, selection beginning when the drug was first used 
and ending when the drug is no longer used. Changes in the frequency of resistance 
alleles can be used to directly measure the strength of selection occurring. This 
combined with a short generation time provides an opportunity to observe the effects 
of selection on a genome with precision over a precisely defined period of time. 
b Drug resistance associated selective sweeps in malaria: Chloroquine 
resistance 
The first of the drug resistance related selective sweeps to be identified was in a 
sample of chloroquine resistant parasites sampled from Africa, southeast Asia, South 
America and Papua New Guinea (Wootton et al. 2002). Although the genetic basis 
for chloroquine resistance is thought to be multigenic, the key determinant is thought 
to be Plcrt on chromosome 7 (Sidhu, Verdier-Pinard, and Fidock 2002). Wootton et 
al took samples of chloroquine resistant and sensitive parasites and using 342 highly 
polymorphic microsatellite markers described patterns of linkage disequilibrium over 
all 14 haploid chromosomes. Through the comparison of chloroquine resistant and 
chloroquine sensitive genomes they were able to identify regions of extensive linkage 
disequilibrium among the resistant isolates. This process identified only one locus, 
namely Plcrt on chromosome 7 which was flanked by a region of>200kb of reduced 
allelic diversity. 
Four chloroquine resistance founding events were identified (Wootton et al. 2002). 
The Pfcrt allele found in high frequencies in both Asian and African chloroquine 
resistant populations, shared the same ancestry. A further three lineages were 
41 
A Population Genetic Analysis of Anti fol ate Resistance in Plasmodiumfalciparum in southeast Africa 
described in two locations in South America and one in Papua New Guinea, in each 
case the Plcrt allele present had arisen only once and was of distinct ancestry to 
alleles sampled at other sites (Wootton et al. 2002). The transcontinental spread of 
the chloroquine resistance allele across Asia and the African continent is consistent 
with the history of chloroquine resistance and its spread out of southeast Asia into 
neighbouring countries (Payne 1989) (Figure 1-2). It is a matter for speculation 
where, when and how many times the allele came to enter the African parasite 
population. 
The key conclusion from this work is that the widespread occurrence of chloroquine 
resistance is not due to numerous de novo mutation events, but rather due to the 
expansion of a limited number of monophyletic resistance lineages. 
c Drug resistance selective sweeps in malaria: SP resistance 
Genetic mapping of resistance traits in mixed samples from many global locations 
can be confounded by admixture. It is therefore preferable to limit detection of 
linkage disequilibrium to samples taken from a single population, where the risks of 
admixture linkage are much reduced. There have been three studies describing the 
ancestry of pyrimethamine resistance, but as opposed to the chloroquine study, these 
were performed in a continent specific manner. 
a.South America 
Analysis of dhfr and dhps alleles and closely linked microsatellite loci, one in an 
intron within dhps and another within the 5' UTR of dhfi',showed strong association 
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of flanking alleles with each of the resistance alleles (Cortese et al. 2002). However, 
matching polymorphism at four micro satellite loci not physically linked to either dhps 
or dhfr,wa s also found and there was linkage disequilibrium between resistance 
alleles at dhfr,dhps ,Pfert and pfmdr 1. The linkage disequilibrium between these 
four resistance loci indicates that recombination between drug resistant parasites and 
drug sensitive parasites is very rare, either due to low transmission or assortative 
mating enforced by intense selection pressure. In populations where transmission is 
low, diversity at neutral loci is generally low, reflecting the low recombination rate. 
Thus descriptions of the full extent of a selective sweep around anyone of the 
resistance loci would be impossible. 
b. Southeast Afriea 
Chronologically the second published report of evidence of a selective sweep around 
SP resistance loci was in populations in southeast Africa. This description was of a 
region encompassing 3 microsatellites within 8kb of dhps on chromosome 8 and 3 
microsatellites within 5kb of dhfr on chromosome 4 (Roper et al. 2003). In South 
Africa and Tanzania we found three separate origins of parasites carrying two 
mutations at dhfr, but just a single origin of parasites carrying the triple mutant 
(N51I+C59R+S 1 08N) dhfr alleles. Microsatellite flanking markers were tightly 
associated with each dhfr resistance allele containing 2 or more mutations and the 
association of different flanking markers with different dhfr resistance alleles 
demonstrates that each has an independent origin (Roper et al. 2003). At dhps the 
double A437G+K540E mutant allele was identified as being monophyletic in South 
Africa and northern Tanzania. The work presented in this thesis extends this work 
describing the full extent of the selective sweeps around these two SP resistance loci 
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in southeast Africa. Here the P. falciparum population is one of the most diverse 
populations with both extremes of global recombination rates. 
c. Southeast Asia 
The full extent of a selective sweep around dhfr on chromosome 4 has been described 
in southeast Asian pyrimethamine resistant parasites collected from clinics on the 
Thailand - Myanmar border. It was described as a region of 12kb of strongly 
reduced gene diversity within a wider valley extending from 58kb upstream to over 
40kb downstream (Nair et al. 2003). The significance of the reduction of 
microsatellite variation within the -100kb region around dhfr was determined by 
comparison of chromosomes carrying the resistance alleles to a deterministic 
hitchhiking model, as sensitive chromosomes were absent in the region (Nair et al. 
2003). 
There was a diversity of resistant alleles at dhfr with mutations at codons 51,59, 108 
and 164. Importantly all alleles carrying 2-4 mutations had identical or very similar 
flanking microsatellites indicating a single ancestral origin. The selective sweep is 
effectively shared between multiple alleles. Selection was not concurrent with the 
time period that the samples were taken (Nosten et al. 2000). Since the cessation of 
drug pressure in the early 1980s, the selective sweep has survived despite 
recombination. The size of this selective sweep around dhfr was smaller than that 
described around Pfcrt. Factors which may explain this are the global sampling 
strategy for the Pfcrt analysis and the age of the dhjiA sweep in Asia. With regard to a 
description of a selective sweep around Southeast Asian sulphadoxine resistant dhps 
alleles, this work is ongoing (T.J.C.Anderson, personal communication). 
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d The importance of dispersal in resistance 
Numerous models describing the evolution of antimalarial drug resistance have made 
the assumption that one mutation should arise de novo per infection. It is clear from 
the above descriptions of the ancestry of SP resistance alleles in South America, Asia 
and Africa, that contrary to expectations highly resistant dhfi~ and dhps alleles arise 
very rarely indeed (Cortese et al. 2002; Nair et al. 2003; Roper et al. 2003). 
Comparing the flanking haplotype at 6 markers over a 30kb region around the d~fr 
triple mutant resistance alleles from Africa and dhfr resistance alleles from southeast 
Asia, it was shown that the triple mutant allele from southeast Asia had been 
introduced into Africa and has subsequently introgressed into the population over 
considerable distances (>4000km) (Roper et al. 2003; Roper et al. 2004). The spread 
of the dhfi~ triple mutant resistance allele from southeast Asia to Africa echoes the 
spread of the chloroquine resistance Pfcrt allele between the two populations 
(Wootton et al. 2002). This is a strong indication that the spread of resistance alleles 
is a more important factor in determining the useful therapeutic life of an antimalarial, 
rather than the de novo mutation rate (Hastings 2004). The differences seen between 
sweeps around genes such as dhfr and Pfcrt and the remarkable effect of 
epidemiological context such as in South America or southeast Asia means that 
further research is needed to explore the African situation. 
IV Thesis Outline 
Chapter 2: We describe a high throughput sequence specific oligonucleotide probing 
(SSOP) dot blot methodology for detection of point mutations at dhfi~ and dhps in 
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field collections of blood from P. Jalciparum infected people. The occurrence of 
single genotype infections allowed us to infer allelic haplotypes consisting of 
different combinations of point mutations present in three northern Tanzania 
populations. We compared the level of resistance between sites by measuring the 
frequency of these allelic haplotypes in each population and made inferences about 
the recent history of SP selection based on allele frequencies and linkage 
disequilibrium between dhfr and dhps resistance alleles. 
Chapter 3: We applied the SSOP-dot blot and allelic haplotype methodology to three 
populations in southeast Africa which have different histories of SP use. We found 
heterogeneity in the frequencies of resistance alleles between the three populations. 
By typing the populations at eight neutral microsatellite markers we showed that this 
heterogeneity exists in the face of strongly homogenising gene flow. In one of the 
populations, South Africa, we found evidence of epidemic expansion of genetically 
similar parasites and high degrees of inbreeding. 
Chapter 4: We describe, for the first time,the full extent of the selective sweep 
around dhfr triple mutant alleles in Africa P. Jalciparum. We compared diversity on 
resistant and sensitive chromosomes. By using triple mutant chromosomes taken 
during a longitudinal study in South Africa, we observe the effects of time on the size 
of a selective sweep. Sampling in other southeast African populations with different 
selection histories and transmission intensities we examine the impact on diversity 
around the triple mutant allele. Using a deterministic model to predict the extent of 
the selective sweep under given selection and recombination conditions we show that 
gene flow was almost certainly important in establishing an initial starting frequency 
greater than l/Ne in all these populations. 
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Chapter 5: We describe the extent of the selective sweep around a dhfr C59R+SI08N 
double mutant allele. The dhfr double mutant allele is less resistant to pyrimethamine 
than the dhfi,o triple mutant and was displaced by the triple mutant allele in South 
African populations where SP was the primary treatment for malaria (Roper et al. 
2003). We find evidence of reduced gene diversity on double mutant chromosomes 
sampled from Tanzania and South Africa. The extent of the selective sweep was 
smaller than that present on triple mutant chromosomes for the same population but 
was not as small as predicted by the deterministic model for the population specific 
selection and recombination parameters. Once again it appears that gene flow in 
determining initial starting frequencies played an important role in defining the size 
and shape of the selective sweep. 
Chapter 6: We describe the extent of the selection sweep around the dhps 
A437G+K540E double mutant allele. This allele is a more recent arrival in southeast 
Africa than resistant dhfr alleles. Chromosomes sampled from two South African 
populations, had significantly reduced gene diversity around the dhps double mutant 
allele when compared with sensitive chromosomes. The extent of the selective sweep 
Was greater than that around the dhfr triple mutant in the same sample. We discuss 
the effects of time, migration, drug use, and selection pressure on the size and shape 
of the selective sweeps around dhfr and dhps. 
Chapter 7: We draw broad conclusions relating to the effect ofSP selection of the 
genome of southeast African P. Jalciparum. 
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Chapter 2 Characterising Point Mutation Haplotypes in the Dihydrofolate 
Reductase and Dihydropteroate Synthase Genes of Plasmodium (alciparum 
I Abstract 
The genetic determinants of in vitro resistance to the two drugs individually are 
shown to be point mutations at seven sites in dihydrofolate reductase (dhfr) 
conferring resistance to pyrimethamine and five sites in dihydropteroate synthase 
(dhps) conferring resistance to sulphadoxine. Different combinations of mutations 
within each gene confer differing degrees of drug sensitivity but information about 
the haplotypic conformations of point mutations and the frequency with which they 
occur has been lacking because of the complicating effects of multiple infection. We 
developed a novel high throughput sequence specific oligonucleotide probing based 
approach to screen for and infer haplotype frequencies. We then demonstrate its 
practical use in an analysis of three P. Jalciparum populations in northern Tanzania. 
This chapter describes the method and haplotype scoring approach and illustrates its 
application in Tanzania. Screening surveys of asymptomatic infections for the 
presence of all known point mutations in dhfr and dhps genes we showed that just 
five dhfr and three dhps allelic haplotypes are present. A high frequency of both 
triple mutant dhfr and double mutant dhps mutant alleles were found in addition to 
significant inter-regional heterogeneity in allele frequency. In vivo studies have 
shown that the co-occurrence of three dhfi,o mutations and two dhps mutations in an 
infection prior to treatment are statistically predictive of treatment failure. We 
combined data for both loci to determine the frequency of two locus genotypes. The 
triple dhfrldouble dhps genotype was present in all three regions with frequencies 
ranging between 30% and 63% predicting that treatment failure rates will be high. 
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This work has been published as Pearce et al 2003 (Appendix 8). 
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II Introduction 
Sulphadoxine - Pyrimethamine (SP) has now replaced chloroquine as the first line 
curative antimalarial in much of East Africa. Resistance to Sulphadoxine and 
Pyrimethamine are associated in vitro with a series of substitutions within the active 
site of target enzymes of the folate biosynthesis pathway, dihydropteroate synthase 
(DHPS) (Brooks et al. 1994; Triglia and Cowman 1994) and dihydrofolate reductase 
(DHFR) (Cowman et al. 1988; Peterson, Walliker, and Wellems 1988; Snewin et al. 
1989) respectively, and this has been demonstrated through laboratory based in vitro 
sensitivity tests and transfection experiments on DHFR with respect to 
pyrimethamine (Zolg et al. 1989; Wu, Kirkman, and Wellems 1996) and DHPS with 
respect to sulphadoxine (Triglia et al. 1997; Wang et al. 1997b; Triglia et al. 1998). 
The sequence changes coding for substitutions that are naturally occurring worldwide 
are summarised in Table 2-1. A Ser to Asn substitution at codon 108 of DHFR 
decreases sensitivity to pyrimethamine by a 100 fold (Wu, Kirkman, and Wellems 
1996). Additional substitutions at codons 51 (N5II), 59 (C59R), and 164 (I164L) 
progressively increase levels of resistance to pyrimethamine (Hyde 1990; Wu, 
Kirkman, and Wellems 1996). Isolates containing all four substitutions have been 
found in South America and Southeast Asia but have yet to have been reported in 
Africa (Wang et al. 1997a; Mutabingwa et al. 2001; Kublin et al. 2002). At DHPS 14 
substitutions at five sites have been characterised world wide of which six have been 
recorded in Africa, with A437G and K540E mutations being the most frequently 
reported (Wang et al. 1997a; Wang et al. 1997b; Eberl et al. 2001). 
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DHFR Probes Probe Name Amino Acid Probe Seguence 
CODON 16 A* ALA CC ATA TGT GCA TG T TGT A 
S SER CCATA TGTTCA TGTTGT A 
V VAL CCATA TGTGTA TGTTGT A 
CODON50& CN* CYSASN TGG AAA TGT AAT TCC CTA 
CODON 5] CN2* CYSASN TGG AAA TGT AAC TCC eTA 
RN ARGASN TGG AAA CGT AAT TCe CTA 
RN2 ARGASN TGG AAA CGT AAC TeC CTA 
Rl ARGILE TGG AAA CGT ATT TCC CTA 
CI CYS ILE TGG AAA TGT ATT TCC eTA 
CODON 59 C* CYS AA TATTTTTGTGCAGTT A 
R ARG AA TATTTTCGTGCAGTT A 
CODON 108 N ASN A AGA ACA AAC TGG GAA AG 
S* SER A AGA ACA AGC TGG GAA AG 
T THR A AGA ACA ACC TGG GAA AG 
CODON 140 V* VAL AT GAA GAT GTT TAT ATC A 
L LEU ATGAAGATCTTTATATCA 
CODON 164 1* ILE GT TTT ATT ATA GGA GGT T 
L LEU GT TIT ATTTTA GGA GGTT 
DHPS Probes 
CODON 436 & SA* SERALA GAA TCC TCT GCT CCT TIT 
CODON 437 SG SERGLY GAA TCC TCT GGT CCT TIT 
FA PHEALA GAA TCC TTT GCT CCT ITT 
FG PHEGLY GAA TCC TTT GGT CCT TTT 
AA ALA ALA GAA TCC GCT GCT CCT TTT 
AG ALAGLY GAA TCC GCT GGT CCT TTT 
CA CYSALA GAA TCC TGT GCT CCT T TT 
CODON 540 K* LYS ACA ATG GAT AAA CTA ACA 
E GLU ACAATGGATGAACTAACA 
CODON 581 A* ALA A GOA TTT GCG AAG AAA CA 
G GLY A GOA TTT GGG AAG AAA CA 
CODON 613 A* ALA GA ITT ATT GCC CAT TGC 
T THR GA TIT ATT ACC CATTGC 
S SER GA ITT ATT TCe CAT TGC 
Table 2-1: Summary of the sites at which a SNP known to be associated with SP 
resistance occurs, and the oligonucleotide probe designed to detect it. The sequence 
in bold represents the codon within which the point mutation occurs. The asterisk 
following the Probe Name indicates the wildtype sensitive codon. Column 3 
indicates the amino acid change that occurs at the relevant codon following the point 
mutation 
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The role of the point mutations at each locus in conferring resistance to SP in vivo 
has been inferred from studies showing predictive association of particular mutations 
with treatment failure (Omar, Adagu, and Warhurst 2001; Kublin et al. 2002), and 
from over-representation of mutations in recrudescent infections after treatment 
(Edoh et al. 1997; Jelinek et al. 1997; Khan et al. 1997; Basco, Tahar, and Ringwald 
1998; Cortese and Plowe 1998; Curtis, Duraisingh, and Warhurst 1998; Jelinek et al. 
1999a; Jelinek et al. 1999b; Basco et al. 2000; Doumbo et al. 2000; Nzila et al. 
2000a). Such studies are complicated by mixed infections, although the blood stage 
parasites are haploid the co-occurrence of more than one genotype in an infection 
means that variation at multiple sites cannot be assigned to an individual parasite line 
within the infection and accordingly the predictive association with treatment 
outcome is complicated. 
To understand the natural history of the point mutations that occur at dhfr and dhps 
one needs to know how they occur in populations. In order to study the frequency of 
alleles at a population level, we have designed a PCR-SSOP high throughput 
approach for detection of known single nucleotide polymorphisms (SNP) in order to 
identify and construct haplotypes. Haplotypes are combinations of SNPs that are in 
the same gene, in the same parasite: as distinct from associations of point mutations 
that co-occur because there is a mixture of parasites of different genotypes within a 
single infection. Haplotypes are biologically meaningful since they determine the 
resistance properties of parasites that are exposed to drug at the time of treatment. 
For example a triple mutant dhfiA haplotype ofN51I+C59R+SI08N has a 1.5 - 3 fold 
higher pyrimethamine resistance in vitro than either ofN51I+S 1 08N or C59R+S 1 08N 
double mutant haplotypes (Sirawarapom et al. 1997). A mixed infection containing 
these two double mutant alleles is less resistant to pyrimethamine than an infection 
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containing the triple mutant allele despite all three mutations being present in either 
case. It is important when comparing populations, to measure the frequency of 
haplotypes, rather than prevalence of each point mutation separately, because 
haplotypes are the determinants of the drug resistance levels. 
The method we have employed involves the PCR amplification of sequence from the 
coding regions of dhfr and dhps genes, which is fixed on to membranes and probed 
with sequence specific oligonucleotide probes (SSOP) (Conway et al. 1999), 
designed to detect each of the single base pair substitutions at all positions 
summarised in Table 2-1. Figure 2-1 is an example of a pair of dot blots probed for 
the polymorphism at codon 59 of dhfr. The SSOP method has advantages for high 
throughput, while retaining the equivalent sensitivity and specificity of other methods 
used for detection of dhfr and dhps SNPs (Abdel-Muhsin et al. 2002; Ranford-
Cartwright et al. 2002). We used tetramethylammonium chloride (TMAC) to 
standardise the melting temperature (Tm) of dioxigenin labelled oligonucleotide 
probes, so enabling duplicate membranes to be probed and washed at a standard 
temperature and sequence variants at all SNP sites to be detected simultaneously. In 
addition to these improvements over other variations on SSOP-dot blotting (Abdel-
Muhsin et al. 2002), we modified the methodology described in (Conway et al. 1999) 
in the following ways: 
I.DNA extractions from bloodspots were performed in 96 well arrays in plates 
designed to take at least one ml capacity. By performing DNA extractions in 
this format, many more extractions could be performed in a shorter period of 
time removing a bottleneck to subsequent high throughput steps. 
2. The se cond modification was to switch the substrate used in the detection of 
bound probe sequence. In the original methodology the detection substrate 
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was CSPD, a chemiluminescent substrate which was used to expose the blots 
to x-ray film. The range of detection of film is limited and a strong signal can 
quickly exceed the upper limit of the sensitivity range. The length of 
exposure of the blot to the film was variable as the strength of signal, a 
function of the quantity of target sequence on the blot, varied between 
populations analysed. To eliminate this, a chemifluorescent signal was used 
instead. The substrate ECF (Enhanced Chemi-Fluorescence) is broken down 
by alkaline phosphatase and then using the Storm phosphoimager the strength 
of signal following excitation with blue laser light (nm=440) is digitised and 
quantified. The intensity of the excitatory light can be raised or lowered to 
adjust for the quantity of target sequence on the blots, thereby decreasing or 
increasing the emission over all spots to fit within the range of sensitivity of 
the Storm Phosphoimager. 
3. The final modification is a benefit of being able to quantify signal from the 
blots as a function of the maximum intensity of signal within a defined area, 
termed volume, as defined by the software Image Quant. Scoring the absence, 
presence and relative abundance of signal was previously performed by eye 
and was open to subjective bias. Quantification of signal has removed this 
subjectivity. A number ofmles for scoring were developed and are described 
below. Essentially the volume of signal for a single sample probe for one 
SNP can be compared to the other SNPs for that locus through their relative 
signal strengths. 
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Figure 2-1: Example of a pair of dot blots detecting polymorphism at codon 59 of 
dhfr. The presence or absence of point mutations and relative amounts of signal in 
each of the samples can be determined by eye or quantitation of digitised signal. 
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We chose to apply this approach to samples collected in northern Tanzania to 
evaluate the resistance status of the parasite population. The earliest reports of 
emerging SP resistance in Africa were from Muheza district in Tanzania during 1994 
and 1995 (Ronn et al. 1996; Trigg et al. 1997). SP was introduced as first line 
treatment for uncomplicated malaria in Tanzania during 2001 following 18 years of 
second line use. It is now a priority to know how widespread genetic determinants of 
SP resistance currently are in the wider regions of northern Tanzania. 
To investigate this we have carried out a population-based genetic analysis of P. 
Jalciparum ofN. Pare, S. Pare and Hai districts, which are distinct geographically. 
There has been no malaria research in these districts since 1965, until recent work 
showing relatively low levels of transmission with an estimate of the entomological 
inoculation rate (EIR) at 24 (infective bites/person/year) in Hai (Drakeley et al. 2005), 
as compared with an EIR in the range of 34-405 in the Muheza district (Ellman et al. 
1998). 
It is widely understood that people self-treat with antimalarial drugs, which can be 
freely purchased (McCombie 1996), as a consequence, a proportion of people 
attending health facilities with signs and symptoms of malaria may have had recent 
prior exposure to drug. In this study we have analysed material from community 
surveys of asymptomatic infections. This, we believe, will be less subject to bias due 
to prior drug selection and therefore representative of the parasite population at large. 
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III Methods and Materials 
a The study area and the samples: 
Plasmodium Jalciparum positive samples were collected from two separate studies 
within the same area of north east Tanzania; one was a study of infants and young 
children in Rai District and the second was a study of people up to 45yrs in age in the 
North/South Pare districts. Both studies were cross sectional malariometric surveys 
across an altitude band of550-1600m and most of the study subjects were 
asymptomatic. 
For the villages in the Rai District samples were collected in May 2001 by D. 
Chandramohan. All <5 year-old children from 16 randomly selected villages were 
invited to attend the survey clinic at a central clinic. A finger prick blood sample for 
blood slide, and filter paper blood sample was collected from <5 year-old children. 
The filter paper blood samples were air dried and stored at 4°C with desiccant. 
Bloodspots from blood film positive children were selected retrospectively for 
genotyping. 
Samples from the North and South Pare mountains were collected in November 2001 
during malariometric cross sectional surveys by C Drakeley and F Mosha. A random 
sample of 1250 individuals (250 per village) under 45 years of age were recruited and 
a finger blood sample taken into an EDT A microtainer. Filter paper blood spots were 
made with 10,.l1 of packed cells from samples of individuals found to be parasite 
positive. 
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b DNA extraction: 
DNA extraction from bloodspots on filter paper was carried out in a 96 well plate 
format. A segment of the bloodspot was first soaked in 0.5% Saponin in IxPBS 
overnight, and then washed twice in Iml IxPBS. The segment was then boiled for 8 
minutes in 100fll PCR quality water plus 50fll 20% chelex suspension in distilled 
water (PH 9.5). 
c peR amplification of dhfr and dhps: 
A 711bp fragment of dhps and a 594bp fragment of dhfr containing the polymorphic 
co dons were independently amplified by nested PCR in a 96 well plate format. PCR 
primer sequences and reaction conditions are indicated in Table 2-2. The 25 fll PCR 
reaction mix contained primers at 0.25flM final concentration, 2mM MgCh, 250flM 
of each dNTP, I x Bioline Taq Polymerase. I fll of template DNA was introduced to 
outer reactions. 1 fll of dhps outer PCR product was introduced into a 25 J.!l inner 
amplification. Aliquots of I fll of three fold diluted dhfr outer PCR product were 
introduced into a 25 fll inner amplification reaction. 
d Molecular genotyping of point mutations using SSOP 
Final round PCR products were heat denatured (95°C for 2 minutes), cooled and then 
spotted onto nylon membranes in I III volumes in a 12x8 grid. A panel of 4 PCR 
samples of known sequence representing all common sequence variants was spotted 
on every blot to act as positive/negative controls for probe specificity. Replicate blots 
were made of each array so that probing with the full panel of oligonucleotide probes 
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for that gene could be conducted simultaneously. After drying, cross-linking was 
performed with 1200 J ultraviolet light. Sequence specific 18bp oligonucleotide 
probes 3'-end labelled with dioxigenin (Roche Boehinger Mannheim, Germany) were 
each designed to compliment the known sequence polymorphisms in dhfr and dhps 
listed in Table 2-1. SNP specific hybridisation was followed by high stringency 
TMAC washes and detection of DIG labelled probes using Alkaline Phosphatase 
conjugated Anti-DIG Fab fragments (Roche Boehinger Mannheim, Germany) as 
described in (Conway et al. 1999). Visualisation was performed through the alkaline 
phosphatase catalysed breakdown of the fluorogenic substrate ECF (Amersham 
Pharmacia Biotech, UK) and scanned on the Molecular Dynamics Storm 840 
Phosphoimager (Amersham Pharmacia Biotech, UK). 
e Scoring 
We scored the presence, absence or relative abundance of the variant sequence 
polymorphism at each site separately. Images of blots probed with variant sequences 
for a single locus were transferred as .tiffiles to ImageMaster Total Lab (Amersham 
Pharmacia Biotech, UK). In the 'array analysis' subsection of the software a standard 
area of each spot was defined and the intensity of chemifluorescence in that area 
measured. Background was adjusted for by subtraction of the volume of the negative 
controls from the volume data. Thus volume of chemifluorescence for each spot was 
calculated as Volume = (MaxIntensity X SpotArea) - Background. To determine the 
threshold of detection per se the presence flagging option was employed. By this 
method the faintest spot considered present and not background was selected to set 
the flagging threshold value. 
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DHFROuter 
650bp 
Inner 
594bp 
DHPS Outer 
770bp 
Inner 
711bp 
Primer Sequence 
Ml 5' TTTATGATGGAACAAGTCTGC 3' 
M7 5' CTAGTATATACATCGCTAACA 3' 
M3b 5'TGATGGAACAAGTCTGCGACGTT 3' 
M9 5' CTGGAAAAAATACATCACAITCATATG 3' 
NI 5'GATTCTTTITCAGATGGAGG 3' 
N25'TTCCTCATGTAATTCATCTGA3' 
R2 5'AACCTAAACGTGCTGITCAA 3' 
R/5' AATTGTGTGATTTGTCCACAA 3' 
PCR reaction conditions 
94°C for 3 min 
94°C x 1 min, 52°C x 2 min, 
72°C x 1 min, 40X 
72°C for 10 min 
94°C for 3 min 
94°C x 1 min, 44°C x 2 min, 
72°C x 1 min, 4X 
94°C x 1 min, 44°C x 1 min, 
72°C x 1 min, 34X 
72°C for 10 min 
94°C for 3 min 
94°C x 1 min, 51°C x 2 min, 
72°C x 1 min, 40X 
72°C for 10 min 
As for Outer 
Table 2-2: Table of peR primer sequences and reaction conditions for the nested 
amplification of dhfr and dhps 
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To compare SNP specific probes at a single site Microsoft Excel bar charts were 
drawn comparing the volume data for each probe on every sample and the presence 
flagging result in each case. The following rules were used to determine whether a 
SNP was present or absent at each site. 
a) A SNP was considered present in a peR product when volume value with a 
particular probe is greater than background. If volume values were low, presence 
flagging provided an internal control to avoid possible biasing between probes or 
blots. 
b) Absent: All volume values below the first gridline on the chart were rejected. No 
set value can be given for this criterion as volume value comparison is relative 
and varies depending on the strength of the probe labelling and binding. 
Samples were categorised into single, majority or mixed at each site as follows: 
Samples were considered to be of mixed haplotypes if the volume value of the 
minority SNP was greater than half the volume value of the majority SNP. Samples 
were considered to be mixed but containing a majority SNP if the minority SNP was 
less than half of the majority value, but greater than the first gridline on the chart. 
Samples were considered to be single if there was only one SNP present at a site 
given the above rules. 
To combine data from all sites in a gene and construct haplotypes it was necessary to 
discard samples in which a mixture was found, but which did not contain a majority 
SNP. Thus for the purpose of generating frequency data one haplotype was scored 
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from each sample, this was of either a single or majority type, because haplotypes 
from mixed infections cannot be constructed. 
Following the same principle, for measuring the frequency of two locus genotypes a 
subset of samples in which a single or majority allelic haplotype was found at both 
dhfr and dhps was used. 
f Statistical Analysis 
Statistical analysis of population differences in haplotype frequencies (Wright's Fsr) 
(Cockerham and Weir 1984) and linkage disequilibrium were carried out using 
Arlequin software (Schneider, Roessli, and Excoffier 2000). Statistical analysis of 
contingency tables of the association ofhaplotypes within two locus combinations 
was performed using a Chi Squared test. 
IV Results and Interpretation. 
Of the 165 bloodspots that yielded PCR products, 10.3% were mixed at dhps and 
1.2% mixed at d~fr, no 'majority' haplotypes were identified. The low number of 
mixed infections was a reflection of the low level of malaria transmission in the three 
regions. On stratification of the populations ofN. Pare and S. Pare into the age 
ranges ofO-4yrs and 5-45yrs, no significant difference was found in the frequency of 
dhfr and dhps allelic haplotypes, allowing comparisons to be made between the 
samples from those sites with those from the Hai district where samples were taken 
exclusively from <5yrs. 
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U sing single genotype infections we were able to determine the point mutation 
haplotypes that were present in the three districts surveyed. The dhji~ and dhps allelic 
haplotypes present in each region are shown in Figure 2-2. Three point mutations in 
dhfi~ were found, occurring at codons 51, 59 and 108. Of the eight possible 
haplotypic conformations of these three SNPs, five were found. This represents only 
a subset of point mutations reported globally, but matches well with previous reports 
of point mutations present in single genotype infections that have been described 
elsewhere in East Africa, namely Kenya and Tanzania (Wang et al. 1997a; Nzila et al. 
2000a). Likewise, at dhps three point mutations were found and of the eight possible 
haplotypes only three were found, namely the sensitive allele, single mutant allele 
S436A and the double mutant allele A437G, K540E haplotype, which has been 
widely recorded in East Africa (Jelinek et al. 1997; Wang et al. 1997a; Jelinek et al. 
1998; Nzila et al. 2000a; Nzila et al. 2000b; Mutabingwa et al. 2001; Kublin et al. 
2002) but not so far in West Africa (PI owe et al. 1997; Wang et al. 1997a; Eberl et al. 
2001). 
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Figure 2-2: Scheme of dhfi" and dhps aIleles found in this study. Shaded blocks 
indicate the site that the constituent SNPs of each haplotype arise. Names of the 
aIleles are composed of the amino acids present at each of the sites, in consecutive 
order of the codon number, described as having a role in SP resistance 
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a Regional Variation in Population Resistance 
Allelic haplotype frequencies in the three regions differed significantly and are 
summarised in Figure 2-3. Not all alleles at dhfr and dhps were present in each of the 
districts. The sensitive dhfr allele was not present in Hai or the S. Pares, the S 1 08N 
substitution having reached fixation. The frequency of the dhfr triple mutant allele 
was high in all districts, highest in Hai (84.1 %). The N. Pare sample set had the 
lowest frequency of dhfr triple mutant allele; nevertheless it was five times greater 
than the frequency of sensitive dhfr alleles. We found no dh.fr I164L at all and 
therefore no quadruple mutant alleles (N51I + C59R + S108N + I164L). The 
frequency of the dhps double mutant allele was extremely high being greatest in Hai 
(64.2%), lowest in N. Pare (43.3%) and S. Pare was intennediate (54.5%). Unlike 
dhfr, the sensitive allele of dhps was found in all districts. Furthennore there was a 
low frequency (4%-7.4%) of the single mutant (S436A) allele in all districts. On 
calculation of the Wright's FST, the pairwise difference in haplotype frequencies at 
both loci between region is shown to be statistically significant when comparing Hai 
District with N. Pare (dhfr FST = 0.0733 P < 0.05; dhps FST = 0.0748 P < 0.05). 
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Figure 2-3: Frequency of a) dhfr alleles and b) dhps alleles found in the three 
districts of Hai, North Pare, and South Pare 
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Interestingly there was no significant difference in the remaining pairwise 
comparisons, despite the differences in haplotype frequencies between North and 
South Pares. These findings point to some difference in selection pressure between 
districts with weaker selection explaining a slower development of SP resistance in 
N. Pare. Possible causes of weaker selective pressure are a greater use of alternative 
antimalarials such as amodiaquine, or a reduced use of antimalarials per se due to 
poor access to health care facilities or raised levels of acquired immunity. The 
differences in resistance allele frequencies between the N. Pares and the remaining 
two sites have occurred in the face of presumably strong gene flow which would be 
acting to make the parasite population homogeneous. Whilst these sites are 
geographically separate they are by no means genetically isolated. A study 
identifying the ancestry of the triple mutant allele showed that the Hai district triple 
mutant was identical to the triple mutant allele found in K waZulu Natal, South 
Africa, over 4000km away. What is maintaining the differences between the study 
sites in the face of gene flow is unclear, but ongoing investigations into treatment 
seeking behaviour and over prescription by providers will aim to further illuminate 
differences in drug use between the three study populations (Swarthout, T., D. 
Chandramohan, F. Mosha, A. Bell, G. Masuki, C. Drakeley, and H. Reyburn. 
Abstr. The 3rd MIM Pan-African Malaria Conference, 2002). 
During an in vivo study in Malawi, a statistical association was found between the 
presence of all three dhfr mutations and both dhps mutations with failure to clear 
parasitaemia after SP treatment (Kublin et aI. 2002). It is probable that in many cases 
this is due to the presence of the two most highly resistant al1eles, triple dhfr and the 
double dhps - and this is supported by analysis of recrudescent infections following 
SP treatment (Kun et al. 1999). Two locus combinations were derived from 'single' 
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infections where only one haplotype was recorded at both dhfr and at dhps. The map 
in Figure 2-4 shows the spatial distribution of frequencies of two locus combinations. 
The reduction in sample size 'n' reflects the loss due to mixed infections. Here we 
directly measured the frequency of the highly resistant two locus genotype consisting 
of the ACIRNVI / SGEAA and found it to be extreme. In Hai it was 63.2%, in SPare 
50%, and in N Pare 22%. Hence there is a clear and testable prediction that SP 
treatment failure rates in these three regions will differ. 
b Selection on dhfr and dhps by SP use 
In N. Pare there was more diversity at both loci and consequently a greater diversity 
of two locus genotypes. The Wright's FST comparing the three populations at both 
loci further confirmed this difference between N. Pare and S. Pare (FST = 0.0583 
p=0.0054) and between N. Pare and Hai (FST = 0.149 p<O.OOOOl). Pair-wise 
comparison ofS. Pare and Hai district populations (FST = 0.011) showed no 
significant difference and were merged for subsequent analysis. Statistical analysis 
of observed and expected two locus combinations was performed on the population 
ofN. Pare and the combined populations ofHai District and S. Pare. We found a 
significant departure from expected in the merged Hai IS. Pare population (X2 test 
p=0.0018, 6d.f.), whereas the distribution in N. Pare was non-significant (X2 test 
p=0.835,8d.f.). Linkage disequilibrium analysis was performed on the combined 
Hai and S. Pare data set, and we found three two locus combinations to be in linkage 
disequilibrium, namely ACICNVI- SAKAA (D'=0.277, p=O.Ol), ACNRNVI-
AAKAA (D'=l.O, p<O.OOOOl) and ACIRNVI-SGEAA (D'=0.229, p=0.03l). No 
other pair of alleles was found to be in LD. 
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Figure 2-4: Map of the three districts of northern Tanzania showing the frequencies 
and distribution of dhjr/dhps two locus genotypes 
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Within populations in Africa it has been observed that dhfr mutations appear earlier 
in the development of SP resistance (Mberu et al. 2000; Nzila et al. 2000a; Sibley et 
al. 2001). Our own data suggests the same sequence of events, with resistant dhfr 
being fixed in Hai and South Pare yet sensitive dhps relatively common. The 
observed linkage disequilibrium between the ACICNVI-SAKAA two locus 
combination and the absence of significant LD between either of the dhfr double 
mutants and the dhps double mutant alleles supports the idea of an interaction, 
between dhfr and dhps in the development of resistance. 
Additionally, there was a statistically significant association between the triple dhfi-
mutant and the double dhps mutant in the combined Hai District and the South Pare 
populations. dhfr is on chromosome 4 and dhps on chromosome 8, so the fact that 
linkage disequilibrium was found between two highly resistant haplotypes at these 
unlinked loci, is indicative of the non-independence of sulphadoxine and 
pyrimethamine selection. This has been reported previously in Kenya (Omar, Adagu, 
and Warhurst 2001) and Malawi (Kublin et al. 2002). The same relationship was not 
apparent in N. Pare, consistent with the frequency of resistance alleles at both loci 
being significantly lower. Both factors imply that drug selection is weaker. This 
finding emphasises the transient nature of linkage, particularly in areas of high 
transmission intensity where recombination rapidly breaks down the linkage between 
dhfr and dhps, and argues for caution in use of 'indicator' mutations as a proxy for 
resistance genotyping. While the co-occurrence of all five mutations in an infection 
in S. Pare and Hai was in fact a reliable indicator of the presence of a quintuple 
genotype, this was not the case in N. Pare. The wide spread use of the antibiotic 
Septrin which contains trimethoprim and sulphamethoxazole to treat other infections 
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may indirectly select on dhfr and dhps resistance mutations and further complicate 
the relationship. 
c Past, present and future of Pyrimethamine and Sulphadoxine use in Northern 
Tanzania 
The three districts described here are found at between 200km and 400km northwest 
of Muheza district, a region historically associated with exceptionally high levels of 
antifolate resistance. Resistance to pyrimethamine alone was reported in 1954 in 
Mngeza in Muheza district, following mass administration of prophylactic doses of 
pyrimethamine monotherapy over a five month period during 1953 (Clyde 1954). 
Use of the SP combination began in Tanzania in 1982 when it was introduced as 
second-line treatment for use in cases of chloroquine failure and as early as 1984 it 
was the policy of the Muheza district hospital to use SP as first line antimalarial 
(Mutabingwa et al. 2001). Studies from the region report that SP was highly effective 
during the eighties but resistance was recorded in Magoda village near Muheza in 
1994 (Ronn et al. 1996) and subsequently reported in villages in the surrounding area 
(Jelinek et al. 1997; Trigg et al. 1997; Jelinek et al. 1998). The emergence of 
resistance to SP in 1994 was attributed by Ronn et al to be in part a result of the 
prophylactic intervention of weekly dapsone pyrimethamine to all children <10 years 
old. Parasitological failure rates in children 7 days post treatment with SP in Muheza 
district hospital was most recently reported to be as high as 45% (Mutabingwa et al. 
2001). 
Two explanations for the high frequency of resistance alleles in the three districts 
described here are the widespread use of SP or related drugs, and the movement of 
resistance from Muheza. However levels of resistance do not show a simple decline 
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with distance from Muheza to Hai (Fig. 2-4), and clearly local drug use is a very 
important factor. What is striking from the data presented here is the significant 
inter-population differences, and it is probable these differences have arisen from 
differing patterns of drug use in these communities. The relationships between 
populations to determine whether they are genetically distinct or homogeneous due to 
gene flow can be elucidated by analysis of marker loci such as micro satellites not 
subject to drug selection. Unfortunately these samples were of poor quality and it 
was not possible to perform this additional step. However this approach is applied in 
the next chapter. 
V Concluding Remarks 
In this chapter we have described a new approach by which to determine the 
frequency of point mutation haplotypes in P. falciparum popUlations using blood 
survey material. It allows quantitation of resistance at the population level and 
enables direct comparison of population resistance levels even when they differ 
widely in the proportion of multiply infected individuals. The issue of multiple 
infections can be problematic when genotyping blood stage parasites, because it 
causes haplotypic conformations of point mutations to be obscured and rare mutations 
to be over-sampled. By recording one genotype per infection and discounting 
minority genotypes we avoid over-sampling of rare genotypes, and estimate the 
frequency of mutation haplotypes in the population in a measure which is 
standardised over all populations of different transmission intensity. With this 
consideration in mind, the SSOP method employed is designed for high throughput 
screening of blood stage infections, to derive haplotype frequencies from survey 
material. 
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Modifications that we made to the original methodology have improved and 
increased the throughput of the technique. A further modification made after this 
work was performed was the use of pre-labelled probe sequences. These are labelled 
and then purified which ensures that only labelled probe sequence is present. The 
quantity of labelled probe used in the experiment is then standardised between 
probes, whereas previously unlabelled probe was also present causing variation in the 
intensity of replicate blots screened with the different probes. 
In the published work describing these findings (Pearce et aI, 2003; Appendix 8) we 
recommended that in vivo studies be performed to confirm that the high frequency of 
resistance alleles is indicative of treatment failure as would be predicted by studies 
elsewhere in Africa. Surprisingly,in vivo studies of samples taken at a nearby site in 
Moshi, northern Tanzania (Alifrangis et al. 2005), identified a rate of only 20% 
parasitological 14 - 28 day treatment failure despite a frequency of 56% for the dhfr 
triple mutant - dhps double mutant combination, similar to that reported for the Hai 
district here (63.2%) (C. Drakeley, Personal Communication). Work is currently 
underway to establish the role of clinical immunity in reconciling this difference 
between expected and observed treatment failure rates. 
We have shown that heterogeneity exists in the frequencies of resistance alleles 
between populations in northern Tanzania. We postulate that this heterogeneity 
exists despite extensive gene flow and we address this question in the following 
chapter. 
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Chapter 3 Population Differentiation between Three Plasmodium falciparum 
Populations in Southeast Africa at Positively Selected and Selectively Neutral 
Markers 
I Abstract 
We identify significant heterogeneity in the frequency of resistance alleles typed at 
sulphadoxine/pyrimethamine resistance genes, dihydrofolate reductase and 
dihydropteroate synthetase, in three southeast African populations; Tanzania, 
Mozambique and South Africa. There are only a small number of alleles present in 
each of the populations, five at dhfr and three at dhps and these were found 
throughout the region. Within countries we observed significant differences in the 
allele frequencies between sites, particularly in the frequency of the two most highly 
resistant alleles; the dhfr N5II+C59R+S 1 08N triple mutant and the dhps 
A437G+K540E double mutant. The differences between countries in resistance allele 
frequencies broadly conforms to our expectations given the known selection histories, 
with the exception of very high resistance allele frequencies in the supposedly drug 
naive Mozambican populations. However, using linkage disequilibrium between the 
dhfiA triple mutant and dhps double mutant allele as a proxy for ongoing selection, 
casts doubt on whether selection was actually occurring in Mozambique at the time of 
sampling. Gene flow homogenises allele frequencies across a region and may explain 
the high frequencies of resistance alleles in Mozambique. Using eight selectively 
neutral microsatellites markers we show that there is no population differentiation in 
the region despite samples being taken over a 1250mile long area. In South Africa 
we identify a number of epidemic expansions, particularly in the population of 
Steenbok that may be the cause or a result of the notably high frequencies of the dhfr 
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triple mutant and the dhps double mutant allele compared to the other South African 
populations. 
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II Introduction 
Gene flow is a homogenising force acting to equilibrate allele frequencies between 
populations. Positive directional selection, such as operating during selection of drug 
resistance alleles, acts to increase to fixation the frequency of a favourable allele in a 
population, and if selection is absent in a second population this generates 
heterogeneity in allele frequencies between them. It is known that in southeast Africa 
each of the SP resistance alleles comprised of two or more mutations have arisen 
once de novo (with the exception of the dhfr double mutant N5II+SI08N allele, 
which has two separate ancestries) and have spread widely (Roper et al 2003); in the 
case of the dhji" triple mutant (N5II+C59R+SI08N) allele the spread includes 
migration from a single origin in southeast Asia (Roper et al 2004). Clearly this 
shows that whilst within populations drug selection is increasing the frequency of the 
resistance alleles, gene flow is moving these alleles between populations. 
The importance of gene flow and understanding its extent is two fold. Firstly, the 
spread of drug resistance is a public health policy concern. If the parasite populations 
in southeast Africa are freely mixing with no regard for 'nationality' and border 
control, decisions taken by policy makers on which antimalarial to use would be best 
made on an international basis rather than nationally. If the parasite population in the 
region is panmictic, using an antimalarial already abandoned by your national 
neighbour will become a false economy as the useful therapeutic life of the drug will 
arguably be short. However, if the parasite populations are more discrete and not 
panmictic, the spread of resistance may be prevented by well applied control 
measures. By looking at the extent of gene flow in south east Africa we can assess 
how easily the resistance alleles have become disseminated. 
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The second reason to detennine the extent of gene flow between populations will 
become more apparent in subsequent chapters where we describe the effects of 
selection on the chromosome sequence flanking the selected site. Whether the 
parasite population in southeast Africa is panmictic or not has implications for this 
and will be discussed where appropriate. 
In this chapter we address the question of how much gene flow occurs between three 
countries in southeast Africa with different drug selection histories. In South Africa 
malaria is a problem limited to north of the country and different provinces have 
taken different approaches to antimalarial treatment policy. The northeast province of 
Mpumalanga, where the South African samples were taken, began using SP as first 
line treatment of P. falciparum malaria infections in 1997. 
The samples taken in Tanzania are from the south of the country, specifically from 
three 'census' regions: Morogoro, Rufigi and KilomberolUlanga. Nationally 
Tanzania only began using SP in 2001 following 18 years of second line usage, 
although as outlined in the previous chapter there is a longer selection history in the 
northern regions. 
Finally, at the time of sampling in 2001, Mozambique had not officially adopted SP 
as first or second line antimalarial. The only recorded exception is the brief use of SP 
as first line antimalarial in Maputo after flooding in the region in 2000 (Alifrangis et 
al. 2003). The samples taken in Mozambique were specifically from populations in 
the south of the country close to the South Africa border. As would be expected, this 
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heterogeneity between populations in drug selection history has generated significant 
differences in the frequencies of the SP resistance alleles between the countries. 
The geographical locations of the sample collection sites in these three countries 
allows us to observe gene flow over short distances (South Africa to Mozambique 
-75 miles) and over considerably larger distances (South Africa to Tanzania> 1250 
miles). It is possible that population differentiation may correlate with distance as we 
would expect if parasite populations were discrete. 
In order to perform the population differentiation we have genotyped unlinked 
selectively neutral microsatellite markers in a cross-section of the parasite 
populations. Microsatellites are short polymorphic tandem repeat sequences that 
change in size through strand slippage increasing or decreasing the number of repeats 
(Kruglyak et aI. 1998). As they can be considered selectively neutral, microsatellites 
are informative of the background level of genetic drift as it is assumed that any 
difference between two populations in the distributions of alleles is not due to 
selection acting on the locus. 
Microsatellite loci in P. falciparum sampled from Africa tend to be highly 
polymorphic in the population (Anderson et aI. 1999; Anderson et aI. 2000a). Using 
simple assumption free parameters such as Wrights fixation index (FST) to determine 
population differentiation can result in an underestimation if applied to highly 
polymorphic markers (Hedrick 1999). F ST is a descriptor of the proportion of genetic 
variation found between populations proportional to that within each population, such 
that a low FST value indicates little difference in allele frequencies between the two 
populations. F ST are calculated from the expected heterozygosity in the total 
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population and the weighted expected heterozygosity in the sUbpopulations. 
Therefore, if diversity is high these two values can approach unity, regardless of 
whether the populations have overlapping or non-overlapping sets of alleles (Paetkau 
et aI. 1997; Hedrick 1999). To minimise the effects of any underestimation of 
population differentiation, we include a test of individual assignment that takes allele 
identity into account in addition to allele frequency distributions (Pritchard, Stephens, 
and Donnelly 2000). 
III Methods and Materials 
a Sample material 
Details of the sample used in this study are given in Table 3-1. DNA extraction from 
bloodspots on filter paper was carried out in a 96 well plate format. A segment of the 
bloodspot was first soaked in 0.5% Saponin in Ix phosphate buffered saline (PBS) 
overnight, and then washed twice in 1ml 1xPBS. The segment was then boiled for 8 
minutes in 100111 peR quality water plus 50111 20% chelex suspension in distilled 
water (PH 9.5). 
b dhfr and dhps point mutation detection 
We typed the point mutations that encode amino acid substitutions at codons 51, 59, 
108, 164 of dhji" and codons 436/437, 540, 581 and 613 of dhps using the sequence 
specific oligonucleotide probing dot blotting technique described in (Pearce et al. 
2003) and in the previous section. The point mutations at dhfr and dhps in samples 
taken from Mozambique and South Africa were typed by A. Keyser. 
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Country District/Province Date 
South Africa Mpumalanga 2001 
Tanzania Ki 10m bero/Ulanga 2000 
(n=549)* 
Rufiji 
(n=583)* 
Morogoro 
(n=245)* 
Mozambiqu Maputo 2001 
e Southeast (n= 
105) 
Southwest (n= 
128) 
Peri urban (n= 
182) 
Collection 
method 
Passive case 
detection at 3 
clinics during the 
transmission 
season. 
Steenbok(n= 103) 
Komatipoort 
(n=153) 
Mangweni 
(n=92) 
Household 
Surveys 
Active detection 
Community 
surveys in: 
I.Catuane and 
Doane (E. 
Mozambique) 
2. Bela Vista and 
Salamanga (W. 
Mozambique) 
Two peri urban 
sites Matola Rio 
and Belulane 
were included in 
the resistance 
allele typing. 
Study Information 
Southeast African Combination 
Antimalarial Therapy (SEACA T). 
htt[2:/lwww.malaria.org.za/Scacatl 
Karen Barnes (Uni. of Cape Town) 
Brian Sharp (Medical Research Council 
(MRC), Durban) 
Molecular technologist 
Alana Keyser (MRC, Durban) 
Interdisciplinary Monitoring Project for 
Antimalarial Combination Therapy in 
Tanzania (lMPACT-Tz). 
htt[2:I/www.111 i mcom .org.lI k/i '~lkarali 111(2 
acLhtm 
Salim Abdulla~ Hassan Mshinda, 
(lfakara Health Research and 
Development Centre (IHRDC» 
Patrick Kachur, Peter Bloland (Center 
for Disease Control, Atlanta.) 
Molecular technologist: 
Allen Malisa (IHRDC, & later Sokoine 
University) 
LSDI 
Lubombo Spatial Development 
Initiative 
htt[2:llwww. mal ari a.org .za/l sd i/hol11c. ht 
ml 
Brian Sharp(MRC, Durban) 
Molecular technologist: 
Alana Keyser (MRC Durban 
Table 3-1: Details of samples used in this study. *Number of samples with complete 
haplotype at either dhfr or dhps 
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The Tanzanian samples were typed by A. Malisa. All typing was performed under 
the supervision of the author. The significance and association of point mutations at 
these codons with treatment failure are reviewed in previous chapters of this thesis. 
However, by way of revision, in Africa the highest form of pyrimethamine resistance 
found common place in field populations is a combination of three substitutions in 
dhfr at codons N5II+C59R+S 1 08N (Wang et al. 1997a; Pearce et al. 2003; Roper et 
al. 2003; Alifrangis et al. 2005), referred to in this thesis as the triple mutant allele. 
Combinations of two point mutations occurring at codon 108 with an additional 
mutation either at codon 51 or 59, are both referred to here as double mutant alleles. 
At dhps the key sulphadoxine resistance allele is composed of substitutions at co dons 
A437G and K540E (Omar, Adagu, and Warhurst 2001; Alifrangis et al. 2003; Pearce 
et al. 2003; Roper et al. 2003). A combination of three mutations at dhfr and two at 
dhps is statistically associated with treatment failure (Kublin et al. 2002). 
c Microsatellite peR amplifications 
The microsatellites ARAII, G377, PfPk2, Poly-a, TAI09, TA42, TA87 and TAI02, 
chosen for use in this study are well described (Anderson et al. 1999; Anderson et al. 
2000b) and have been used before in descriptive studies of P. falciparum population 
structure (Anderson et al. 2000a). They are dispersed throughout the genome and 
therefore will not be biased by linkage to a selective event on anyone chromosome. 
The primer sequences for the microsatellites are described by (Anderson et al. 1999). 
The microsatellites were amplified in a semi-nested manner. The primary reaction 
comprised: 1111 template, 3.0mmol/l Mg2+, 0.75pmollL primer and 1 unit of Taq 
polymerase. The reaction was cycled as follows: 2 min at 94°C and then 25 repeated 
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cycles of 30s at 94°C, 30s at 42°C 30s 40°C and 40~ at 65°C followed by 2 min at 
A third fluorescently labelled primer (Applied Biosystems, Warrington, Cheshire, 
UK) is incorporated into a second round PCR of total volume 11 J..lI containing 
2.5mmolll Mg2+, 2pmolIL primer, 1 unit ofTaq polymerase and 1 J..lI of outer nest 
template. Cycling conditions were: 2min 94°C then 25 cycles of 20s at 94°C 20s at 
45°C 30s at 65°C final step of2 min at 65°C. 
Samples were diluted 1 in 100 and run with LIZ-SOO size standard on an ABi 3730 
genetic analyzer (Applied Biosystems, Warrington, Cheshire, UK). Fragments were 
sized using the GeneMapper software (Applied Biosystems, Warrington, Cheshire, 
UK). In the event of a two or more alleles being detected, the majority allele was 
used if the minority peaks were less than SO% of the height of the majority. Ifpeaks 
were of equivalent height, the representative allele was allocated at random. The 
microsatellite typing was performed by the author with the assistance of H. Pota. 
d Statistics 
Gene diversity values were calculated as He = [nJ (n-l)][I-LP?] where n is the 
number of samples and Pi is the frequency of the ith allele. The variance of the gene 
diversity was calculated using Nei and Roychoudhury's formula (Nei and 
Roychoudhury 1974): 
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Wright fixation index (FST) values were calculated in Arlequin (Schneider, Roessli, 
and Excoffier 2000) and PowerMarker (Liu and Muse 2004). The number of 
migrants per pairwise comparison calculated using the frequencies of rare alleles 
(Barton and Slatkin 1986) was performed using Genepop (Raymond and Rousset 
1995). The software "Structure" was used in the assignment of individuals to 
populations in a probabilistic manner (Pritchard, Stephens, and Donnelly 2000). 
Priors were set as default for the 'admixture' model and bumin and run length were 
105 and 106 Markov chain Monte Carlo (MCMC) iterations respectively. Further 
details of the software are found below. 
The index of association was calculated using the software LIAN (Haubold and 
Hudson 2000). The distance measure 1-Ps (Bowcock et al. 1994) was calculated 
using the software Microsat (Minch et al. 1997). Neighbour joining trees were 
calculated using the PHYLIP v3.6 (Felsenstein 2004) package "neighbor". 
Consensus trees were constructed using "con sense" (Felsenstein 2004) and visualised 
using the software Tree View (Page 1996). 
IV Results and Interpretation 
a Frequency of dhfi" and dhps alleles in each country 
The point mutations present at dhfiA and dhps in parasites sampled from three 
southeast African countries were typed in each of the three countries using the 
sequence specific oligonucleotide probing (SSOP) dot blot hybridisation method as 
described by (Pearce et al. 2003) and in chapter 2 of this thesis. 
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dhfr dhps 
Rare Rare 
Locality CNCS CNCN CNRN CICN CIRN alleles* N= SAKAA AAKAA SGEAA alleles* N= 
Matola Rio 0.08 0.06 0.16 0.02 0.68 0.00 50 0.70 0.04 0.26 0.00 66 
Beluluane 0.07 0.03 0.17 0.03 0.70 0.00 59 0.68 0.06 0.25 0.01 68 
BelaVista 0.14 0.00 0.17 0.00 0.69 0.00 36 0.79 0.00 0.21 0.00 42 
Mozambique Salamanga 0.12 0.00 0.37 0.05 0.46 0.00 43 0.75 0.04 0.19 0.02 47 
Catuane 0.15 0.02 0.22 0.07 0.54 0.00 46 0.80 0.04 0.14 0.02 50 
Boane 0.29 0.00 0.19 0.00 0.52 0.00 31 0.75 0.00 0.22 0.03 32 
Average 0.14 0.02 0.21 0.03 0.60 0.00 0.75 0.03 0.21 0.01 
Steenbok 0.19 0.02 0.16 0.00 0.63 0.00 83 0.73 0.03 0.22 0.01 98 
Mpumalanga Koomatipoort 0.28 0.02 0.11 0.06 0.53 0.00 104 0.90 0.07 0.02 0.02 122 
Mangweni 0.35 0.03 0.16 0.06 0.41 0.00 69 0.85 0.08 0.07 0.00 89 
Avera~e 0.27 0.02 0.14 0.04 0.52 0.00 0.83 0.06 0.10 0.01 
Morogoro 0.43 0.00 0.16 0.09 0.32 0.01 180 0.56 0.31 0.10 0.03 163 
Tanzania Rufigi 0.36 0.01 0.12 0.11 0.38 0.02 455 0.74 0.15 0.07 0.03 413 
Ulanga 0.51 0.02 0.07 0.11 0.28 0.01 376 0.68 0.18 0.12 0.02 363 
Average 0.43 0.01 0.12 0.10 0.32 0.01 0.66 0.22 0.10 0.03 
--------------------- -- -- - - - - --- - -
Table 3-2: Allele frequencies of the most common dhfr and dhps haplotypes. *Rare alleles \vere defined as having a frequency of less 
than 50/0 in the population and were pooled 
> 
~ 
-g 
[ 
0" 
::l 
o 
t"1> 
::l 
t"1> 
e" o 
~ 
'~ 
;n" 
o 
...... 
~ §i 
~ 
~ 
CI> 
;n" § 
o 
t"1> 
5" 
'"tl 
tl ~ 
c 
~ 
:= 
~ 
;:)' 
i:j" 
~ 
5" 
CI> 
o 
c: 
So 
t"1> 
~ 
> ~ 
CS" 
f>l 
Population Differentiation between Three Plasmodiumfalciparum Populations in Southeast Africa at Positively Selected and 
Selectively Neutral Markers 
As observed in the northern Tanzania study we found a limited number of haplotypes 
at the selected loci, namely a total of 5 common (>5% frequency) haplotypes at dhfi-
and 3 at dhps. The frequencies of each haplotype at each site in every country are 
given in Table 3-2. We detected a number of rare alleles «5% frequency in 
population), and these are summed together in the table. We observed most rare 
alleles in the country with the largest sample size, Tanzania where a further 2 
haplotypes of 1 or 2 point mutations at dhfr (C59R; N5II+C59R) and a further 6 
haplotypes of 1 or 2 point mutations at dhps were seen (S436F; S436C; A437G; 
K540E; A581 G; S436F+K540E). In both Mozambique and South Africa there were 
no additional haplotypes at dhfr and only a further 2 at dhps (A437G; S436A+A437G 
in Mozambique S346F; S436A + A437G + K540E in South Africa). We did not 
detect a point mutation at codon 164 of dhfr and thus the most highly pyrimethamine 
resistant mutant, comprised of four substitutions, was not observed in any of the three 
countries. 
b Between country differentiation through allele frequencies at dhfr and dhps 
Of the common dhfr and dhps haplotypes, the frequencies were broadly similar across 
the 3 countries (Table 3-2). Surprisingly, the frequency of the allele conferring the 
greatest pyrimethamine resistance the d~fr triple mutant (N5II+C59R+SI08N) allele 
was highest in Mozambique (0.60) compared to 0.52 in South Africa and 0.32 in 
Tanzania. Similarly, the most highly resistant dhps allele, the double mutant 
(A437G+K540E) was highest in Mozambique (0.21), a frequency double that 
observed in Tanzania and South Africa (both 0.10). 
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dhps 
Mozambique Mpumalanga Tanzania 
Mozambique 0.030 -0.041 
dhfr Mpumalanga 0.022 0.040 
Tanzania 0.120 0.048 
Table 3-3: Between popUlation FST analysis at dhps (above the diagonal), and d~fr 
(below the diagonal). Cells shaded in light grey are significant at the p = 0.05 level 
In Tanzania, the generally lower frequencies of these particular resistance alleles, in 
addition to the greater number of alleles at dhfr and dhps, was more in line with our 
expectations, given the short SP selection history. Summarizing the allele 
frequencies , we observed that the resistance levels of the three countries could be 
ranked thus: Tanzania <Mpumalanga <Mozambique. To determine whether there 
was any significance to the differences between countries, the frequencies of dhfi~ and 
dhps alleles were compared. 
Table 3-3 show the Wright's fixation index and significance values for these pairwise 
comparisons. The F ST values for comparisons with Tanzania were highest, 
particularly so at dhfr (Tanzania versus Mozambique FsT=0.12, p<O.OOOI), probably 
due to the three times higher frequency of the sensitive dhfr alleles in Tanzania. 
c Sub -population differentiation through allele fi~equencies at dhfi~ and dhps 
Sites within countries were compared through pairwise F ST and the results are shown 
in Table 3-4. Within Mozambique the dhps allele frequencies at all sites were not 
significantly different, while at dhfr the Salamanga subpopulation differed 
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significantly from three others (with the exception ofCatuane). Inspection of Table 
3-2 reveals that an unusually high frequency of the C59R + Sl08N double mutant 
allele is common to Salamanga and Catuane. 
Comparing South African sites,the subpopulation of St eenbok was significantly 
different from Mangweni and Komatipoort at dhps. The frequency of the double 
mutant dhps allele in the subpopulation ofSteenbok was 0.22 compared to 0.07, and 
0.02 in Mangweni and Komatipoort respectively. At dhjiA Steenbok differed 
significantly from Mangweni, the former having a higher frequency of the triple 
mutant allele and greatly reduced frequency of sensitive. Inter-site differences at dhfr 
and dhps are consistent with Steenbok having the most resistant alleles in both genes. 
Finally in Tanzania, the subpopulation of Morogoro was significantly different 
having the single mutant S436A allele at a frequency of twice that found in Rufigi or 
KilomberolUlanga. The high frequency of this allele is curious, since the alanine 
substitution at codon 436 is thought to not have a great deal of influence in 
sulphadoxine resistance as it lacks the phenyl side chain that can cause 
conformational chains in the enzyme active site (D. Warhurst, Personal 
Communication) The three sites did not differ at dhfr. 
Comparing all sUb-populations pairwise some interesting observations emerge. 
Inspection of table 3-4 indicated that broadly there were fewer significant differences 
among pairwise intra country comparisons versus inter country pairwise comparisons. 
In particular the Mozambican sample sites were identified as having more significant 
and moderately high FST values in pairwise comparisons with South African or 
Tanzanian locations. Interestingly, one exception to this was the population of 
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Steenbok, which was similar to the Mozambican subpopulations at both dhfr and 
dhps. All pairwise comparisons involving the Tanzania population of Morogoro 
resulted in high and significant FST values at dhps. This was due to the particularly 
high frequency of the dhps single mutant allele S436A, exceptional in this dataset. 
d The dhfr-dhps two locus genotypes 
The frequency of the two locus genotypes is given in Appendix 1 and illustrated in 
Figure 3-1. Tanzania had the highest number of two locus combinations (29) 
reflecting the high number of alleles present at dhfr and dhps,but over half of these 
genotypes had frequencies of less than 5%. By contrast there was an average of eight 
two locus combinations in the other two countries. The frequency of the most highly 
resistant combination, triple mutant dhfr - double mutant dhps was highest in 
Mozambique, followed by South Africa then Tanzania. The general trend of the F ST 
analysis was that only the differences in allele frequencies between the Tanzanian 
subpopulations and those from South Africa or Mozambique were significant for the 
majority of pairwise comparisons (Table 3-5). Within country pairwise comparisons 
were broadly non significant. 
To look for evidence of recent selection through use of SP we tested for linkage 
disequilibrium. Steenbok was the only population with significant linkage 
disequilibrium between the dhfr triple mutant allele and the dhps double mutant allele 
(D'=O.8026 p=O.OII). This might have arisen because ofa higher degree of 
relatedness between the parasites sampled from this epidemic setting. 
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- 0.05 -0.01 -0.01 -0.01 -0.01 0.00 0.10 0.04 
.. --
. -
-- ,,-- . - - . 
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-
BelaVista 0.03 -0.01 0.08 -0.02 -0.02 
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-0.02 -0.01 0.13 0.03 
-... _-------
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.... ..--.. 
--- -
Salamanga 0.06 0.05 0.05 0.06 0.06 0.06 - -0.01 0.08 0.02 
.. 
Catuane 0.01 0.00 
~-.-
0.03 0.01 0.01 0.00 0.00 - 0.10 .,"~ ~ 0.00 
Morogoro 0.01 0.07 0.00 0.12 0.13 0.11 0.11 0.05 
-
0.12 
. , 
Rufigi -0.01 0.01 
~~--
0.01 0.03 0.04 0.02 
-
0.04 0.00 0.00 
-
Ulanga 0.00 0.04 
- . -
-0.01 0.09 0.10 
- . 
0.07 0.07 0.03 -0.02 0.00 
- - - ---
Table 3-4: Within and between population pairwise F ST values for comparisons between the individual sampling 
locations. Above the highlighted diagonal dhps, below the diagonal dhfr. Boxed groups of pairwise comparisons 
indicates within population comparisons indicates within population 
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To test this, a subset of 60 unrelated individuals (as established by typing of 8 
unlinked microsatellite loci - see below) were also tested for LD between dhfr and 
dhps resistance alleles. We found significant LD between the triple mutant dhjifO allele 
and the dhps double mutant allele (D'=0.8413 p=O.OOll) in this sample of unrelated 
individuals. 
In Mozambique the 3 out of 5 populations had moderately positive D' values between 
these two alleles (D'= 0.455 to 0.657), but not significantly so. In Tanzania, Rufigi 
and Ulanga have weakly positive D' values (D'= 0.161 to 0.255) whereas in 
Morogoro the triple double combination was positively disassociated (D' = -0.533); a 
reflection of the high frequencies of the S436A substitution in the population. That in 
only one population were the dhfr triple and dhps double mutant in linkage 
disequilibrium is interesting. 
The presence of the all five mutations comprising the dhfr triple and dhps double 
mutant is statistically associated with treatment failure, and intense use of SP will 
maintain an association between these sites. 
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Other <5% 
CNRN...,.AAKAA 
CNCS-fiAKAA 
Figure 3-1: Map showing the frequencies of the dhjr/dhps two locus genotypes of 
alleles in the approximate location of the population sampled 
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e Resistance allele frequency data summary 
To summarise: Broadly we have observed differences in the resistance allele 
frequencies within and between the three countries that reflects the heterogeneity in 
drug selection pressure as mandated by national policy. The sole exception to this 
generalisation was Mozambique where we conclude that the high frequencies of the 
triple mutant dhfr allele and the double mutant dhps allele observed suggest that SP 
was in use, however there is no official sanction of this practice. This may be 
explained through the anecdotal evidence of migration of individuals back and forth 
across the Mozambican - South African border by those seeking treatments in 
KwaZulu Natal (C. Roper Personal Communication). In Tanzania, the relative 
absence of the dhps double and the number of rare haplotypes is in line with the 
known selection history of this population where SP had not been first line anti-
malarial at the time of sampling. Within South African we found heterogeneity in 
allele frequencies where we observed that Steenbok was more like the Mozambican 
subpopulations, suggesting either an underlying population structure or more 
realistically heterogeneity in the selection pressure between the sites. 
92 
\0 
W 
dlifr 
dhps 
K 
- - - -
Steenbok M C Belul Sal MatolaR' BelaV' M Rufie.i UI 
Komatipoort -
Steenbok 0.01 -
Mangweni 0.01 0.02 -
Catatuane 0.01 0.01 -0.01 -
~ . ---
Beluluane 0.04 0.00 f 0.08 0.04 -
....... ---
- -
- . -~l 
Satamanga 0.03 0.03 0.02 -0.01 0.06 
-
" -- --, - --.. -
MatolaRio 0.00 -0.01 " 0.03 0.00 0.00 0.0) -
BelaVista -0.02 -0.01 0.02 0.01 0.00 0.02 -0.01 -
-,--..----.. ,,~....-- -_ .... -
,,;,. ,"" 
Morogoro 0.06 0.06 0.01 0.01 0.11 0.03 
" 
0.06 0.07 -
Rufigi 0.04 0.04 0.00 
---
0.00 0.09 0.03 0.05 0.04 0.00 
-, .. _. ~ 
Ulanga 0.08 ,0.07 0.02 ~"" _ 0.03 0.13 
'" 
0.07 . 
- --- -- -
0.09 
- -
"" 
0.09 0.01 0.01 ~t -
-- ---- - ----------
Table 3-5: Within and between population pairwise comparisons F ST 2 locus combination. Boxed groups of pairwise 
comparisons indicates within population con1parisons. Cells shaded in light grey are significant at the p = 0.05 level 
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f Population differentiation at neutral polymorphic markers 
We postulated that the differences in resistance allele frequencies exist whilst the 
parasite populations are continuous and overlapping. To test this we selected a subset 
of samples from a number of sites within Mozambique (n= 96), South Africa (n = 
188) and Tanzania (n=475) and genotyped them at eight microsatellite loci (Anderson 
et al. 1999; Anderson et al. 2000b). The samples were taken regardless of the dhfr or 
dhps allele present, thus avoiding any biasing in allele frequencies at the neutral 
alleles as a result of changes in population structure due to drug selection. Due to 
sample number limitations the sites within Mozambique were grouped into East 
(Boane and Catuane; n=48) and West Mozambique (Bela Vista and Salamanga; 
n=48). 
The eight micro satellite loci used are from sites located throughout the genome and 
unlikely to be biased by a loss of diversity in anyone region of the genome. The 
genomic locations of the microsatellites can be found in table 3-6. Three loci are 
found on chromosome 12 within a region of over 70cM, sufficient distance apart that 
they can be assumed to be in linkage equilibrium (Su et al. 1999). This also applies 
to the two loci present on chromosome 6. One locus, Poly-a, is found on 
chromosome four, but is sufficiently distant from dhfr (>215kb) that any reduction in 
gene diversity at this locus due to drug selection at dhfr is unlikely. The region of 
reduced diversity described on selected chromosomes in southeast Asian populations 
only extended as far as --100kb around dhfr (Nair et al. 2003). 
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Mpumalanga Mozambique Tanzania 
Marker Chromosome n=]88 n=96 n=475 
ARAII 11 0.875 0.879 0.832 
0377 ]2 0.623 0.573 0.503 
PfPk2 12 0.911 0.911 0.896 
PolyA 4 0.883 0.845 0.860 
TA109 6 0.838 0.818 0.814 
TA42 5 0.498 0.507 0.380 
TA87 6 0.858 0.845 0.853 
TA102 12 0.849 0.809 0.839 
Mean 0.792 0.773 0.747 
Table 3-6: Microsatellite locations and diversity values per population. 
The gene diversity of each locus was calculated for each country and is given in table 
3-6. In each country the average gene diversity across all markers was high (0.747 -
0.792) and comparable to previous estimates for other African populations as 
expected for neutral loci (0.76-0.80) (Anderson et al. 2000a). Loci TA42 and 0377 
had lower gene diversity than the other loci, averaging across the 3 countries at 0.462 
and 0.566 respectively. The locus on chromosome 4, Poly-a, has gene diversity 
values comparable to those for the majority of the loci sampled, namely 0.883 in 
South Africa, 0.845 in Mozambique and 0.860 in Tanzania. There was no dramatic 
reduction in the gene diversity at each of the microsatellite markers when the country 
samples were subdivided into the individual dhfiA or dhps resistance allele classes. 
g Population differentiation at the international level at neutralloei 
The three populations of Mozambique, South Africa and Tanzania were compared 
using Wrights fixation index (Table 3-7). In all three pairwise comparisons the FST 
values were low, ranging from 0.0087 to 0.0152, indicating little difference in the 
frequencies of the alleles present in the three populations suggesting that the parasite 
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population in southeast Africa is panmictic. The pairwise comparisons involving 
Tanzania generated moderately higher F ST values than that between the two southern 
countries. However, the 95% confidence intervals on the F ST in the comparison 
excluding Tanzania overlapped, with those including Tanzania and we rejected the 
hypothesis of increased differentiation over distance. 
The F ST values for the comparison of the three populations are comparable to a prior 
estimate of F ST between the African countries of Uganda, Congo and Zimbabwe 
(0.003 to 0.012) as shown by Anderson et al. A conclusion ofpanmixia was reached 
to explain the relationship between parasites from these countries (Anderson et al. 
2000a). We can not directly compare the alleles present in the three previously 
reported countries with those reported here as the two studies were analysed on 
different instrumentation and there is no standardised allele size between the two 
instruments. However, it is likely that if the six nations were to be analysed together 
we would not find any significant differences, as the locations of the two studies 
interweave. 
Mpumalanga 
Mozambique 
Tanzania 
Mpumalanga 
0.0087 (±O. 0072 ) 
0.0104 (±O.O 055) 
Mozambique 
0.0152 (±O.O 12) 
Table 3-7: Pairwise popUlation differentiation (FST) using microsatellite allele 
frequencies. 95% CI given in parenthesis. 
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In addition to calculating F ST we also determined the degree of population 
differentiation using Slakin's RST (Slatkin 1995). This is analogous to FST but is 
adapted to use with microsatellites by assuming a high-rate stepwise mutation model 
(SMM) rather than an infinite-allele mutation model. This assumption of a stepwise 
mutation model, may not be applicable to a majority of P. Jalciparum micro satellites, 
that due to complex mutations such as indels and duplications do not follow simple 
rules of length variation (Anderson et al. 2000b). Of the eight microsatellites used 
here, SMM is the appropriate model for four, namely TA87, ARAII, G377 and PfPK.2 
(Anderson et al. 2000b). 
U sing the software Microsat (Minch et al. 1997), we calculated RST values between 
the three populations based on this subset of microsatellites (Table 3-8). The values 
generated were not significantly different from zero as indicated by the 95%CI 
calculated from bootstrapping the data exhaustively, supporting a conclusion of 
panmlxla. 
Mpumalanga 
Mozambique 
Tanzania 
Mpumalanga 
0.047 (±0.106) 
0.024 (±0.045) 
Mozambique 
0.01 J (±0.03J) 
Table 3-8: Population differentiation using Slatkin's RST on only loci where the 
stepwise mutation model could be applied. 950/0 CI given in parenthesis 
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h Population differentiation at the international level by population assignment 
As gene diversity was high at each of the microsatellite markers, the FST values 
maybe an underestimation of the actual population differentiation (Hedrick 1999). 
Therefore, we ran the dataset through a Bayesian probabilistic clustering algorithm 
implemented by the software Structure (Pritchard, Stephens, and Donnelly 2000). 
The algorithm addresses whether the current population is structured due to an 
ancestral admixture event between user-defined 'k' numbers of ancestral populations. 
The algorithm uses a Markov chain Monte Carlo (MCMC) scheme to allocate 
individuals to one of the 'k' number of clusters on the basis of similarities in the 
allele distribution at a combination of loci, generating a likelihood value such that the 
most probable 'k' can be identified. It also estimates the proportion, Q, of 
membership of each individual to each cluster, estimating the proportion of an 
individuals' genome inherited from some ancestral population. For example ifk=2 
was assumed and the proportion of an individuals genome coming from ancestral 
population 1 was Q = 0.5 (=I/k), its' genome will come from each 'k' population with 
equal proportions. In this particular example such a result repeated over an entire 
dataset would infer that there was only one population present in the data set rather 
than the two tested for. 
The algorithm performs this clustering individual by individual and ignores all 
information regarding the sampling populations. Thus we used Structure to 
determine whether the individuals comprising the datasets of ancestral, double mutant 
and triple mutant chromosomes would be clustered into populations matching those 
defined by the allele present at the selected site, dhfr. 
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The algorithm can implement three models to test for sUbpopulations and determine 
the population ancestry of individuals, namely the 'no admixture', 'admixture' and 
'linkage between sites' models. As the majority of these markers are physically 
unlinked, we used the admixture model, and ignored the less appropriate no 
admixture model that assumes absolute population subdivision. The admixture 
proportions for each individual are independently modelled from a symmetrical 
Dirichlet distribution with hyper-variable a. If a is high the distribution is random, 
whereas if a is below 1, the distribution approximates a negative binomial 
distribution and it models each individual as having originated mostly from a single 
population, with each population being equally likely. 
We tested a number of 'k' clusters from k=l to 8 to test for between country 
population differentiation. We found that k=l was the most likely number of clusters, 
supporting the FST estimates and the conclusion ofpanmixia. At all other k the 
likelihood was low and the Dirichlet parameter a was above one indicating that each 
individual has allele copies originating from all countries in equal proportions 
(Pritchard, Stephens, and Donnelly 2000). 
i Population differentiation within countries at neutral loci 
We calculated the Wright fixation index between the sites within each country (Table 
3-9) and found that there was no significant population differentiation between the 
various sites, with the one exception of Morogoro versus Rufigi in Tanzania where 
we observed a significant but low FSTvalue. RsT estimates of population 
differentiation, using only the four microsatellites that the SMM could be applied to, 
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found no significant population differentiation values for within country pairwise 
comparisons (Table 3-10). 
Comparing all sites pairwise across countries significant differences become apparent 
(Table 3-9). The population of Steenbok stands out as being significantly different 
from all non South African populations (FST in the range 0.017- 0.023), although this 
is not supported by the RST analysis which finds no significant population 
differentiation. The South African population of Mangweni is also significantly 
different from 3 of the five non South African populations; the difference between 
Mangweni and Morogoro and Rufigi supported by significant, but low RST values. 
The highest sigl1ificant FST values observed are those between East Mozambique and 
the Tanzania populations ofMorogoro and Rufigi at 0.032 and 0.033 respectively, yet 
somewhat lower than the upper range of significant population differentiation 
observed in the dhfr and dhps allele frequencies (0.13 dhfr; 0.22 dhps from Table 3-
4). 
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W. E. 
K M Steenbok Mozamb' Mozamb' VI M 
Komatipoort 
-
Mangweni -0.005 
-
Steenbok 0.003 0.004 
-
W. Mozambique -0.001 0.007 0.018 -
E. Mozambique 0.014 0.018 0.023 0.021 
-
KilomberolUianga 0.006 0.011 0.017 0.020 0.022 -
Morogoro 0.006 0.016 0.022 0.024 0.032 0.009 
-
Rufigi 0.006 0.008 0.023 0.020 0.033 0.006 0.009 
~----~~----.--
Table 3-9: Within and bet\veen population painvise comparisons FST of micro satellite alleles. Boxed 
groups of pairwise comparisons indicate \vithin population comparisons. Cells shaded in light grey are 
significant at the p = 0.05 level. 
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Komatipoort Mangweni Steenbok W. Mozambique E. Mozambique Ulanga Morogoro 
Komatipoort 
Mangweni -0.004 (±O.014) 
Steenbok 0.019 (±0.069) 0.041 (±O.OSI) 
W. Mozambique 0.017 (±0.07J) 0.039 (±0.OS1) 0.086 (±0.21) 
E. Mozambique -0.005 (±O.024) 0.02 (±0.027) 0.069 (±O.159) -0.003 (±O.020) 
U1anga -0.004 (±O.008) 0.0 II (±0.031) 0.018 (±O.047) 0.058 (±0.125) 0.023 (±0.078) 
Morogoro 0.045(±0.084) 0.074 (±0.067) 0.105(±0.202) -0.004(±0.012) 0.006 (±0.022) 0.051 (±O.l14) 
Rufigi -0.011 (±O.004) 0.03 (±0.029) 0.027 (±O.076) 0.045 (±O.l25) 0.015 (±0.OS9) 0.004 (±0.006) 0.044 (± 0.082) 
Table 3-10: Within and between population painvise comparisons using Slatkin's RST of micro satellite alleles for only those 
that a stepwise mutation model could be applied. 95% CI given in parenthesis. 
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j Population differentiation at the intra national level by population assignment 
Intra-population analyses for all three countries using the software 'Structure' 
(Pritchard, Stephens, and Donnelly 2000) found that in Tanzania k=1 was the most 
likely number of ancestral populations, denoting no population differentiation. In 
Mozambique, k=2 was the most likely, but the Dirichlet parameter a was high, and 
therefore k=1 was the most robust conclusion. In South Africa the admixture model 
testing k=3 began to identify individuals that clustered together, however k=l was the 
most likely number of clusters. Closer inspection of the individuals clustering in the 
k=3 run identified the majority as from Steenbok. Testing this population separately, 
k=3 identified a number of individuals as clustering together,diff erent from the 
majority of the Steenbokian individuals. However, the variance on the log likelihood 
for this run was large, casting doubt on the robustness of the k=3 conclusion,and k=1 
was determined as the most robust. 
Thus in all three countries analysis of population differentiation using structure 
reached a conclusion of panmixia between all sites. However, the tendency of some 
individuals in Steenbok to cluster together in k>2 tests, in addition to the relatively 
high FST values for pairwise comparisons involving Steenbok and non South Africa 
populations, suggested that this population warranted further investigation. 
k Epidemics in South Africa 
One explanation for the observed high FST values in the comparisons between non 
South African sites and Steenbok, and to a lesser extent Mangweni (Table 3-9), is that 
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whilst micro satellite diversity was high in each population, an over representation of 
one or more alleles in one of the two compared populations,would be sufficient to 
generate the magnitude ofFsT values we have observed. 
An over representation of an allele or set of alleles in a population can occur due to 
the epidemic expansion of a single lineage. This may be detected by looking for 
evidence of linkage disequilibrium. Plasmodium Jalciparum has a very high 
recombination rate at 17kb/cM (Su et al. 1999) but this is tempered by the degree of 
inbreeding in a population, determining the effective recombination rate (Dye and 
Williams 1997; Conway et al. 1999). In the majority of African populations, malaria 
transmission is high and a large proportion of infections contain multiple genetically 
distinct parasite lineages. Linkage disequilibrium distances tend to be small between 
loci on the same chromosome, and are even less likely to occur between physically 
unlinked sites, such as the majority of these loci are. However, epidemic expansions 
of a parasite lineage increase the inbreeding coefficient, reducing the effective 
recombination rate and can generate linkage disequilibrium between sites. 
The Entomological Inoculation Rate (EIR) is a measure of transmission intensity that 
can be used as an approximate guide to expectations of effective reconlbination rates 
in a population, namely that when EIR is high, the inbreeding coefficient is low and 
the effect recombination rate is high. In Tanzania an EIR of 584 infective bites per 
adult per annum (Charlwood et al. 1998) has been estimated for a population within 
the study area. An EIR of this magnitude implies a high effective recombination rate 
as multiple infections are prevalent. The EIR for Mozambique is substantially lower 
at 12 infective bites per adult per annum (Hay et al. 2000). Contrast this with the EIR 
of the South African population, estimated as <1 infective bite per adult per annum 
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(K. Barnes Personal Communication). Populations such as South Africa are prone to 
epidemic expansions of parasite lineages as transmission is so low that clinical 
immunity, gained over successive resolved cases of malaria, develops later in life (in 
the teens as opposed to in childhood) and as such the prevalence of naive hosts 
favours epidemic transmission (Kleinschmidt and Sharp 2001). 
The linkage disequilibrium measure called the "index of association (Is A)" (Haubold 
and Hudson 2000) tests for a departure from random associations between the 
microsatellite loci. The expectation was that where the EIR is high there would be no 
association between the eight markers. Where the EIR is low the effective 
recombination rate will be lower and one may expect there may be associations 
between loci, particularly those on chromosome 12, that would not persist in a higher 
recombination rate. 
In line with this expectation we found that in both the South African populations of 
Steenbok and Mangweni there was significant departure from a null hypothesis of 
linkage equilibrium (Table 3-11), suggesting that there is a high degree of inbreeding 
occurring in this population to maintain linkage between the eight physically unlinked 
loci. 
Komatipoort 
Mangweni 
Steenbok 
W. Mozambique 
E. Mozambique 
KiloUlanga 
Morogoro 
Rufigi 
Standardized IA 
0.008 
0.027 
0.033 
-0.030 
-0.005 
0.005 
0.006 
0.01 1 
Parametric P 
0.3332 
0.0001 
0.0000 
1.000 
1.000 
0.340 
0.284 
0.088 
Table 3-11: Departures from an assumption of linkage equilibrium between the eight 
microsatellite loci as calculated by LIAN (Haubold and Hudson 2000). 
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I Identification of epidemically expanding lineages in South Africa 
To identify the relationships of the isolates causing the LD in Steenbok and 
Mangweni, a neighbour joining tree was constructed using the distance measure of I-
Ps (Bowcock et al. 1994) where Ps is the proportion of alleles shared in a pairwise 
comparison of two isolates, calculated using the software "Microsat" (Minch et al. 
1997)(Figure 3-2). Ps is a measure of similarity between two isolates calculated as 
the proportion of alleles shared summed over loci/(2 x number of loci compared) 
(Bowcock et al. 1994). Pairs of samples that have the highest Ps values are those that 
are most alike. The distance file of 100 bootstraps was made and the trees were 
constructed using "neighbor" and a consensus tree was compiled using the 
"consense" components of the software collection PHYLIP (Felsenstein 2004). 
A node had to be present in greater than 75% of the bootstrapped trees for inclusion 
into the consensus tree. Inspection of the consensus tree clearly shows that the 3 
major countries are not structured as the majority of the samples are equidistant from 
each other (Figure 3-2). There is no clustering of parasites into groups as defined by 
the population that they were sampled from, unsurprising given the earlier conclusion 
of panmixia. 
What is notable is that there were a number of independent expanding lineages 
containing between 2 and 5 isolates. The isolates within these expanding lineages 
were all from South African sites explaining the LD values in Steenbok and 
Mangweni. The details of those isolates involved can be found in table 3-12. 
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S145 
S195M27 S98 
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91 S60 M48 
Figure 3-2: Neighbour joining tree constructed using the distance measure 1-Ps. 
Bootstrap values are given for each of the expanding lineages. Sample names are 
found at branch tips. 
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Close inspection identifies that the majority of the epidemic expansions occurred in 
Steenbok supporting the hypothesis that population structure events are behind the 
differences in microsatellite allele frequencies between Steenbok and the non South 
African populations. 
Note that whilst the expansion was not predetermined by whether or not there was a 
resistant allele at dhfr or dhps, they were predominant (Only 6 of the 27 isolates have 
the sensitive allele at dhfi,o). A few of these expansions are likely to reflect very local 
transmission where samples have been taken from the same family, for example 
M261M27 and M48/M49. It is likely that in these situations the patients will all have 
been infected by the same mosquito. However, there were also several lineages 
containing isolates sampled from different sites within South Africa. The high degree 
of identity between these isolates across the 8 loci is unlikely to have occurred by 
chance. 
The epidemiology inferred by the presence of the c10nallineages of parasites in South 
Africa supports the hypothesis that selection pressure in Steenbok was high, as 
implied by the higher frequencies of the resistance alleles compared to the other 
South African populations. Epidemically expanded lineages imply a population of 
hosts with a minimal prevalence of clinical immunity to P. Jalciparum, which in tum 
implies an increased reliance on antimalarial resolution of infections. 
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-----------------------------------------------------------------~----------
Sam21e P02ulation dh(r dhe.s ARATT G377 PolvA PtPk2 TAI09 TA42 TA87 TA102 
814 Steenbok CIRN SGEAA 69 100 166 192 176 186 102 129 
SI95 Steenbok CTRN SGEAA 69 100 166 192 176 186 102 129 
M26 Mangweni CNCS SAKAA 66 100 159 189 173 186 102 141 
M27 Man~eni CNCS SAKAA 66 100 159 189 173 186 102 141 
SI45 Steenbok CIRN SAKAA 105 97 172 177 173 189 108 132 
S49 Steenbok CIRN SAKAA 105 97 172 177 173 189 108 132 
898 Steenbok CIRN SAKAA 105 97 172 177 173 189 108 132 
S60 Steenbok CIRN SAKAA 105 97 172 177 173 189 108 132 
S126 Steenbok CIRN SAKAA 105 97 172 177 173 189 108 132 
M48 Mangweni CIRN SAKAA 69 97 178 189 173 186 102 117 
M49 Man~eni CIRN SAKAA 69 97 178 189 173 186 102 117 
K297 Komatipoort CIRN 8GEAA 69 100 175 181 173 186 96 129 
MIOI Man~eni CIRN SGEAA 69 100 175 181 173 186 96 129 
KI20 Komatipoort CNRN SAKAA 78 100 143 162 176 242 ]02 129 
K235 KomatiI!0ort CNRN SAKAA 78 100 143 162 176 242 102 129 
M104 Mangweni CNCS SAKAA 72 97 153 175 158 186 100 117 
S200 Steenbok CNCS SAKAA 72 97 153 175 158 186 100 117 
MI07 Mangweni CIRN SAKAA 75 100 159 169 161 189 ]00 126 
S1I8 Steenbok CIRN SAKAA 75 100 159 169 ]61 ]89 ]00 ]26 
8147 Steenbok CTRN SAKAA 75 100 159 169 ]6] 189 100 126 
S38 Steenbok CNCS SAKAA 72 97 153 166 161 242 108 117 
S124 Steenbok CNCS SAKAA 72 97 153 192 161 242 108 117 
S61 Steenbok CNCN SAKAA 72 97 ]53 192 ]61 242 108 117 
S44 Steenbok CNRN SAKAA 72 100 175 172 170 242 87 123 
S67 Steenbok CNRN SAKAA 72 100 175 172 170 242 87 123 
S242 Steenbok CIRN SAKAA 66 ]00 156 186 173 186 96 ]26 
S270 Steenbok CIRN SAKAA 66 100 156 186 ]73 ]86 96 ]26 
Table 3-12: Sample details of the 'epidemic' expansions. 
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m Observation regarding the rate oj de novo point mutations at dhfr 
The mutation rate for substitutions at codon 108 of dhjiA has been determined in the 
laboratory as being less than 2.5xl 0-9 mutationslDHFR gene/replication (Paget-
McNicol and Saul 2001) and it can been argued numerically that, given that a patent 
infection contains 1010 - 1012 parasites, there is an expectation for single mutant 
resistance parasites to arise regularly if not within the course of a single infection. 
This observation was confirmed in description of numerous flanking sequence 
haplotypes of dhjiA S108N single mutants in KwaZulu Natal (Roper et al. 2003). 
I t is with this in mind that we note that in one isolate within an expanding lineage of 
dhji- sensitive parasites there has been a substitution of asparagine for serine at codon 
108. The single mutant isolate S61 from Steenbok has an identical genotype to 
isolate S124 and only one allele different to isolate S38, which both carry the 
sensitive allele at codon 108. This suggests that the mutation has appeared within the 
recent lifetime of the lineage expansion, although this was not confirmed by direct 
sequencing. 
V Discussion 
We have typed the point mutations present at the SP resistance loci dhfr and dhps in a 
population sample of Plasmodium Jalciparum infections taken from the field in three 
southeast African countries, Mozambique, Tanzania and South Africa. We found that 
throughout the region there were only a limited number of common alleles, namely 5 
at dhfr and 3 at dhps, echoing a finding of Chapter 2. We found that whilst there are 
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other alleles present outside of the common eight, they are rare with less than 5% 
frequency in the population. 
We have shown that significant heterogeneities in the frequencies of the 5 dhfi,o and 3 
dhps resistance alleles exist both between and within the three countries. For 
example the frequencies of the most highly resistant dhfr triple mutant 
(N5II+C59R+SI08N) and the dhps double mutant (A437G+K540E) alleles were 
found to be highest in Mozambique followed by South Africa and then Tanzania. In 
the case of the latter two countries, this pattern is almost certainly due to 
heterogeneity in selection pressure as mandated by differences in national treatment 
policy, where as the exception to this generalisation, Mozambique, has no official 
drug selection history. 
We observed some heterogeneity in dhfr and dhps allele frequencies within countries 
most notably in South Africa where the frequencies of the dhfr triple mutant and dhps 
double mutant were considerably higher in Steenbok than in the neighbouring South 
African sites, such that the allele frequencies in Steenbok were not significantly 
different from those in Mozambique. However, when we considered the frequencies 
of the two locus genotypes, the within country differentiation between sites was not 
as pronounced as the greater differences existing between countries. 
The hypothesis that these differences in allele frequencies exist between countries due 
to heterogeneity in selection pressure can be tested through description of population 
differentiation using selectively neutral markers. Using 8 microsatellites we found 
that in both inter and intra country comparisons there was no evidence of population 
subdivision and we make the conclusion of panmixia of parasite populations within 
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and between Tanzania, Mozambique and South Africa. Therefore that the 
heterogeneity exists between these countries in the frequencies of the resistance 
alleles is evidence of the heterogeneity in drug selection intensity as the gene flow in 
the region that has homogenised neutral allele frequencies has failed to do so at the 
selected loci. 
a Measures o/Selection 
The high frequencies of the resistance alleles in Mozambique suggest that selection is 
occurring in this population, but this conclusion does not square with the known 
history of selection and national policy. Therefore is selection actually occurring in 
this population or are the high frequencies of the resistance alleles a result of gene 
flow from neighbouring South Africa, in particular KwaZulu Natal where the drug 
had been abandoned due to the high numbers of treatment failures (Roper et aI, 
2003). Linkage disequilibrium between dhfr and dhps resistance alleles is an indirect 
measurement of the level of selection occurring in a population. The combination of 
the dhfi~ triple mutant and dhps double mutant is the highest form of SP resistance 
present in southeast Africa and in populations where selection is intense these two 
alleles although physically unlinked will become associated through assortative 
mating. Therefore the presence of LD between these two aIIeles in a population 
would suggest that an association is being maintained through intense selection. In 
Mozambique there was no significant linkage disequilibrium between the dhfi~ triple 
mutant and dhps double mutant at any of the sites suggesting that selection was not 
occurring at the time of sampling or at least it was not intense or of sufficient 
coverage in the population to maintain an association between the two loci. Clearly 
linkage disequilibrium is only an indirect indicator of selection, and only a direct 
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observation, such as plasma levels of drug in patients would give the best estimate of 
the level of selection in the population. However, assuming that the indication is 
correct and there is no selection occurring, the high level of gene flow occurring in 
the region points to another cause of the widespread resistance aIIele, one that has 
significant policy implications for the region. 
b The effect of gene flow 
The evidence from the microsateIIite markers strongly concluded that the parasite 
population in the region was panmictic across the three countries, and that a great 
deal of mixing was occurring in the parasite population such that resistance aIIeIes 
could diffuse from a site where the drug is in use to sites where drug pressure is 
officiaIIyabsent. This has been observed historicaIIy by Clyde (Clyde 1967) who in 
Tanzania in the 1950s,trea ted semi-immune individuals in the three villages of 
Mkuzi, Enzi and Kilulu found to the north of Muheza with a monthly dose of 
pyrimethamine. Resistance was quick to develop and spread out of the area to sites 
where selection was absent. At sites up to 100miIes away and over a period of 
several years, individuals treated with 25mg or 75mg of pyrimethamine showed the 
presence of resistant parasites. The initial focus of intense selection was chosen by 
Clyde because it was thought that its isolation from other parasite populations due to 
isolation from other human populations would reduce the opportunity of gene flow of 
resistance genes. This was conclusively found not to be the case. 
This extent of gene flow between neighbouring countries wiII have significant 
implications for national policy towards antimalarial usage and for the future use of 
that antimalarial in a much wider area than described by national borders particularly 
if high level resistance aIIeIes have already entered the region. 
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c Epidemics in South Africa 
The only site where significant LD was observed between the dhfr triple mutant and 
the dhps double mutant was in the South African population Steenbok. In 
conjunction with the high frequencies of the SP resistance alleles in Steenbok, the 
significant and strong linkage disequilibrium values suggests that selection was more 
intense at this site than elsewhere in the country. 
However, the microsatellite data identified that in Mangweni and Steenbok epidemic 
expansions had occurred, predominantly amongst parasites carrying the dhfr and dhps 
resistance alleles. It is not clear whether these expansions are as a result of intense SP 
selection pressure or the cause of it in the population. 
d Microsatellites: the pros and cons of their use 
One concern about the applicability of microsatellites in description of population 
differentiation is that the high levels of polymorphism can lead expected 
heterozygosity values within and between populations to reach unity (Hedrick 1999) 
and thus underestimate the population differentiation. To account for this we 
included the probabilistic individual assignment test implement by the software 
Structure, in addition to allele frequency based tests such as Wrights fixation index 
FST. We found that both types of test concluded that the popUlations were panmictic 
at the micro satellite loci. 
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However, there is an additional concern about the use of microsatellites, which would 
not be resolved by the use of different tests, namely the assumption of selective 
neutrality of the micro satellite size. Microsatellites are useful because they can be 
considered as selectively neutral. However, it has been postulated through a 
modelling approach there is likely to be constraint on the size of a microsatellite 
(Nauta and Weissing 1996) through the tendency of mutation pressure to shift 
different populations towards the same distribution of alleles and empirical evidence 
identified an equilibrium between slippage rate enforcing a maximum size and point 
mutation rate removing repeat sequences from a microsatellite (Goldstein and Pollock 
1997; Kruglyak et al. 1998). This constraint could generate a distribution of allele 
sizes centred on a mean stable microsatellite repeat size (Kruglyak et al. 1998). In 
such cases neither fixation indices nor population assignment tests would be able to 
provide resolution. The similar distributions of alleles in the two hypothetical divided 
populations would generate a low FST value, and the overlapping allele identity would 
confound population assignment. For example such a constraint on microsatellite 
size and the allele frequency distributions has been blamed for poor differentiation of 
populations of closely related bear species from more divergent populations in North 
America (Paetkau et al. 1997). 
Applying this to the population under discussion here it can be argued that 
populations of malaria parasites in southeast Africa if not continuous, could appear so 
because the levels of genetic diversity at the microsatellites are very high and 
plausibly there has been sufficient time for the microsatellite allele distributions to 
drift to a similar mean. However, the conclusion of large scale gene flow in southeast 
Africa is the most rational, particularly as this is supported by the rapid dispersal of 
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the triple mutant allele after its migration from Southeast Asia (Roper et al. 2003; 
Roper et al. 2004). 
It is questionable whether such an approach as microsatellite typing should be applied 
to ancient populations with high genetic diversity, if there is any reason to expect 
population subdivision. 
VI Concluding remarks 
The intensity of selection for drug resistance alleles in east Africa is heterogeneous 
between sites generating heterogeneity in allele frequencies. This is unequivocally 
occurring in the face of a strongly homogenising gene flow across a large region. In 
the subsequent three chapters I shall explore the effects of different intensities of 
selection on chromosomes carrying the selected sites, dhfr and dhps. Having 
established that differences in allele frequencies between Mpumalanga and Tanzania 
are maintained despite gene flow, I shall use these populations to describe the effects 
of the different selection pressure intensities on the resistance alleles present on 
chromosomes four and eight. 
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Chapter 4 Reduced Variation Around Drug Resistant dhtr Alleles in African 
Plasmodium (alciparum. 
I Abstract 
We have measured micro satellite diversity at 26 markers around the dhfr gene in 
pyrimethamine sensitive and resistant parasites collected in southeast Africa. 
Through direct comparison with diversity on ancestral chromosomes we have found 
significant loss of diversity across a region of 70kb around the most highly resistant 
allele which is evidence of a selective sweep attributable to selection through 
widespread use of pyrimethamine (in combination with Sulphadoxine) as treatment 
for malaria. Retrospective analysis through four years of direct and continuous 
selection from use of sulphadoxine-pyrimethamine as first-line malaria treatment on a 
Plasmodiumfalciparum population in KwaZulu Natal, South Africa has revealed how 
recombination significantly narrowed the margins of the selective sweep over time. 
A deterministic model incorporating selection coefficients measured during the same 
interval indicates that the transition was towards a state of recombination-selection 
equilibrium. We compared loss of diversity around the same resistance allele in two 
populations at either extreme of the range of entomological inoculation rates (EIR), 
namely under one infective bite per year in Mpumalanga, South Africa, and more 
than one per day in southern Tanzania. Entomological inoculation rates determine 
effective recombination rates and are expected to profoundly influence the 
dimensions of the selective sweep. Surprisingly the dimensions were broadly 
consistent across both populations. We conclude that despite different recombination 
rates and contrasting drug selection histories in neighbouring countries, the region-
wide movement of resistant parasites has played a key role in the establishment of 
117 
Reduced Variation Around Drug Resistant dhfr A1Ieles in African Plasmodiumfalciparum. 
resistance in these populations and the dimensions of the selective sweep are 
dominated by the influence of high initial starting frequencies. 
This work has been accepted for publication and is currently in press with Molecular 
Biology and Evolution 
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II Introduction 
Drug treatment remains the primary means of clearing potentially lethal Plasmodium 
Jalciparum malaria infections and drug use has applied strong positive directional 
selection for resistance mutations. Theory predicts that selection will have a 
significant impact on genomic diversity (Smith and Haigh 1974). Initially there is a 
complete association between the new favoured mutation and the genome in which it 
arose. As the selected allele increases in frequency more distant associations are 
quickly broken down by recombination until only associations between the selected 
allele and sequences immediately flanking the gene remain - this type of association 
is often referred to as hitchhiking (Smith and Haigh 1974; Kaplan, Hudson, and 
Langley 1989). Eventually the signature of selection is a pattern of reduced gene 
diversity (expected heterozygosity (He» at the region of sequence flanking the 
selected locus (Kaplan, Hudson, and Langley 1989). This loss of diversity is known 
as a selective sweep. Selective sweeps have been described in maize, humans and 
drosophila (Quesada et al. 2003; Bersaglieri et al. 2004; Palaisa et al. 2004), often 
long after the initial selection events which created them. Over time the eroding 
effects of new mutations and recombination obscure the signature of the original 
selection event, but in the case of P. Jalciparum drug selection is recent and 
measurable. We have looked at selection of resistance alleles at dhfr through use of 
pyrimethamine for treatment of P. Jalciparum in the present day, and made direct 
measurement of selection coefficients over a 4 year period of drug use (Roper et al. 
2003). Here we examine the impact of selection, recombination and migration on 
chromosome diversity around the highly pyrimethamine resistant triple-mutant allele 
which is prevalent throughout southeast Africa. 
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The antimalarial drug pyrimethamine is a competitive inhibitor of the folate 
biosynthesis pathway that targets the active site of the enzyme dihydrofolate 
reductase (DHFR) and resistance to pyrimethamine is associated in vitro with 
substitutions within the active site of DHFR (Cowman et al. 1988; Peterson, Walliker, 
and Well ems 1988; Snewin et al. 1989). In Africa resistant forms of the enzyme 
contain substitutions at three different sites and permutations of these substitutions 
confer a range of sensitivities to the drug, the higher the number of substitutions, the 
greater the insensitivity to pyrimethamine (Wu, Kirkman, and Wellems 1996). In 
southeast Asia more resistant parasites are found containing a mutation at a fourth 
position, codon 164. 
Microsatellite variation has been described around dhfr carrying 2-4 mutations 
sampled from 11 southeast Asian populations and diversity was significantly reduced 
in sites within a 100kb region around dhfr; a region of 12kb with strongly reduced 
gene diversity within a valley extending from 58kb upstream to over 40kb 
downstream (Nair et al. 2003). Selection was not concurrent with the study as use of 
the drug was discontinued some 10 years prior to the study (Nosten et al. 2000). 
Importantly all alleles had identical or very similar flanking microsatellites indicating 
a single ancestral origin. In Africa the situation is different. Although microsatellite 
flanking markers are tightly associated with dhfr resistance alleles containing 2 or 
more mutations, three separate origins of parasites carrying two mutations, but just a 
single origin of parasites carrying the triple mutant (N 51 I +C5 9R +S 1 08N) dhfi- alleles 
was identified in two populations in southeast Africa (Roper et a1.2003). In both 
Africa and Asia alleles containing a single mutation all have different flanking 
microsatellites suggesting multiple origins for single mutants. Comparing resistance 
alleles from Africa and southeast Asia and using allele sharing at 6 markers over a 
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30kb region around dhjr, we showed that the Africa triple mutant shared ancestry 
with the southeast Asian resistance expansion (Roper et al. 2004), indicating that it 
was introduced into Africa and introgressed into the popUlation over considerable 
distances (>4000km). 
To further explore the dynamics underlying the introgression of this allele in Africa 
and to describe the extent of the selective sweeps around it, we have measured the 
loss of diversity at microsatellite loci through comparison to a baseline of high 
diversity described on chromosomes carrying the drug sensitive allele. Loci are 
described at increasing distances from the dhjr gene in three different population 
contexts each with differing recombination rates and selection histories. It is these 
parameters that determine the size of a selective sweep. Selection acts to maintain 
high frequencies of the favoured allele and thereby the associations with hitchhiking 
loci (Barton 2000; Kim and Stephan 2002). A high recombination rate will act to 
dissolve the associations between hitchhiker and selected site, increasing variation at 
the flanking loci. The intensity of malaria transmission, by multiplying the number of 
genotypes infecting the same individual and increasing opportunities for outcrossing 
has a profound effect on effective rates of recombination. 
Analysis of a genetic cross has estimated the recombination rate in Plasmodium 
Jalciparum to be 17kb/cM (Su et al. 1999), which is considerably higher that found in 
other eukaryotes. However this rate is moderated in the field according to the 
epidemiology of the parasite. Blood-stage Plasmodium is haploid and recombination 
only occurs during meiosis in the mosquito vector. The rate of outcrossing and 
therefore detectable recombination is determined by transmission intensity (Dye and 
Williams 1997). In regions of higher transmission intensity, as indicated by high 
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entomological inoculation rates (EIR), there are more multiple infections, increasing 
the number of different clones ingested by the mosquito and increasing the 
probability of out crossing during meiosis. The effective recombination rate is a more 
accurate measure of the recombination rate of the parasite as it also incorporates the 
degree of inbreeding (F) in the population (Babiker et al. 1994; Dye and Williams 
1997; Conway et al. 1999). 
Using a panel of26 microsatellite loci we have mapped the gene diversity along drug 
sensitive chromosomes, reflecting ancestral state of diversity on chromosome 4 and 
triple mutant chromosomes with dhfr as a central point. We have examined a single 
population where the selection coefficient is known during a 4 year period of drug 
selection (Figure 4-1). Having a standardized effective recombination rate across two 
time points, we can describe the reduction in gene diversity at flanking loci over time 
due to a known strength of selection. To quantify the effect of recombination on the 
dimensions of the selective sweep around dhfr resistant chromosomes we compared 
loss of diversity around the same resistance allele from two popUlations on either 
extreme of a spectrum of transmission intensity in Southeast Africa. In this 
comparison we test the hypothesis that we should see significant differences in the 
dimensions of selective sweeps for parasite populations with differing effective 
recombination rates. 
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Figure 4-1: The change in the frequency of the five most common dhfr allelic 
haplotypes. The haplotype names are derived from the mutated positions in dhfi~ in 
the codon order 50, 51, 59 and 108. Selection coefficients (in brackets) were 
calculated from the change in allele frequencies over 12 generations (1 year being 
equivalent to 3 generations). The arrows indicate the sample points. Data taken from 
(Roper et al. 2003) 
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Population History of SP$ usage Frequency of the EIR? 
and (first line unless triple mutant dhfr (Infectious bites 
sample date stated otherwise) allele (51/59/1 08) per annum) 
KwaZulu Natal 
1996-1999 
Mpumalanga 
2001 
Tanzania 
2001 
1988 - 2000 
1997 - present day 
2001 - present day 
(after 18 years second 
line) 
22% - 38%* 
<0.8t (42% - 62%)*§ 
52% ?§ <O.l4t 
40% ? 584~ 
Table 4-1: Study population details * (Roper et al. 2003); $ Sulphadoxine-
Pyrimethamine; § clinical samples; ? unpublished;t personal communication K. 
Barnes; ~ (Charlwood et al. 1998) 
III Methods and Materials: 
a Study Samples: 
To explore the effects of direct selection through time, parasite populations were 
sampled over two time points (1996 and 1999) in KwaZulu Natal. Samples were 
collected from patients presenting to a healthcare facility. The sites used for 
contrasting effective recombination rates were in the south of Tanzania and in 
Mpumalanga, a province in the northeast of South Africa. The Tanzanian samples 
were collected during household surveys of the three districts of Kilombero, Ulanga 
and Rufiji as a part of the Interdisciplinary Monitoring Project for Antimalarial 
Combination Therapy in Tanzania (IMPACT -Tz) artesunate combination therapy 
trial. The samples from Mpumalanga were from symptomatic malaria patients prior 
to treatment, as a component of the Southeast African Combination Antimalarial 
Therapy (SEACAT) evaluation. Table 4-1 summarises the drug use and 
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epidemiological context of the populations sampled. All three study sites are 
endemic for P. Jalciparum. 
Typing of point mutations at co dons 50/51, 59, 108, 164 was performed according to 
the method of (Pearce et al. 2003), using hybridization of sequence specific 
oligonucleotide probes (SSOP) to PCR amplified products as described in chapter 2. 
As blood stage parasites are haploid, the point mutation haplotypes are immediately 
evident except where multiple genotypes are co-infecting one person. For the 
purposes of looking at flanking sequence polymorphism on chromosomes carrying 
specific allelic forms of dhfr we deliberately selected a subset of samples that were 
unmixed at any polymorphic loci at dhfr. 
b peR amplification and analysis oj microsatellite sequences: 
The micro satellites primer sequences can be found in Appendix 3. The 
microsatellites were amplified in a semi-nested manner. The primary reaction 
comprised: 1/-11 template, 3.0mmol/l Mg2+, 0.75pmollL primer and 1 unit ofTaq 
polymerase. The reaction was cycled as follows: 2 min at 94°C and then 25 repeated 
cycles of 30s at 94°C, 30s at 42°C 30s 40°C and 40s at 65°C followed by 2 min at 
65°C. 
A third fluorescentIy labelled primer (Applied Biosystems, Warrington, Cheshire, 
United Kingdom) incorporated into a second round PCR of total volume 11/-11 
containing 2.5mmol/l mg2+, 2pmolIL primer, 1 unit ofTaq polymerase and 1/-11 of 
outer nest template. Cycling conditions were: 2min 94°C then 25 cycles of 20s at 
94°C 20s at 45°C 30s at 65°C final step of2 min at 65°C. 
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Samples were diluted 1 in 100 and run with LIZ-500 size standard on an ABi 3730 
genetic analyzer (Applied Biosystems, Warrington, Cheshire, United Kingdom). 
Fragments were sized using the GeneMapper software (Applied Biosystems, 
Warrington, Cheshire, United Kingdom). As the samples were pre selected and 
consequently multiple alleles in the same isolate was a rare occurrence. In the event 
of a two or more alleles being detected, the majority allele was used if the minority 
peaks were less than 50% of the height of the majority. Ifpeaks were of equivalent 
height, the data was recorded as missing for that locus in that isolate. 
c Statistics and Software 
Gene diversity values were calculated as He = [n/ (n-l)][I-LP?] where n is the 
number of samples and Pi is the frequency of the ith allele. The variance of the gene 
diversity was calculated using Nei and Roychoudhury's formula (Nei and 
Roychoudhury 1974): 
The software PowerMarker (Liu and Muse 2004) was used to calculate population 
differentiation theta values. The software 'bottleneck' (Comuet and Luikart 1996) 
was used to determine He levels given the observed number of alleles using a 
coalescent simulation. The output was used to test the significance of allele 
distribution shown in the data. Whilst the stepwise mutation model (SMM) is a 
suitable model for evolution for a majority of microsatellites, the frequency of 
126 
A Population Genetic Analysis of Antifolate Resistance in Plasmodiumfalciparum in southeast Africa. 
complex mutations in P. Jalciparum microsatellites suggests that observations based 
on purely SMM could produce some spurious results (Anderson et al. 2000b). 
Therefore, both SMM and infinite allele model (lAM) were used, representing the 
upper and lower limits of the analysis. Differences between observed and 
'bottleneck' predicted gene diversity values were tested for significance using 
Wilcoxon's tests. 
We measured the significance in differences between gene diversity between pairs of 
chromosomal populations by permutation (Nash et al. 2005). The ratio of gene 
diversities between a pair of populations was calculated at each locus in the observed 
data sets and in 10000 simulated datasets where the alleles at each locus were 
reshuffled amongst all parasites. To obtain the level of significance we counted the 
number of occasions that the simulated ratio of diversities exceeded that for the 
observed data. The statistical package R (Team 2005) was used to generate the 
permutations. 
Wiehe (Wiehe 1998) developed a model to describe the pattern of reduced variation 
in microsatellites flanking a selected site. This framework was subsequently 
modified by (Nair et al. 2003) who adapted it for P. Jalciparum specifically to 
describe changes in expected heterozygosity (or gene diversity) rather than variance 
in repeat number. This was necessary because of the often complex nature of P. 
Jalciparum microsatellite repetitive sequences. The model simulates the combined 
effects of recombination (incorporating the inbreeding coefficient to determine an 
effective rate of recombination), mutation, selection, and effective population size to 
predict the dimension of a selective sweep at equilibrium. The assumption of the 
model is that the allele under selection has reached fixation in the population. In the 
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case of southeast African P. falciparum populations (unlike those in Thailand as 
described by Nair et a12003) the alleles associated with SP resistance are not fixed. 
We selected chromosomes according to whether they carried a resistance allele, and 
we contrasted diversity on these and on chromosomes carrying the sensitive allele. 
This artificially creates a "selected population" consisting only of resistance alleles, 
but importantly these chromosomes are still in a dynamic phase in the wider 
population and not in equilibrium or fixation. The important difference between the 
sampled chromosomes and those in the model is that they are still able to recombine 
with sensitive chromosomes carrying high diversity and or with resistance 
chromosomes surrounded by selective sweeps of different origin. The purpose of 
using the model is to guide interpretation of changes and differences in selective 
sweep dimensions measured under a number of different scenarios, and to examine 
what the predicted endpoint would be given the selection coefficients, recombination 
and migration rates in them. 
I.Effective recombination rate, r ': The recombination rate r has been estimated 
by (Su et al. 1999) from observations of the genetic cross between parasite 
lines Hb3 and Dd2 to be 5.88xl 0-4 Morganlkb/generation. The transmission 
intensity in a region determines the proportion of P. falciparum infections 
that result in self fertilization (Paul et al. 1995) and this inbreeding affects the 
apparent rate of recombination. Dye and Williams (Dye and Williams 1997) 
established a relationship between the inbreeding coefficient, F, and the 
recombination rate, r, such that r'= r(1-F). The value ofF used here was 
estimated from the number of mixed infections detected at dhfr in the original 
survey. As we are most interested in the amount of recombination that occurs 
between chromosomes carrying the different dhps alleles these estimates are 
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not unduly affected by being unable to detect multiple genotypes hidden by a 
shared dhps allele. It should however be noted that the inbreeding coefficients 
calculated this way may be an underestimate. 
2.Mutation rate, Jl: The mutation rate of microsatellite loci in P. Jalciparum has 
been calculated as Jl=1.59 x 1 0-4 mutations/locus/generation (Anderson et al. 
2000b). 
3.Selec tion coefficient, s: The calculation of s from directly observed frequency 
changes in these populations is described in (Roper et al. 2003) 
4.Effective population size, Ne: Ne for each popUlation were estimated under 
infinite alleles model using the formula NeJl = H/4(l-H), where H = gene 
diversity of neutral markers on sensitive dhji~ chromosomes (i.e. not under the 
influence of selection) and Jl, the mutation rate. We used the estimate of Jl of 
1.59xl0-4 mutations/locus/generation made by (Anderson et al. 2000b). 
5. 
These parameters are incorporated into the formula: 
H = 1- e(8J.l+2r')/s 
e 
where e is the initial frequency of the favourable allele in the population. (N air et al. 
2003) estimated e as lINe because the resistance allele mutations had occurred de 
novo in southeast Asia. For this study of African resistance mutations we considered 
e to be the initial frequency of the mutant allele to be more variable because spread of 
resistance by gene flow is more likely how these mutants were introduced into 
African populations, rather than de novo mutation. Therefore e is equal to miNe 
where m is the number of migrants from one population to another. To adjust the 
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diversity predicted by the model to the baseline level of diversity per locus, the 
predicted values at a locus was multiplied by the observed gene diversity at that locus 
on the sensitive chromosomes. 
IV Results and Interpretation: 
Microsatellites occur in high frequency in the P. Jalciparum genome on average one 
per kilobase (Su et al. 1999). dhfr occurs at a central point on chromosome 4 using 
the published sequence of the 3D7 parasite line (Gardner et al. 2002). We were able 
to identify microsatellite markers at or close to 10, 20, 30, 40, 50, 60, 70, 75, 80, 90, 
100, 125, 150,250 and 350kb both upstream and downstream from codon 108 of dhJr 
(Primer sequences, chromosome location, repeat unit and allele size range for each 
locus are summarised in Appendix 3). The markers spanned 700kb, 58% of 
chromosome 4. Of the 30 markers, 5 were discarded either for having an inconsistent 
repeat size or greater than 35% missing data suggesting the occurrence of null alleles. 
The KwaZulu Natal sample consisted of 80 unmixed infections collected from 
patients in 1996 and 1999 which were selected as representative of the triple mutant 
dhfr allele (1996 n=14; 1999 n=28) and the sensitive allele (1996 n=14; 1999 n=14). 
Ten were removed because they were of a chromosomal haplotype present more than 
once in the sample set and were therefore presumed to be siblings. A further 11 
samples were removed as they had greater than 35% missing data. 
a The pattern oj diversity around the sensitive dhfiA allele 
The pattern of diversity at all microsatellites flanking the sensitive alleles supports the 
interpretation that the sensitive form of the dhfr allele is considered to be the ancestral 
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state of dhfr. The mean level of gene diversity in micro satellite loci on sensitive 
chromosomes was similar in the two time points being 0.678 ± 0.077 in 1996 (n= 9) 
and 0.699 ± 0.077 in 1999 (n=12). The sample sets of the two years were merged as 
there was no significant differentiation between them (Wrights' fixation index FST = 
0.025 average of all loci). The mean gene diversity of the merged ancestral 
population was 0.784, consistent with previous estimates in African populations of 
between 0.76 and 0.80 based on polymorphism at microsatellite markers dispersed 
throughout the genome (Anderson et al. 2000a). Table 4-2 summarises the average 
expected heterozygosities of markers when grouped by the repeat unit size. The gene 
diversity value for the trinucleotide repeats is slightly lower than previously reported, 
but not significantly so. The gene diversity values of the individual markers together 
with 95% confidence intervals (Nei and Roychoudhury 1974) plotted against distance 
from codon 108 of dhfr are shown in Figure 4-2a. 
Gene diversity at marker loci around sensitive alleles should reflect baseline gene 
diversity in the ancestral state. To test for population events which may potentially 
confound this assumption we tested for excess of heterozygosity. The software 
'bottleneck' (Cornuet and Luikart 1996) carries out a Wilcoxon signed rank test 
comparing observed heterozygosity at each locus across the 700kb region and 
expected values generated under lAM and SMM. It was found that under lAM there 
was significant excess of expected heterozygosity (Wilcoxon test one tail p=0.008), 
but not so under SMM indicating that the population had not recently undergone a 
reduction in size. The high level of diversity at each marker, and the absence of a 
difference in alleles present between the two time points, together with the lack of 
evidence for a population structure event, means that the sensitive population can be 
used as representation of the ancestral state of each locus. 
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Repeat type N (loci) 
Di- 15 
lrri- 7 
Other 3 
Expected Gene diversity 
(from sensitive 
population) 
0.839 ± 0.076 
0.593 ± 0.098 
0.920 ± 0.114 
Expected Gene Diversity 
(from (Anderson et al. 
2000b» 
0.781 
0.688 
0.636 
lrable 4-2: Gene diversity at microsatellite loci divided by repeat type 
b The pattern of diversity around the triple mutant dhji'" alleles sampled in 
KwaZulu Natal, South Africa 
lrhe diversity at loci on triple mutant chromosomes was compared with that on 
sensitive chromosomes. Figures 4-2b and c show plots of gene diversity on the 
sensitive chromosomes compared with that on triple mutant chromosomes collected 
in 1996 (n=13) and in 1999 (n=17) respectively. lrhe most striking observation in 
each case is the valley of significantly reduced gene diversity on the selected 
chromosomes. In addition to this there are differences between 1996 and 1999. In 
1996 when the frequency of triple mutants in the popUlation was 22% (Figure 4-1) 
the core region of significantly reduced diversity extended across 70kb from locus 
U60 upstream to DI0 downstream. In 1999 when the frequency of the triple mutant 
had increased to 38% (Figure 4-1) the core region was constricted to 50kb, extending 
from U40 upstream to D 1 0 downstream (Figure 4-2c). 
lrhe core region of reduced gene diversity was taken as the range of markers between 
which there was an unbroken significant reduction in gene diversity. In some cases, 
where single locus spikes in diversity defined the outer edge of the core region there 
was significant diversity loss beyond the limits of the core region, for example the dip 
in diversity at locus U70 particular in 1996. In that case this may be considered to 
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have occurred as a result of selection on the favourable allele and an extended region 
of interrupted reduced diversity could be described. However this locus was not 
included in defining the core region of the selective sweep that would be compared 
between populations. 
Interestingly, at both time points a significant asymmetry in the shape of the selective 
sweep is apparent with the region of reduced gene diversity extending 4-6 times 
further upstream than downstream. An additional microsatellite locus was identified 
between U75 to U70 to ascertain whether the dip in diversity relative to the sensitive 
chromosome population at U75 was an anomaly or suggestive of an additional site 
under selection. Diversity at this intermittent marker was midway between the two 
flanking markers in 1996 and had returned to baseline levels in 1999. It was 
concluded that if selection was occurring at a site proximal to locus U75 it was only 
very weak and more likely that the dip in diversity was an anomaly. 
The size and direction of difference in gene diversity at micro satellite loci on the 
triple mutant chromosome from 1996, the triple mutant chromosomes from 1999 and 
the sensitive chromosomes are summarised in Figure 4-3. The significance levels 
were determined by the proportion of permutated diversity ratios that exceeded the 
observed diversity ratio for a given locus. Paired comparison of sensitive with triple 
mutant chromosomes from 1996 found diversity values were by permutation of the 
dataset significantly lower than on sensitive chromosomes at 8 loci spanning the 70kb 
core region. On the downstream side of dhfr in that comparison there several loci at 
which diversity was lower on the sensitive chromosomes indicating that diversity had 
fully returned on the resistant chromosomes. 
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Figure 4-2: The gene diversity at each locus for populations of a) merged sensitive 
dhfr alleles (dashed line in all subsequent charts); b) triple mutant dhfiA allele from 
KwaZulu Natal in 1996 (solid line), c) triple mutant dhfr allele from KwaZulu Natal 
in 1999 (solid line). Distances shown are actual physical distances from codon 108 of 
dhfr in bp. 95% CI were calculated from the unbiased variance of gene diversity as 
given by Nei and Roychoudbury (1974) 
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On the triple mutant chromosomes from 1999, diversity was significantly lower at 
each of the 7 core loci (spanning 50kb) and the magnitude of the difference in 
diversity was reduced from 0.53-0.76 in 1996 to 0.19-0.50 in 1999. 
c Time and its effects on the pattern oj diversity around dhfr: longitudinal data 
from KwaZulu Natal 
The observed recovery in diversity over time could be caused by recombination 
through outcrossing with sensitive chromosomes or by the generation of diversity 
through de-novo mutation at microsatellite loci. To further examine the contributory 
factors influencing the dimensions of the selective sweep we have used the Wiehe 
model (Wiehe 1998), modified by Nair et al (Nair et al. 2003) which simulates the 
combined effects of recombination, mutation, selection, effective population size and 
inbreeding to predict the dimension of a selective sweep at equilibrium. To estimate 
the size of the effective population of P. Jalciparum in KwaZulu Natal we used gene 
diversity averaged across the loci on the sensitive (ancestral) chromosomes which 
gives a value of 4904 under an assumption of lAM. The selection coefficient is 
calculated as 0.048 based upon the measured changes in frequency of the triple 
mutant allele during the interval between 1996 and 1999 (described in figure 4-1). 
An inbreeding coefficient (F) of 0.7 was assumed. This is the rate at which selfing 
occurs and was estimated from the number of infections in which a single dhfi-
haplotype was detected in the original survey material. As it has been shown that the 
triple mutant allele did not arise in Africa but was imported (Roper et al. 2003), rather 
than assume an initial frequency reflecting the single mutation event, we used an 
estimate that reflects the number of migrants (m) between populations within the 
region and therefore the spread by gene flow. 
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We estimated the baseline number of migrants into a southeast African population 
from the F ST estimate of population differentiation of parasites randomly sampled 
from Mpumalanga province of South Africa and Tanzania and typed at eight 
microsatellites dispersed throughout the parasite genome (Chapter 3). The FST of 
0.011 estimates 24 migrants per generation from one population to the other. This is 
comparable to a F ST estimate between two East African populations separated by 
approximately 2000km, Zimbabwe and Uganda, where m was determined as 20 
(Anderson et al. 2000a). Estimating the initial frequency based on the number of 
migrants in this manner is a coarse approach as it may be an over estimate, as this 
simple approach assumes that all migrants are carrying the triple mutant allele. 
However, it provides a relative scale of the differences between populations in the 
initial starting frequencies in the explanation of the observed selective sweep data. 
For this analysis we used an estimate of 20 migrants per generation. 
The predicted values from the model were adjusted at each locus for the baseline 
level of gene diversity on the sensitive chromosomes. The dimensions of the 
selective sweep in 1999 very closely resemble those of one predicted on the basis of 
these parameters (Figure 4-4). The goodness of fit was measured by the modelled 
data being not significantly different, by 95% confidence intervals, from the observed 
data (loci marked by an asterisk in Figure 4-4). This was true at 4 out of the 5 loci 
within the core region U40 to D 1 0 already defined as having reduced diversity 
significantly below that of the sensitive population, and at 17 out of the total 26 loci, 
with the majority of the similarity in the portions of the selective sweep closest to 
dhfi·. There is an apparent transition between 1996 and 1999 as the competing effects 
of selection and recombination reach equilibrium. 
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Figure 4-4: Prediction ofa line of best fit by a deterministic model of hitchhiking on 
the chromosome. The grey solid line is the plot of the actual data in KwaZulu Natal 
in 1999. Dashed lines above this line represent the 95% confidence intervals around 
the actual data. The solid black line and dashed grey line are the model predictions 
for KwaZulu Natal and Thailand respectively. Parameters used for KwaZulu Natal 
were Ne = 4904, Jl = 1.59xl0-4, r = 5.88xl0-4, s = 0.048, m = 20, F= 0.7. The 
asterisks above the chart indicate when the modelled data using these parameters falls 
within the 95% CI of the actual data. Parameters used for the Thai prediction were as 
reported by Nair et al (2003). The squares indicate when the modelled data for the 
Thai population falls within the 95% CI of the KwaZulu Natal actual data 
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A selective sweep around dhfr has been described in a P. Jalciparum population on 
the Thai-Myanmar border. In this population an additional mutation at codon 164 is 
present and resistance alleles contain between 2-4 mutations. Drug selection, which 
took place between 1976 and 1989, completely displaced the sensitive alleles (Nair et 
al. 2003). Approximately 90 generations after drug selection ceased the selective 
sweep conformed to a shape predicted on the basis of a selection coefficient of 0.1, 
inbreeding co-efficient of 0.8 and a population size of 1000. The underlying 
microsatellite mutation rate and basic recombination rate not adjusted for the effects 
of inbreeding are assumed to be the same between KwaZulu Natal and Thailand. The 
assumption of the same underlying recombination rate makes the assumes that the 
genetic cross between parasite lines Hb3 and Dd2 is representative of the 
recombination rate throughout the total parasite population (Su et al. 1999). 
The selective sweeps predicted under these two site-specific sets of circumstances are 
shown in Figure 4-4. Whilst the model data from parameters estimated for southeast 
Asia has not been adjusted for the baseline level of gene diversity at each locus for 
that population, the predicted line also appears fit the observed data set from 1999, 
yet only lout of 5 loci is not significantly different from the observed data within the 
region of significantly reduced gene diversity and only 8 out of 26 loci across the 
whole region (loci marked by a square in figure 4-4). We argue that the model using 
the parameters estimated for K waZulu Natal is a better fit to the observed data. In 
KwaZulu Natal, the selective sweep is half as wide and just two thirds of the depth of 
that found in southeast Asia (Nair et a1.2003; Anderson 2004) and this difference is 
explained by the lower selection coefficient (Figure 4-4) and to a lesser degree the 5 
times smaller population size in southeast Asia. The effect of reduced selection is 
more opportunities for recombination to occur between selected and unselected 
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chromosomes. A smaller population size results in a shorter time until fixation of a 
favourable mutation, thereby also reducing the opportunities for recombination events 
(Kim and Stephan 2002). The difference in the magnitude of the selection coefficient 
between southeast Asia and KwaZulu Natal is probably a true reflection of the 
coverage of treatment and may also reflect the presence of even more highly resistant 
alleles containing substitutions at codon 164 in southeast Asia. There is a spectrum 
of selection coefficients acting on drug resistance loci in natural populations of P. 
Jalciparum and these are reviewed elsewhere (Anderson 2004). Effective 
recombination rates in Africa are much higher in general but in the case of K waZulu 
Natal they are very similar to Thailand 
d The effect oj different effective recombination rates: from low in 
Mpumalanga, South Ajhca to high in Tanzania 
Although inbreeding coefficients of KwaZulu Natal and Thai-Myanmar populations 
were similar, transmission intensity in the African region spans an enormous range 
and populations in general have a much higher effective recombination rate there 
(Babiker et al. 1994; Anderson 2004). To examine the role of effective 
recombination rates we compared the selective sweep on triple mutant chromosomes 
in KwaZulu Natal with Mpumalanga, where the inbreeding coefficient (F) is high and 
southern Tanzania where F is low (Table 4-1). 
The valleys of reduced gene diversity found surrounding the triple mutant dhfr allele 
present in populations in Tanzania (n=48), and Mpumalanga (n=56) are shown in 
Figure 4-5a and 4-5b. Consistent with previous findings, hitchhiking alleles 
immediately flanking the triple mutant alleles in all three populations were identical 
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indicating that they are descendants of one ancestral triple mutant (Roper et al. 2003; 
Roper et al. 2004). In the samples taken from the Tanzanian population, a 50kb core 
region extending from loci U40 to D 10 was found to have significantly lower gene 
diversity than the sensitive baseline. In Mpumalanga the core region of significantly 
reduced gene diversity was 70kb extending from loci U60 to DIO. 
When the population pair wise comparisons of the gene diversity values for each 
matched pair of loci were plotted, we found a strong correlation for comparisons 
between the triple mutant allele populations of Mpumalanga with KwaZulu Natal 
1999 (r2 = 0.934 p«O.OOOI), Tanzania with KwaZulu Natal 1999 (r2= 0.889 
p«O.OOOl) and Mpumalanga with Tanzania (r2 = 0.772 p=O.OOI). The strong 
correlate is a good indication of the similarities in the dimensions of the selective 
sweeps in Tanzania, Mpumalanga and KwaZulu Natal in 1999. However, correlates 
between Mpumalanga, Tanzania and the triple mutant population from K waZulu 
Natal in 1996 were much weaker (Mpumalanga r2= 0.664 p=O.OIO; Tanzania r2 = 
0.620 p=0.018). 
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Figure 4-5: The gene diversity at each locus for populations of a) triple mutant dhfr 
chromosomes from Mpumalanga and b) triple mutant dhfr chromosomes from 
Tanzania. Distances shown are actual physical distances from codon 108 of dhfi" in 
bp. 95% CI were calculated from the unbiased variance of gene diversity as given by 
Nei and Roychoudbury (1974). 
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Figure 4-6: The significance and direction of differences in gene diversity between 
sensitive and triple mutant chromosomes from Mpumalanga, Tanzania and KwaZulu 
Natal '99 at each locus. Light grey = p<O.05; dark grey = p<O.OOl; black = 
p<O.OOOl. 
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The significant differences between loci and their direction and magnitude are 
summarised in Figure 4-6. The differences between triple mutant chromosomes from 
the three sites are limited. Two significant observations were that the selective sweep 
from Mpumalanga is larger, and secondly, the KwaZulu Natal 1999 selective sweep 
has reduced depth at the markers closest to dhfi" relative to that in Tanzania. The lack 
of major differences in the dimensions of the three selective sweeps from 
Mpumalanga and Tanzania in 2001 as compared with that from KwaZulu Natal in 
1999 is in contrast to the reduction in size that occurred over three years from 1996 to 
1999 in KwaZulu Natal. We have suggested that a relatively weak selection 
coefficient versus a high rate of recombination explains the differences in the size of 
the selective sweeps in KwaZulu Natal between the two time points. Extrapolating 
the rates of breakdown of the selective sweep between 1996 and 1999 one may have 
expected on the Mpumalangan and Tanzanian derived chromosomes in 2001 to be 
more than 10kb smaller than that found in KwaZulu Natal in 1999. By contrast we 
find that the Mpumalangan selective sweep is actually significantly wider, and that 
the Tanzanian selective sweep whilst being the same width, is significantly deeper 
than in 1999. Differences in both width and depth imply the recombination has not 
occurred to the same extent in these populations as it has in KwaZulu Natal. The 
differences between the populations expected from the differences in EIR and 
effective recombination rate, were not apparent. In addition to EIR, assortative 
mating through drug pressure killing sensitive parasites in mixed infections could also 
cause an increase in the inbreeding coefficient. 
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e The importance of gene flow and initial starting frequencies on patterns of 
diversity 
Using the model of expected diversity along a chromosome at equilibrium, we 
determined a line of best fit to the valleys of reduced gene diversity in Tanzania and 
Mpumalanga, using population-specific parameters calculated as follows. Inbreeding 
coefficients of 0.7 and 0.4 were estimated for Mpumalanga and Tanzania respectively 
from the number of single infections detected at dhfr across all samples in the initial 
surveys. The effective population sizes (Ne) were estimated from the average gene 
diversity of 8 microsatellites (Anderson et al. 1999) dispersed throughout the parasite 
genome (Chapter 3). The Ne was determined to be 5987 in Tanzania and 
Ne = 4642 in Mpumalanga. These estimates are comparable to KwaZulu Natal and 
to other southeast African populations (Anderson et al. 2000a) and larger than 
estimated for southeast Asia. The selection coefficient of 0.048, directly measured 
from frequency changes in KwaZulu Natal (Figure 4-1) was used and is the only 
direct measurement available for Africa at present. 
In southeast Asia the initial frequency of the favoured allele will reflect the 
underlying mutation rate of dhji", whereas in southeast Africa it is a reflection of the 
amount of gene flow between populations. Using the model, we estimated the 
number of migrants (m) required for best fit to the actual data was 1000 in Tanzania 
and 200 in Mpumalanga, 50- and 10-fold larger than the estimate based on an FST in 
the region. These may be overestimates because, unlike KwaZulu Natal, the selective 
sweep in populations of Tanzania and Mpumalanga are not yet likely to be at 
equilibrium. Alternatively the selection coefficient used in our simulation may be 
underestimated. In the case of Tanzania, an increase in the selection coefficient to 
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approximately 0.2 is equivalent to increase of m from 20 to 1000. However, it is 
unlikely that the coverage of pyrimethamine usage in Tanzania was higher than in 
KwaZulu Natal, Mpumalanga or on the Thailand-Myanmar border, since in Tanzania 
the first-line treatment at the time of sampling was chloroquine, the EIR is high 
resulting in acquired malaria immunity and more asymptomatic infections (Snow et 
al. 1997; Kleinschmidt and Sharp 2001). 
In attempting to identify key parameters that explain the dimensions of the selective 
sweeps in the different sites using the model it becomes clear that it is not possible to 
distinguish a clear effect of recombination. However, over and above selection and 
recombination is an unquantifiable but important influence, namely the homogenizing 
effect of gene flow across the entire southeast African region. Drug treatment use in 
the various nation states has historically varied widely and local frequencies of 
resistance alleles will reflect this. The number of migrant triple mutant alleles 
entering a country will be determined by movement of people from neighbouring 
states and the frequency of that allele in the region or country they come from. 
Although we have quantified recombination rates, the strength of pyrimethamine 
selection and its duration cannot be inferred from national treatment policy histories. 
In Tanzania, SP was the recommended second-line treatment at the time of sampling 
and had been for 18 years. In addition it is available through private suppliers and 
used in self treatment (Goodman et al. 2004). In northern Tanzania the frequency of 
the triple mutant allele can be as high as 84% (Pearce et al. 2003) reflecting a higher 
local level of use and a history of resistance (Ronn et al. 1996; Trigg et al. 1997). 
Gene flow between northern and southern Tanzania is likely to be high (Clyde 1967). 
A possible explanation for the larger than expected dimensions of the selective sweep 
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is that its initial frequency in the population was generated by high levels of gene 
flow from northern Tanzania, effectively reducing the population size and thus 
opportunities for out-crossing. 
The parameters used to fit the line of equilibrium to the selective sweep on the triple 
mutant chromosomes in Mpumalanga are feasibly close to those of the actual 
equilibrium values. The estimate of s equivalent to the m of 200 is only slightly 
higher at 0.06 than the measured s in K waZulu Natal (0.048). The drug selection 
history in Mpumalanga is shorter than in K waZulu Natal as SP only became first line 
anti-malarial in 1997, nine years after its implementation in KwaZulu Natal. 
1 Asymmetric pattern 01 diversity around dhfr 
A major characteristic of the selective sweeps around the triple mutant dhfr allele in 
KwaZulu Natal, Tanzania, Mpumalanga and southeast Asia is a pronounced 
asymmetry, and interestingly in every case the region of reduced gene diversity 
extends further on the upstream side of dhfr. There are a number of competing 
explanations for this phenomenon, and the most obvious is that rates of 
recombination differ on either side of the gene. Considerable variation in the 
distribution of crossover events, differing greatly from their genome average can 
reflect recombination hotspots or cold spots as well as other genome features such as 
proximity to centromeres and telomeres. (Barnes et al. 1995; Lichten and Goldman 
1995). However the dhfr gene is in the centre of chromosome 4 and the distribution 
of meiotic crossover events on P. lalciparum chromosomes has been shown to be 
relatively uniform in the progeny of a laboratory cross (Su et al. 1999). 
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Alternatively, the asymmetry may be due to stochastic nature of recombination events 
during short phases of intense selection. In a model of the pattern of genetic variation 
along a recombining chromosome, Kim and Stephan (Kim and Stephan 2002) 
showed that in a population where the time to fixation was short, such as when 
effective population size (Ne) was small, the selective sweep would be asymmetrical 
around the selected site. The short lineage of the rapidly expanding selected allele 
decreases the amount of time for recombination events to occur and the pattern is 
more of stochastic noise. In southeast Asia, pyrimethamine resistance swept to 
fixation in only six years (White 1992). In Africa the triple mutant is yet to reach 
fixation, so it is likely that the lineage is long and therefore the asymmetry can not be 
easily explained. Intense selection pressure can result in rapid epidemic expansions 
of resistant parasites in local populations in Africa and as such this would facilitate 
the formation of the asymmetry. The caveat to this hypothesis is that it assumes that 
the asymmetry is random, and therefore by chance it has fallen to same side of dhfr in 
East Africa as it has in southeast Asia. 
Recent analysis of the genetic cross between parasite lines Hb3 and Dd2 has 
identified a 48.6kb region of chromosome 4 as in complete linkage with the folate 
salvage phenotype, thought to abrogate the killing effect of the sulphadoxine 
component ofSP (Wang et al. 2004a). On this fragment were 7 open reading frames 
including dhfr. If there were a resistance enhancing or a resistance compensating 
adaptation in the region upstream of the dhjiA triple mutant allele, such as one 
favourable for folate salvage then there would be reason to expect consistent 
asymmetry in the same direction. However the changes we observed over time do 
not support this as the area of lowest diversity became more condensed and mapped 
onto the dhfr gene itself. We observed a gradient in the depth of the selective sweep, 
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which becomes is progressively deeper as you get nearer to the gene. We observed 
no further dips in the levels of diversity along the chromosome that would indicate a 
putative second site under selection. 
V Concluding remarks 
In African populations there was a consistently narrower selective sweep than found 
on the Thailand - Myanmar border and this was expected because effective 
recombination rates are in general much higher in Africa due to the higher 
transmission intensity. We observed that over time in KwaZulu Natal the selective 
sweep reduced in size towards equilibrium between selection and recombination. 
When we compared the three African populations of KwaZulu Natal, Mpumalanga 
and Tanzania we did not observe a clear relationship between the width of the area of 
reduced diversity and transmission intensity/effective recombination rates. The key 
factors appear to be the strength of selection, length of time over which drug selection 
has acted and the starting frequency of resistance mutants. Although the extent of 
gene flow is high between populations in this region, resistance levels are 
heterogeneous because of selection imposed in neighbouring countries implementing 
different treatment policies. Importantly, the founder events in Asia were determined 
by mutation rates whereas in Africa, these were dictated by resistance levels in 
neighbouring states and the contribution of diffusion of resistance alleles in 
determining starting frequencies has been significant. 
The size of the observed selective sweep in Tanzania is contrary to expectation given 
the population genetic parameters of the region, but may be explained by large 
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numbers of migrants into that population. Our data underlines the importance of gene 
flow in the spread of resistance between African countries. 
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Chapter 5 Characteristics of a Selective Sweep Flanking the Double Mutant dhfr 
Allele in Two Southeast African Plasmodium falciparum Populations. 
I Abstract 
The dhfr double mutant allele has previously been shown not to confer the ability to 
survive the initial concentrations of pyrimethamine in the host plasma and was 
apparently displaced by the triple mutant allele in K waZulu Natal under SP selection. 
Yet lineages possessing the double mutant allele are widespread throughout the 
southeast African region. To examine the effects of selection on this allele we looked 
for evidence of selective sweeps. Here we describe the genetic diversity at thirteen 
microsatellite loci covering an approximately 120kb region flanking the 
pyrimethamine resistant dhfr C59R+S 1 08N double mutant allele. By comparing 
diversity present on sensitive chromosome 4 with double mutant chromosomes,we 
identified a region of significantly reduced diversity. Samples from Mpumalanga 
province of South Africa and in southern Tanzania were compared. In each case the 
region of reduced gene diversity was smaller than that previously described on triple 
mutant chromosomes sampled in the same populations. However, it was not as small 
as predicted by a deterministic model given a directly observed selection coefficient 
and quantified degree of gene flow. We find evidence of recombination between 
double and triple mutant chromosomes that had obscured the size of the original 
selective sweep on the double mutant chromosome. We discuss the implications of 
this with reference to the size and stability of the selective sweep on double mutant 
chromosomes. 
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II Introduction 
The two dhfr double mutant alleles common to southeast Africa are comprised of 
amino acid substitutions at co dons C59R+S108N, orN51I+S108N (Pearce et al. 
2003; Roper et al. 2003). Descriptions of flanking sequence polymorphism on South 
African and Tanzanian double mutant chromosomes within 5.5kb of dhji", identified 
that these alleles had arisen infrequently; once in the case of the 59/108 allele and 
twice in the case of the 511108 allele (Roper et al. 2003). All double mutant lineages 
had separate ancestries from the triple mutant N5II+C59R+S108N allele (Roper et al. 
2003). As the two alleles identified in KwaZulu Natal have separate origins, the 
identification of hitch hiking alleles would become complicated if the two 51 1108 
double mutant chromosomes had recombined, and thus we have chosen to describe 
the selective sweep on double mutant chromosomes carrying the single ancestry 
C59R+S 1 08N dhfi" allele. 
The double mutant dhfr allele confers both a selective advantage in the presence of 
drug and a fitness cost in the absence of drug selection (Watkins et al.1997 ; Fohl and 
Roos 2003). It has been shown in vitro that the double mutant allele confers the 
ability to survive plasma concentrations of pyrimethamine inhibitory to sensitive 
parasites, but not the higher full treatment dose concentrations that the triple mutant 
allele can survive (Watkins et al. 1997). There is for the double mutant allele 
effectively a window of survival beginning 7 to 15 days after initial dosing until at 
least 52 days subsequently, in which the concentrations of SP in the plasma select for 
double mutant and higher forms of pyrimethamine resistance but are inhibitory to the 
sensitive parasites. Arguably selection for the double mutant allele can only occur if 
a new infection occurs or if the parasite emerges from the liver stage within the 
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selective window. The chances of new infection by a parasite carrying the dhfr 
double mutant allele within this 7-52 day window are increased in populations where 
the intensity of transmission is high. 
It is likely that the double mutant allele has existed in the region for longer than the 
triple mutant allele. In KwaZulu Natal we detennined the frequency change of the 
dhfr alleles between 1995 and 1999, whilst SP selection was operating (Roper et al. 
2003). We found that whilst the frequency of the triple mutant allele was increasing 
(22% to 38%), the frequency of the double mutant allele decreased (30%-15%). It is 
clear from the ancestry of the two resistance allele lineages that the frequency 
changes observed are not due to transitional steps of double mutant to triple mutant in 
the evolution of resistance as observed in southeast Asia (Nair et al. 2003), but reflect 
the fitness differential between the two. 
We have looked for evidence of a selective sweep around the double mutant allele in 
the fonn of regions of reduced 'diversity on the 59/108 double mutant chromosomes 
through comparison to diversity on ancestral chromosomes. These regions of 
reduced diversity around the double mutant allele are likely to be more transient due 
to its' longer time in the population and weaker SP selection operating on it around 
double mutant than triple mutant alleles and thus we compare resistant chromosomes 
sampled from the same population. As with the work on the triple mutant allele 
populations (see chapter 4), we address the effect of transmission intensity in the 
breakdown of the selective sweep by sampling double mutant chromosomes from 
Tanzania, where the entomological inoculation rate is high, and Mpumalanga where it 
is low (See Table 5-1). 
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Population History of Sp$ usage Frequency of the EIR? 
and (first line unless double mutant dhfr (Infectious bites per 
sample date stated otherwise) allele (59/108) annum) 
Mpumalanga 1997 - present day 14% ?§ <O.l4t 2001 
Tanzania 2001 - present day 10.5% ? 
2001 (after 18 years second 584~ line) 
Table 5-1: '" (Roper et al. 2003); $ Sulphadoxine-Pyrimethamine; § clinical samples; ? 
unpublished; t personal communication K. Barnes; ~ (Charlwood et al. 1998) 
III Methods and Materials 
a Study samples: 
The study sites used in this investigation are regions of southern Tanzanian and the 
north eastern province of South Africa, Mpumalanga. The Tanzanian samples were 
collected in 2001 during household surveys of the three districts of Kilombero, 
Ulanga and Rufiji,par t of the Interdisciplinary Monitoring Project for Antimalarial 
Combination Therapy in Tanzania (IMP ACT -TZ) artesunate combination therapy 
trial. The samples from Mpumalanga were collected in 2001 from symptomatic 
malaria patients prior to treatment, as a component of the Southeast African 
Combination Antimalarial Therapy (SEACAT) evaluation. Table 5-1 summarises the 
drug use and epidemiological context of the populations sampled. Sensitive 
chromosomes were sampled in KwaZulu Natal in South Africa where the frequency 
of multiple infections is low. A full description of these samples can be found in the 
methods of Chapter 4. The typing of the point mutations present in dhfr and dhps 
were performed as described in chapter 2. 
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b peR amplification and analysis of microsatellite sequences: 
The microsatellites primer sequences can be found in Appendix 3. The PCRs were 
performed as described in Chapter 4. 
c Statistics and Software 
Gene diversity values were calculated as He = [n/ (n-l)][I-LPi2] where n is the 
number of samples and Pi is the frequency of the ith allele. The variance of the gene 
diversity was calculated using Nei and Roychoudhury's formula (Nei and 
Roychoudhury 1974): 
The software PowerMarker (Liu and Muse 2004) was used to calculate population 
differentiation theta values. We measured the significance in differences between 
gene diversity between pairs of chromosomal populations by permutation (Nash et al. 
2005). The ratio of gene diversities between a pair of populations was calculated at 
each locus in the observed data sets and in 10000 simulated datasets where the alleles 
at each locus were reshuffled amongst all parasites. To obtain the level of 
significance we counted the number of occasions that the simulated ratio of 
diversities exceeded that for the observed data. The statistical package R (The R 
Core Development Team 2005) was used to generate the permutations. 
Wiehe (Wiehe 1998) developed a model to describe the pattern of reduced variation 
in microsatellites flanking a selected site. The model is described in full in Chapter 4. 
The selection coefficient's' directly observed from the frequency changes in 
155 
Characteristics of a Selective Sweep Flanking the Double Mutant dhfr Allele in Two Southeast African Plasmodiumfalciparum 
Populations. 
Tanzania was calculated using Pn=Po x esn where Pn = frequency at n generations, Po 
= frequency at start, and n= number of generations (Hartl and Clark 1997). 
Clustering of individuals into 'k' populations was carried out using the software 
Structure (Pritchard, Stephens, and Donnelly 2000; Falush, Stephens, and Pritchard 
2003). Bumin (minimising the effects of the starting parameter configuration) and 
run lengths were 105 and 106 Markov chain Monte Carlo (MCMe) iterations 
respectively. All other parameters were as default for the software. 
IV Results and Interpretation 
Previous work (Chapter 4 and Pearce et al. MBE in press) has shown reduced 
diversity around the triple mutant allele that had, at its greatest width, reduced 
diversity from 60kb upstream to 10kb downstream. Accordingly, a narrow subset of 
micro satellites was used in this study of double mutant chromosomes. These were 
70, 60, 40, 30, 20 and 10kb upstream and 10, 20, 30, 40 and 50kb downstream of 
codon 108 of dhfr. In addition, two microsatellites located at 5.3kb and 4.4kb 
upstream used in a previous study were included (Roper et al. 2003). Levels of 
diversity at each micro satellite locus were compared with that in the sample of 
sensitive chromosomes from KwaZulu Natal described in Chapter 4, which we used 
as representative of the region. The high gene diversity and low population 
differentiation described between southeast African populations in Chapter 3 
indicates that there is no reasonable expectation that patterns of high gene diversity 
observed on sensitive chromosomes identified in KwaZulu Natal would differ on non 
selected chromosome 4 populations in either of the other populations. 
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a Patterns of reduced gene diversity on double mutant chromosomes 
At the time of sampling the frequencies of the double mutant alleles in the field were 
14% in Mpumalanga and 10.5% in Tanzania. To examine the effect of selection we 
compared the Mpumalanga (n = 27) and Tanzanian (n = 21) double mutant 
chromosomes with the baseline of diversity on the sensitive chromosomes. We 
plotted gene diversity with 95% confidence intervals for each microsatellite against 
distance from codon 108 of dhji" (Figure 5-1). Significantly reduced gene diversity 
existed around the selected site covering 30kb (U20 to DI0) in Mpumalanga and 
50kb (U40 to D 10) in Tanzania. The direction and extent of change in gene diversity 
at loci with significant differences between ancestral and double mutant 
chromosomes are given in Figure 5-2 and were determined as the proportion of 
permutated diversity ratios that exceeded the observe diversity ratio for a given locus. 
This process identified a core region of U40 to D20 in Mpumalanga and U40 to D20 
in Tanzania as being significantly different, but in both cases locus D20 had 
considerably lower diversity in the sensitive chromosome population. As in Chapter 
4 the core region of the selective sweep is defined as the range of markers between 
which there was an unbroken significant reduction in gene diversity. Both of the 
selective sweeps are asymmetrical with greater diversity on the downstream side of 
dhfr. Interestingly the same asymmetry was observed in the selective sweep 
described around the dhfr triple mutant chromosome. 
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Figure 5-1: The gene diversity at each locus for populations of a) the double mutant 
dhfr chromosomes sampled from Mpumalanga, South Africa (solid line) and b) 
double mutant dhfr chromosomes sampled from Tanzania (solid line). On both plots 
diversity at loci flanking sensitive dhfr alleles sampled from KwaZulu Natal, 
represented by the dashed line. Distances shown are actual physical distances from 
codon 108 of dhfr in bp. 95% CI were calculated from the unbiased variance of gene 
diversity as given by Nei and Roychoudbury (1974). 
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The upstream markers U5.3 and U4.4 are the microsatellite loci closest to the selected 
site. Alleles of 199bp and 186bp at these loci respectively are the same as previously 
reported for KwaZulu Natal and northern Tanzania (Roper et al. 2003), confirmation 
that the monophyletic dhfr double mutant has spread widely. 
b The selective sweep present on the double mutant chromosomes is smaller 
than that on triple mutant chromosomes 
Comparisons were made of the size of the selective sweeps on double mutant and 
triple mutant chromosomes sampled from the same population (Figure 5-3). In 
Mpumalanga the region of reduced diversity on the triple mutant chromosome 
extended from marker U 60 upstream to D 1 0 downstream. The double mutant 
chromosome population has significantly higher gene diversity at each locus within 
this range, with the exception of loci U4.4 and DI0. In Tanzania, the triple mutant 
selective sweep extended from U40 to D 1 0; however only at U20-U4.4 was the 
diversity significantly lower than that on the double mutant chromosome; there was 
no significant difference at the remaining sites (U40-U30). Across the two double 
mutant chromosomes there were only two loci at which there was a significant 
difference in the depth of the selective sweep namely U4.4 and U60, reflecting a 
lower gene diversity on the Tanzanian double mutant chromosomes. 
c The archetypal selective sweeps in Tanzania and South Africa 
As the two derived chromosomal lineages coexist in Tanzania and Mpumalanga, it is 
likely that recombination has occurred between them. Recombination between the 
double mutant chromosomes and an expanding lineage of triple mutant chromosomes 
could cause an apparent extension in the size of the selective sweep on the double 
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mutant chromosomes. Conversely, recombination with sensitive chromosomes will 
reduce the extent of chromosome covered by the selective sweep. To investigate the 
extent of triple and double mutant recombination, we determined the 'archetype' 
triple mutant and double mutant chromosomes for each popUlation. These were 
inferred by selecting the allele with the highest frequency at each locus for resistance 
allele in the two populations. Archetypal alleles are shown in Figure 5-4 for the 
regions of the chromosome where diversity is significantly reduced. 
Inspection of figure 5-4 shows clear differentiation at close loci V4.4 and V5.3 but 
further out on the double mutant chromosomes there were alleles common to both the 
double mutant and triple mutant lineages, namely loci VI0, D 1 0 and D20. Locus 
VI0 on the sensitive chromosomes had a distribution of alleles more typical for a site 
where diversity is high suggesting that at this locus recombination had occurred 
between the two resistant chromosomes. At locus D20 convergence is explained by 
the fact that it is also most common on the sensitive chromosome. At locus D 10 the 
shared allele had moderately high frequency among the sensitive chromosomes. The 
pattern of allele sharing between the triple and double mutant chromosomes at D 1 0 
and D20 can be explained by the lack of variability in the ancestral state. These loci 
are not informative in determining how much recombination has occurred. 
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Figure 5-3: The significance and direction of differences in gene diversity between double mutant 
and triple mutant chromosomes from Mpumalanga and Tanzania at each locus. Light grey = 
p<O.05; dark grey = p<O.OOl; black = p<O.OOOl. 
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Figure 5-4: The archetypal haplotypes of flanking sequence loci for sites within the region of reduced 
diversity defined on the triple mutant chromosome. See text for method of definition of archetype 
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Excluding the loci described above, it was observed that there was a notable 
frequency of contaminating archetype triple mutant alleles at a number of loci on the 
double mutant chromosome sampled in both Mpumalanga and Tanzania. In 
Mpumalanga the loci on the double mutant chromosomes with the triple mutant 
archetypal hitchhikers were U60 (31 %), U40 (32%), U20 (19%), U5.3 (5%) and U4.4 
(13%). In Tanzania archetype triple mutant alleles were found at loci U60 (15%), 
U40 (45%), U20 (5%), U5.3 (10%) and U4.4 (35%). In neither double mutant 
chromosome popUlation was the archetypal triple mutant allele found at locus U30. 
The contamination of loci on the double mutant chromosomes by archetypal triple 
mutant alleles obscures the extent of reduced gene diversity occurring purely due to 
selection on the double mutant allele. To estimate the extent to which recombination 
with triple mutants had reduced diversity around the double mutant, we recalculated 
the gene diversity at each site using only the frequency in the data set of the archetype 
double mutant alleles, ignoring the frequency of the triple mutant chromosome 
associated alleles and of the rare alleles (which contribute least to the calculation). In 
Mpumalanga, the recalculation of gene diversity increased the range of loci where 
gene diversity was significantly lower than on the sensitive chromosomes to U30 -
D 1 0 as compared to U20 - D 1 0 when all alleles present were used in the calculation. 
In Tanzania this recalculation decreased the number of loci with significantly lower 
diversity than on ancestral chromosomes to U30 - DI0 (excluding U4.4), smaller 
than the region of U40 - D 10 described when all alleles were included in the 
calculation. 
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d Recombination and epidemics in Mpumalanga 
In Mpumalanga we found evidence of an epidemic expansion of a recombinant 
double mutant chromosome. In the process of defining the archetypal double mutant 
chromosomal haplotype in Mpumalanga, at each of the loci U30 and U20 were two 
alleles that could be defined as double mutant archetypal hitchhiking alleles (Figure 
5-4). The uniquely Mpumalangan haplotype 165/211 on the double mutant 
chromosome is found in the population at a frequency of29.6%. The U301U20 
haplotype of alleles 1511203 is common to both study populations of double mutant 
chromosomes, specifically found at a frequency of33.3% in Mpumalanga. When 
testing for the presence of the 165/211 haplotype within the Mpumalangan triple 
mutant chromosome population it was not found. However,the 165 a llele at U30 
was found at 5% frequency, whereas the common 151 allele at U30 was found at a 
frequency of 15%. The U20 al1eles 211 or 203 were found in much lower 
frequencies although 1511203 was found as a complete haplotype in the 
Mpumalangan triple mutant chromosome population on two occasions. 
From the core haplotype of U30 and U20 alleles it was possible to extend the 
haplotype in the 165/211 type double mutant chromosome to loci U40 and U 60 
constructing the haplotype 232/2201165/211, which had a frequency of 14.8% in the 
population. On double mutant chromosomes that had the common east African 
1511203 haplotype there was no associations with specific alleles further upstream 
past U40. 
The presence of two double mutant sUbpopulations is consistent with the rapid 
epidemic expansions of parasite lineages which we have described in Chapter 3. It 
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appears that the novel double mutant lineages derive from epidemic expansion of a 
recombinant double mutant chromosome at loci U60 through to U20. 
e (Structure' analysis - allocation of populations 
We tested the robustness of the definition of archetypes by running the dataset 
through a probabilistic clustering algorithm implemented by the software Structure 
(Pritchard, Stephens, and Donnelly 2000; Falush, Stephens, and Pritchard 2003). The 
algorithm infers whether the current population is structured due to an ancestral 
admixture event between an user defined 'k' number of ancestral populations using a 
Markov chain Monte Carlo (MCMC) scheme to allocate individuals to one of the 'k' 
number of clusters on the basis of similarities in the allele distribution at a 
combination of loci, generating a likelihood value for the allocations. It also 
estimates the proportion, Q, of membership of each individual to a cluster, essentially 
estimating the proportion of an individuals' genome inherited from an ancestral 
population. For example, ifk=2 was assumed and the proportion of an individuals' 
genome coming from ancestral population 1 was Q = 0.5 (=l/k), it will have equal 
proportions of its' genome from both assumed k popUlations; such a result repeated 
over an entire dataset would infer that there was only one population rather than the 
two tested for. For each individual,t he admixture proportion 'q' is independently 
modelled from a symmetrical Dirichlet distribution with hyper-variable a. If a is high 
the distribution is random, where as if a is below 1, the distribution approximates a 
negative binomial distribution and it models each individual as having originated 
mostly from a single population, with each population being equally likely. 
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The algorithm performs the clustering individual by individual and ignores all 
information regarding the sampled populations. Thus we used Structure to determine 
whether the individuals comprising the datasets of ancestral, double mutant and triple 
mutant chromosomes would be clustered into populations matching those defined by 
the allele present at the selected site, dhfr. 
The algorithm can implement three models to test for sUbpopulations and determine 
the population ancestry of individuals, namely the 'no admixture', 'admixture' and 
'linkage between sites' models (Pritchard, Stephens, and Donnelly 2000; Falush, 
Stephens, and Pritchard 2003). The latter model was the most applicable to the 
dataset of linked markers, whereas the other models assume linkage equilibrium 
between the markers. The 'linkage between sites' model infers the ancestral 
admixture event by estimation of the population origin of chromosomal chunks of 
linked markers passed between admixing individuals during meiotic crossover 
(Falush, Stephens, and Pritchard 2003). The chromosomal chunks are defined by 
correlations of allele frequencies between markers in individuals within a cluster. 
In addition to producing a value for the proportion of occasions that an individual was 
grouped into one specific cluster, the linkage between sites also produces a locus by 
locus estimate of the proportion q. From this it is possible to identify chunks of 
chromosome that have remained in linkage during the assumed admixture event and 
identify the ancestral population they may have originated in. 
Structure was run on the dataset of 103 and 90 individuals from the ancestral, double 
mutant and triple mutant chromosomes from Mpumalanga and Tanzania respectively, 
using loci U70dd to D50 and dhfr itself. We included the allele at the selected site, 
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dhjr, as we found that its inclusion did not bias the clustering. Using the linkage 
model, we found that whilst the k=3 assumption was the most likely; the model was 
unable to cluster individuals into a specific population, deviating only slightly from 
proportions close to 11k. This may be because over all loci in the dataset there were 
insufficient differences between the populations to distinguish them. Furthennore, 
the Dirichlet hyper parameter a was above 1, indicating that each individual had 
allele copies originating from all populations in equal proportions (Pritchard, 
Stephens, and Donnelly 2000). 
The locus by locus analysis ofk=3 populations is shown in Figure 5-5. In both 
Mpumalanga and Tanzania large chunks of chromosome were identified as belonging 
to the same cluster. In all cases loci closest to dhfr were most confidently placed in 
one specific cluster. Clusters broadly matched the subdivision of populations into 
subpopulations defined by the allele at dhfr as expected. Within the two derived 
populations the chunks of chromosome identified by the algorithm as having come 
from the same ancestral population extended across a similar number of markers as 
when the region of the chromosome was described by reduced diversity. 
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Figure 5-5: The locus by locus ' structure ' analysis of population differentiation of 
sensitive, double mutant and triple mutant chromosomes in a) Mpumalanga and b) 
Tanzania. Each separate column of colour represents at each locus (cont' d over) the 
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proportion of an individual coming from either the sensitive population (red), the 
double mutant population (yellow) or triple mutant chromosome population (blue) 
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Outside the central core of loci where almost all individuals were confidently placed 
in one specific cluster, the proportion q of an individuals genome finding ancestry in 
only one of the k=3 clusters decreased with increased distance from dhji", such that at 
the loci furthest from the selected site were clustered in all three k clusters with near 
equal proportions. This was particularly pronounced in Tanzania. In Mpumalanga, a 
number of double mutant and triple mutant individual chromosomes remained in one 
cluster for the entire extent of the region genotyped. This reflected the number of 
chromosomes within the dataset that were the relatives, but not direct siblings, of 
recent epidemically expanded lineages. 
By calculating the proportion of individuals that had greater than q = 0.9 proportion 
of ancestry in one of the k populations at each locus, we determined the dimensions 
of the region of reduced diversity using a lower threshold of 20% as the minimum 
number of individuals exceeding this value for q. It was observed that on both the 
Mpumalangan and Tanzanian double mutant chromosomes this process described a 
region from marker U30 to the gene dhfr, agreeing the description of the selective 
sweeps dimensions as determined by calculation of the gene diversity in the absence 
of triple associated and rare alleles. 
f A modelled description of the selection coefficient and amount of gene flow 
required to generate observed patterns of gene diversity 
Wiehe (1998) developed a model later modified by Nair et al. (2003) that describes 
the pattern of diversity at microsatellite loci on chromosome flanking a selected site 
when there is equilibrium between the recombination, selection and mutation rates 
acting on the chromosome, when the selected allele is at fixation. Using this model 
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we can determine the strength of selection required to generate a line of best fit to the 
observed gene diversity on the chromosome. 
The model has been described in full in chapter 4. The values for recombination rate 
(r = 5.88x1 0-4) and micro satellite mutation rate (Jl = 1.59x10-4), in addition to 
population size (Ne = 4624 Mpumalanga; 5987 Tanzania) and inbreeding factor (F = 
0.7 Mpumalanga; 0.4 Tanzania) were as used in that prior section. A selection 
coefficient was calculated from the frequency change between 2000 and 2001 of the 
double mutant allele in Tanzania (s=0.025) based on the change from 9.8% to 10.5%, 
and weaker than the selection coefficient s=0.056, based on the change in triple 
mutant allele frequency (33% to 39%) (Malisa et al unpublished data) over the same 
period. In South Africa from 1995 to 1999 the selection coefficients for the double 
and triple mutant were -0.076 and 0.048 respectively (Roper et al. 2003). 
g Selection versus gene flow 
We input the values calculated for the parameters detailed above, and used the model 
to estimate the upper number of migrants (m) required to generate the gene diversity 
seen on the double mutant chromosomes. In Mpumalanga this was m - 50 and in 
Tanzania it was m = 500 (Figure 5-6). 
The m values predicted for the double mutant chromosomes of m - 50 and m = 500 
are four times lower than the m = 200 and m =2000 estimated by the model for the 
triple mutant populations of Mpumalanga and Tanzania respectively. In chapter 3 we 
described the patterns of gene flow between Tanzania, Mpumalanga and 
Mozambique, concluding that the sites were panmictic. 
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Figure 5-6: Prediction of a line of best fit by a deterministic model of hitchhiking on 
the chromosome. The grey solid line is the plot of the actual data in a) Mpumalanga 
and b) Tanzania. Dashed lines flanking this line represent the 95% confidence 
intervals around the actual data. The solid black line is the model predictions for 
each population using the parameters defined in the text (cont'd over) 
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and s= 0.025 and m=50 (Mpumalanga) or m=500 (Tanzania). The asterisks above 
the chart indicate when the modelled data using these parameters falls within the 95% 
CI of the actual data. 
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The numbers of migrants per generation in any single direction assuming symmetrical 
migration calculated from Wrights' fixation index were in the range of 16 to 28, 
considerably lower than the values of m predicted by the model. 
If the initial starting frequency was fixed at the measured level of gene flow, the 
predicted sweep would be very much smaller. The high initial starting frequencies of 
the resistance allele in the population are required because the measured selection 
coefficient is too weak to counter the effects of recombination. 
It is probable that selection coefficients were higher in the recent past. The K waZulu 
Natal study shows the C59R+S 1 08N frequency dropping, displaced by the triple 
mutant allele (Roper et al. 2003). By fixing the starting frequency of the double 
mutant allele to that when selection began, the selection coefficient required to 
generate the best fit line to the observed selective sweep on the double mutant 
chromosome can be estimated. In Mpumalanga s was only moderately higher than 
the estimated selection coefficient from the frequency changes of the Tanzanian 
double mutant allele when we assumed that the starting frequency was 20 migrants. 
However, using this assumption in Tanzania, the selection coefficient would have 
needed to be double its actual value to generate the same goodness of fit to the 
observed data. 
V Discussion 
We have described the presence of a selective sweep on the C59R+S 108N double 
mutant chromosome sampled from populations in South Africa and Tanzania. The 
selective sweeps in both populations cover a significantly smaller region of the 
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chromosome than the selective sweep present on the triple mutant chromosome, 
which is consistent with their weaker resistance predicted by estimates based on 
measured selection coefficients for this allele in South Africa and Tanzania. In fact 
the extent of the sweep was considerably larger than predicted by the deterministic 
Wiehe model (Wiehe 1998). Gene flow may be an important factor in maintaining 
the size of the selective sweep in the population when selection was absent or very 
low. Also recombination with triple mutant chromosomes was identified as a factor 
important in maintaining the width of the selective sweep present on the 
chromosomes sampled from both populations. 
The double mutant allele is a peculiarity. The very presence of a detectable selective 
sweep is surprising when one considers the factors affecting the survival of the allele 
in a population. The treatment dose of SP is lethal to dhfr double mutant alleles. 
There is an approximately 45 day window between 7 and 52 days post treatment with 
SP when a double mutant allele has fitness advantage over the sensitive allele 
(Watkins et al. 1997). Selection for the double mutant allele can only occur when 
chance re-infection or emergence from the liver occurs during this window. The 
probability of a double mutant parasite infecting a host during this selective window 
will depend on the intensity of transmission in the region and the frequency of the 
double mutant which regionally is only 10-15% (Chapter 3). 
Furthermore, in the absence of drug, resistance mutation at dhfiA may actually have a 
fitness cost. The C59R+S108N double mutant allele was shown to have a 
reproductive impairment relative to the drug sensitive allele (Fohl and Roos 2003). 
This was identified through transfection work in Toxoplasma gondii where the P. 
Jalciparum double mutant and sensitive alleles of dhfr replaced the native gene and 
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the rates of growth were compared in vitro and in vivo in absence of pyrimethamine. 
It was found that in vivo the double mutant allele conferred a 1.8% fitness cost on the 
numbers of parasites produced per generation (Fohl and Roos 2003). In the absence 
of selection, this fitness cost is unlikely to be sufficient to remove the double mutant 
allele from the parasite population in short time; a decline in the population frequency 
of the double mutant allele from 20% to 10% would take approximately 13 years and 
over 4 times that to drop below 1 %. 
The fitness of the double mutant allele relative to the triple mutant allele in the 
absence of drug is not known. It has been suggested that the triple mutant has a 
greater fitness defect as the alterations in the active site of dhfiA are greater (Warhurst 
2002), however, this is not resolved empirically. 
a Selection conditions at the emergence of the double mutant allele 
One explanation for the selective sweep around the double mutant in 2001 is that the 
selection conditions at the onset of emergence of this allele may have been different. 
In the 1950s pyrimethamine monotherapy was used widely (Peters 1970) and these 
alleles may date from then. If that is the case, then it becomes an open question what 
the effect of present day use of pyrimethamine has on the form of drug selection to 
the selective sweep. There is evidence for present day selection for the double mutant 
allele, such as the survival of the selective sweep in areas such as Tanzania where the 
high rate of effective recombination would otherwise be expected to rapidly break up 
the selective sweep. 
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b The fitness cost of the double mutant and assortative mating 
It can be argued that the selective sweep present around the double mutant allele is 
maintained by assortative mating brought about by selective killing of sensitive 
parasites by drug or poor competitive fitness in mixed infections (Taylor, Walliker, 
and Read 1997; Taylor and Read 1998). If, in the absence of drug the double mutant 
allele has a fitness cost relative to the sensitive allele then during co-infections the 
double mutant parasites will be out competed. The result of this scenario would be 
that the proportion of mutants outcrossing with the sensitive chromosome would be 
reduced. Such inbreeding can reduce the effects of recombination on the selective 
sweep around the double mutant allele. In the presence of drug the same would 
occur, except that the relative fitness of the two alleles is reversed. 
c Recombination, asymmetry and epidemics 
We observed that the selective sweeps present on the double mutant chromosomes 
were asymmetric. The same asymmetry was observed on triple mutant chromosomes 
and we concluded this was due to a stochastic pattern of recombination breakpoints 
(Kim and Stephan 2002), that had by chance occurred more often on the downstream 
arm of the chromosome. However, the convergence of these observations might 
suggest recombination hotspots downstream of dhfr, but the occurrence of two 
invariant loci downstream of dhfr at the edge of the double mutant sweep has clouded 
the description. 
In Mpumalanga we identified an indirect method for maintenance of the selective 
sweep on the double mutant chromosome without recourse to positive selection. 
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During epidemic expansions the rapid increase in the frequency of hitchhiking alleles 
maintains associations with the selected site and outcrossing becomes rare. 
Recombination between siblings within a lineage has no effect on diversity and the 
size of the selective sweep is maintained. 
VI Concluding Remarks 
If the double mutant aIIele can only increase in frequency and maintain a selective 
sweep by chance, it is not clear why the selective sweep on the double mutant 
chromosome present in a population like Tanzania has not disappeared completely. 
Are the chance infections of hosts with sufficiently low drug plasma concentrations 
sufficient to maintain its' frequency in the population and the sweep around it? Or 
are there low levels of drug usage in the population from poor drug quality and sub 
therapeutic dosing? We address these questions in chapter 7. 
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Chapter 6 Reduced Variation Around Drug Resistant dhps Alleles in African 
Plasmodium falciparum 
I Abstract 
Using 25 microsatellites covering an approximately 675kb region of chromosome 8 
we have described the patterns of diversity of sequence flanking the drug sensitive 
and drug resistant double mutant alleles at dhps, the locus encoding dihydropteroate 
synthetase. This folate biosynthesis pathway enzyme is the target of the 
sulphonamide component of the antimalarial sulphadoxine-pyrimethamine (SP). A 
key difference to mutations at dhjiA is that emergence of dhps resistance alleles has 
been considerably more recent. In KwaZulu Natal, a province of South Africa, the 
double mutant resistance allele was absent in 1995 but by 1999 it had reached a 
frequency of 15%. On double mutant chromosomes sampled from this population we 
observed an approximately 275kb region of significantly reduced diversity that 
extended from 125kb upstream to 150kb downstream; a region considerably larger 
than that described on pyrimethamine resistant dhfr triple mutant chromosomes from 
the same population and time point. We then described the patterns of diversity on 
resistant and sensitive chromosomes in neighbouring province Mpumalanga in 2001 
and found that that the region of reduced gene diversity had narrowed to 80kb in 
width extending from 50kb upstream to 30kb downstream. We argue that the 
difference reflects the instability of selective sweeps around recently emerged 
resistance alleles under strong directional selection and their movement towards 
equilibrium over time. 
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II Introduction 
Resistance to the sulphonamide component of sulphadoxine pyrimethamine (SP) is 
associated in vitro with a series of substitutions within the active site of the target 
enzyme of the folate biosynthesis pathway, dihydropteroate synthase (DHPS) 
(Brooks et al. 1994; Triglia and Cowman 1994). This has been demonstrated through 
laboratory based in vitro sensitivity tests and transfection experiments (Triglia et al. 
1997; Wang et al. 1997b; Triglia et al. 1998) 
In the enzyme DHPS 14 substitutions at five codon sites have been characterised 
world wide of which six have so far been recorded in Africa in a variety of haplotypic 
conformations (Figure 6-1) (Wang et al. 1997a; Wang et al. 1997b; Eberl et al. 2001). 
In southeast Africa the most prevalent of the resistance alleles is that comprised of 
substitutions A437G and K540E. 
The role of these in conferring resistance to sulphadoxine in vivo has been inferred 
from studies showing the over-representation of mutations in recrudescent infections 
after treatment (Khan et al. 1997; Basco, Tahar, and Ringwald 1998; Curtis, 
Duraisingh, and Warhurst 1998; Jelinek et al. 1999b; Basco et al. 2000; Nzila et al. 
2000a). This important dhps allele is referred to here as the double mutant allele. 
Despite the above evidence, the role of mutations at dhps in clinical SP treatment 
failure has been argued to be minimal (Watkins et a11997) in comparison to dhfr· It 
was argued that the ability of P. falciparum to use exogenous folate in media or in 
host plasma effectively bypasses the need for functional dhps in the folate 
biosynthesis pathway. However, it has recently been shown through transfection 
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studies that parasites require dhps activity to remain viable (Wang et al. 2004b). This 
indicates that the action of sulphadoxine in disabling dhps is lethal and consequently 
the mutations confer resistance. 
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Figure 6-1: The amino acid substitutions at dhps reported in Africa. The allele name 
is taken from the amino acid present at each codon, with letters in bold identifying the 
locus at which the mutation occurred. Data taken from: (Wang et al. 1997a; Wang et 
al. 1997b; Eberl et al. 2001) 
There is growing evidence that dhps mutations are predictive of treatment failure. 
(Omar, Adagu, and Warhurst 2001; Kublin et al. 2002). A recent study in Uganda 
found that the substitution K540E at dhps was the strongest predictor of treatment 
failure (Dorsey et al. 2004), where as others have found that the presence of three 
mutations (N5II+C59R+SI08N) at dhfil' together with (A436G+K540E) at dhps were 
associated with treatment failure (Kublin et al. 2002). 
Further evidence that dhps has a role in SP resistance is the observation that there is a 
population expansion of the dhps double mutant. In K waZulu Natal the double 
mutant allele increased in frequency from 0% to 15% over four years whilst SP 
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treatment failures were the subject of a rapid increase. Analysis of closely linked 
micro satellite markers (with 8kb) has shown that one particular lineage of this double 
mutant alleles has spread over a region of at least 4000km spanning Tanzania and 
South Africa (Roper et al. 2003). As with dhjr, the spread of resistance alleles by 
gene flow is a more pertinent concern in southeast Africa, than de novo mutation. 
The earliest reports of the dhps double mutant allele in Africa have come out of the 
east of the continent. Malawi was the first country to adopt SP as first line 
antimalarial in 1993. Samples taken in 1995-1996 were shown to have the point 
mutations comprising the double mutant allele, namely A437G and K540E, at a 
frequency of approximately 60% and 70% respectively (PI owe et al. 1997). While in 
Tanzania samples from Magoda village in the Tanga region collected in 1995 and 
1996 were found to have high frequencies of both the A437G and K540E 
substitutions (Jelinek et al. 1998). In west Africa the dhps double mutant is rare. In a 
recent study in Ghana, the double mutant allele (A437G+K540E) was only found at a 
frequency of2.6%, whereas the A437G alone was 93.4% and the dhfr triple mutant 
was found at a frequency of 60% (Marks et al. 2005). The authors had not typed 
codons 436,581,613. Two populations sampled in southern Mauritania were more 
extensively screened and the K540E allele was entirely absent, yet there were 
mutations at other loci in particular S436A S436F A437G and A613S, but it is not 
possible to identify in what haplotypic conformations these mutations were found. 
To address the issue of selection on mutant dhps we have examined the extent of the 
region of reduced gene diversity around double mutant alleles during first line use of 
SP sampled from two South African populations, KwaZulu Natal in 1999 and 
Mpumalanga in 2001 (Table 6-1). 
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III Methods and Materials: 
a Study Samples: 
Samples from KwaZulu Natal were taken at two time points (1995 and 1999), 
collected from malaria patients presenting to a healthcare facility, either Mozvold 
Hospital or its' satellite clinic at Ndumu. Samples were also taken in Mpumalanga, 
from symptomatic malaria patients prior to treatment, as a component of the 
Southeast African Combination Antimalarial Therapy (SEACAT) evaluation. Table 
6-1 summarises the drug use and epidemiological context of the populations sampled. 
Population History ofSP$ Frequency of the EIR? 
and usage double mutant dhps (Infectious bites per 
sample date (first line unless allele (437/540) annum) 
stated otherwise) 
KwaZulu Natal 1988 - 2000 0% - 15%· <0.8 t 1995-1999 (0% - 47%)·§ 
Mpumalanga 1997 - present 10% ?§ 
<0.14t 2001 day (2%-22%): 
Table 6-1: ' (Roper et al. 2003); $ Sulphadoxine-Pyrimethamine; § clinical samples; ! 
unpublished; t personal communication K. Barnes; :Range of allele frequencies 
among the three sampling sites; evidently the majority of samples were taken from 
Steenbok 
P. Jalciparum malaria at both sites is historically endemic, but features 
characteristics of epidemic malaria (Kleinschmidt and Sharp 2001). 
The typing of the point mutations present in dhfr and dhps were performed as 
described in chapter 2. 
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b peR amplification and analysis of microsatellite sequences: 
The microsatellites primer sequences can be found in Appendix 6. The PCRs were 
performed as described in Chapter 4. 
c Statistics and Software 
Gene diversity values were calculated as He = [nJ (n-l)][I-Lp?] where n is the 
number of samples and Pi is the frequency of the ith allele in the sample set (Nei 
1987). The variance of the gene diversity was calculated using Nei and 
Roychoudhury's formula (Nei and Roychoudhury 1974): 
The software PowerMarker (Liu and Muse 2004) was used to calculate population 
differentiation theta values. The use of the software 'bottleneck' (Comuet and 
Luikart 1996) is described in Chapter 4. We measured the significance in 
differences between gene diversity between pairs of chromosomal populations by 
permutation (Nash et al. 2005). The ratio of gene diversities between a pair of 
populations was calculated at each locus in the observed data sets and in 10000 
simulated datasets where the alleles at each locus were reshuffled amongst all 
parasites. To obtain the level of significance we counted the number of occasions 
that the simulated ratio of diversities exceeded that for the observed data. The 
statistical package R (The R Core Development Team 2005) was used to generate the 
permutations. 
The distance measure I-ps (Bowcock et al. 1994) was calculated using the software 
Microsat (Minch et al. 1997), bootstrapping the dataset 100 times. Neighbour joining 
185 
A Population Genetic Analysis of Antifolate Resistance in Plasmodiumfalciparum in southeast Africa. 
trees were calculated using the PHYLIP v3.6 (Felsenstein 2004) package "neighbor". 
Consensus trees were constructed using "consense" (Felsenstein 2004) and visualised 
using the software Tree View (Page 1996). 
The Wiehe model used in this chapter is as described in chapter 4. Ne was calculated 
for these populations from the gene diversity of neutral markers on sensitive dhps 
chromosomes. 
IV Results and Interpretation 
a Gene diversity levels on sensitive chromosome populations from two time 
points sampled from KwaZulu Natal 
To describe the extent of reduced gene diversity on chromosome 8 in parasites 
carrying the dhps double mutant allele, it was first necessary to describe the pattern of 
diversity along chromosomal sequence flanking the sensitive allele. Samples of 
sensitive chromosomes were taken from two time points, namely in 1995 when the 
double mutant resistance allele was not detected at all, and in 1999 where it was 
found at a frequency of 15% (Roper et al. 2003). Over this time, the frequency of the 
sensitive allele decreased apparently displaced by the double mutant allele. 
Forty microsatellite markers spanning a 963kb region of chromosome 8 were 
identified from the 3D7 genome sequencing project (Gardner et al. 2002). Of the 
forty loci, ten loci were discarded as null alleles. We compared gene diversity on 
sensitive chromosomes sampled from KwaZulu Natal in both 1995 and 1999 to test 
that there was no change over time or that the emergence of the double mutant 
chromosome had no effect on diversity of the sensitive chromosomes. The gene 
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diversity at each locus on the sensitive chromosomes from 1995 (n=24) and 1999 
(n=20) was calculated. These values are summarised in Table 6-2. Diversity at the 
majority of the microsatellite loci was high (0.423 - 0.945 in 1995; 0.511 - 0.961 in 
1999), however in both years three loci were found to be monomorphic (D30, D40 
and D450) and a further two loci had notably low diversity (U40.2 and D20). 
Comparison of 95% confidence intervals between the two time points showed that 
there were few significant differences in diversity at a loci apart from U40.2 
(p=0.014) and UI0 (p=0.025) where diversity was higher in 1995. 
As the 1995 sample of sensitive chromosomes was taken prior to the emergence of 
the double mutant resistance allele we can exclude the possibility that gene diversity 
at this time point was affected by recombination with resistant chromosomes. Loci 
that were monomorphic or had low gene diversity «0.200) were excluded from 
analyses, as they were uninformative. 
To determine whether there was a significant excess or deficiency in the observed 
gene diversity at each locus when compared to the expected distributions simulated 
under stepwise (SMM) or infinite allele (lAM) mutation models for the observed 
number of alleles, a Wilcoxons' rank test implemented by the software 'bottleneck' 
(Comuet and Luikart 1996) was used. As no specific mutation model has been fitted 
to the microsatellite loci used here, the lAM and SMM represent the lower and upper 
limits of expected gene diversity respectively. The sensitive chromosomes sampled 
from KwaZulu Natal in 1995 had a significant excess of gene diversity under lAM (p 
= 0.0063) but not under SMM. Locus U40 had a significant excess of gene diversity 
relative to the expected generated under both SMM and lAM (Hobs = 0.944 vs. SMM 
Hexp =0.916 p=0.009; lAM Hexp =0.897 p=O.OOI). 
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KZN 1995 KZN 1999 
Marker Distance n= Gene diversity 95%CI n= Gene Diversity 95%CI P value 
U125 -124300 24 0.772 0.076 20 0.853 0.077 0.153 
UIOO -100502 23 0.929 0.054 19 0.906 0.074 0.625 
U80 -77874 24 0.562 0.081 20 0.574 0.102 0.854 
U75 -74856 21 0.871 0.07 19 0.901 0.073 0.574 
U60 -59750 19 0.912 0.07 19 0.889 0.074 0.656 
U50 -50542 22 0.801 0.076 20 0.842 0.08 0.468 
U50.2 -49173 16 0.917 0.083 20 0.911 0.066 0.909 
U40 -40411 22 0.944 0.052 19 0.942 0.063 0.958 
U40.2 -37676 24 0.359 0.087 20 0.195 0.089 0.014 
U30 -30534 22 0.797 0.076 20 0.711 0.096 0.173 
U30.2 -26958 24 0.754 0.073 20 0.726 0.092 0.647 
U20 -19600 23 0.858 0.066 18 0.895 0.078 0.472 
U20.2 -18014 23 0.423 0.091 20 0.558 0.106 0.064 
UIO -10749 12 0.723 0.152 20 0.511 0.102 0.025 
DI0 10721 22 0.892 0.064 20 0.9 0.069 0.864 
D20 18810 24 0.083 0.052 19 0.105 0.072 0.624 
D20.2 21592 10 0.911 0.146 19 0.912 0.07 0.987 
030.2 29011 9 0.944 0.151 19 0.889 0.074 0.473 
D30 31957 1 Monomorphic n/a 20 0.195 0.089 -
D40 39849 10 0.2 0.167 1 Monomorphic nla -
D50.2 50736 10 0.644 0.2 19 0.76 0.097 0.259 
D60 61522 15 0.81 0.11 19 0.766 0.091 0.552 
D70 71248 8 0.857 0.202 14 0.879 0.106 0.837 
D75 73587 21 0.719 0.089 16 0.65 0.125 0.371 
DI00 100542 23 0.866 0.065 20 0.932 0.061 0.158 
0125 126314 23 0.925 0.054 19 0.871 0.078 0.264 
D]50 ]47878 23 0.945 0.05 18 0.96] 0.062 0.690 
D350 352476 21 0.871 0.069 16 0.783 0.106 0.165 
0450 451061 24 0.083 0.052 1 Monomorphic n/a 
-
D550 530114 17 0.721 0.115 17 0.809 0.101 0.267 
Average 
- 19 0.727 - 18 0.744 -
Table 6-2: The observed gene diversity at microsatellite loci flanking the 
sulphadoxine sensitive dhps allele (Grey shaded boxes indicate where p<O.05) 
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Fourteen loci were identified as having a deficiency in observed gene diversity (Hobs 
), but only two were significantly different from expected diversity (Hexp) under 
SMM, namely locus U125 (Hobs = 0.772 vs. Hexp =0.876 p=O.OOI) and locus D550 
(Hobs = O. 721 vs. Hexp =0.850 p=0.0110) and none under lAM. 
The sample taken in 1999 had a significant excess of gene diversity under lAM 
(p=0.0044) but under SMM there was a mildly significant deficiency (p= 0.0263). 
Seventeen of the 25 loci tested had lower gene diversity under the SMM than the 
observed, but only in two was the difference significant, namely U50 (H obs. = 0.842 
vs. H expo =0.870 p=0.0320) and Ul 00 (H obs. = 0.906 vs. H expo 0.953 p= 
0.0040). No single locus had a significant excess of observed gene diversity. 
The 'bottleneck' analysis indicated that the sensitive chromosomes from both time 
points had not undergone any population event that would cause a reduction in gene 
diversity and equally none that would cause an excess of gene diversity such as a 
bottleneck where the number of alleles is reduced faster than the gene diversity, such 
that the observed gene diversity is higher than the expected from the observed allele 
number. 
b Population differentiation of sensitive chromosomes between 1995 and 1999 
populations in KwaZulu Natal 
Having determined that there was no significant difference in diversity levels between 
the two time points, the allele distributions at each locus for the two populations of 
sensitive chromosomes were compared using Wrights' fixation index (F ST), with a 
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view to merging them (Table 6-3). Significant differences were identified at two loci 
(U50 and D550) due to the presence of private alleles. However, the overall FST 
between the two populations was low (FsT = 0.0089). In subsequent descriptions, the 
diversity at each locus on the sensitive chromosome is described from the merged 
dataset. The sensitive chromosomes are a baseline against which to compare the 
effect of selection on resistant alleles and maybe regarded as the ancestral state of 
chromosome 8. 
The microsatellites were classified according to repeat type and compared with 
previous estimates of gene diversity calculated for different micro satellite repeat 
types in P. Jalciparum (Anderson et al. 2000b) (Table 6-4). They follow a similar 
trend where the simpler repeats have the highest levels of diversity and overall 
diversity was slightly higher at these markers than those published previously. 
The gene diversity at each locus for the merged ancestral dataset is plotted against 
distance from the midpoint of dhps in Figure 6-2. The pattern across the ancestral 
chromosome was of high diversity with occasional dips to more moderate diversity 
values. These dips in diversity were not restricted to anyone microsatellite repeat 
type, or to any single region on the sensitive chromosomes. Loci D350 and D550 are 
excluded from the figure for the convenience of scale. The diversity at these loci was 
comparable to elsewhere on the chromosome shown in table 6-2. 
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Locus FST -Value 
U125 -0.002 0.434 
UIOO -0.013 0.700 
U80 -0.009 0.404 
U75 -0.004 0.297 
U60 0.009 0.234 
U50 0.078 ' ! 
U50.2 0.002 0.181 
U40 0.004 0.319 
U30 0.066 0.167 
U30.2 -0.033 0.696 
U20 0.000 0.269 
U20.2 -0.021 0.468 
UIO 0.023 0.133 
DIO -0.003 0.607 
D20.2 -0.033 0.841 
D30.2 -0.005 0.286 
D50.2 -0.024 0.650 
D60 -0.052 0.848 
D70 0.064 0.095 
D75 -0.047 0.977 
DIOO 0.001 0.446 
DI25 0.032 0.093 
DI50 -0.012 0.752 
D350 -0.024 0.654 
D550 0.181 
Overall .0.0089 
Table 6-3: Population differentiation values and significance for comparisons at each 
micro satellite locus between dhps sensitive chromosomes sampled from K waZulu 
Natal in 1995 and 1999 
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c Diversity of sequence flanking the double mutant allele 
A sample of thirteen double mutant chromosomes from KwaZulu Natal in 1999 was 
typed at the 25 informative microsatellite loci. The gene diversity at each locus is 
compared using 95% confidence intervals with diversity on sensitive chromosomes 
(Figure 6-3). Loci D350 and D550 were excluded from the figure, but mutant and 
sensitive chromosomes did not differ significantly. The major trend is for lower 
diversity at all loci on the resistant chromosomes. The core region of statistically 
significantly lower gene diversity covers 125kb of the double mutant chromosomes 
extending from U50 upstream to D75 downstream. Within this region two loci were 
completely invariant. 
Repeat Type Gene Diversity 95%CI Expected Gene Diversity 95%CI (from Anderson et al 2000) 
di- 0.818 (n=] 6) 0.041 0.781 (n=12) 0.050 
tri- 0.773 (n=5) 0.043 0.688 (n=12) 0.044 
Other 0.883 (n=l) 0.034 0.636 (n=l2) 0.169 
Table 6-4: Gene diversity by repeat type in the merged KwaZulu Natal sensitive 
chromosome population 
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Figure 6-2: Gene diversity at microsatellite loci at increasing distances upstream and 
downstream from the midpoint of dhps on drug sensitive/ancestral chromosomes 
sampled from KwaZulu Natal. 95% confidence limits calculated from variance in 
gene diversity 
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Figure 6-3: Gene diversity at microsatellite loci at increasing distances upstream and 
downstream from the midpoint of dhps on drug sensitive chromosomes (dashed line) 
and dhps double mutant chromosomes (solid line) sampled from KwaZulu Natal. 
95% confidence limits calculated from variance in gene diversity. 
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The gene diversity at each locus on the double mutant and sensitive chromosomes 
was tested for significant difference using the method described in chapter 4. The 
extent and direction of the difference is given in Figure 6-4. With the exception of 
the loci U80,D50.2 and D70 the gene diversity on the double mutant chromosome 
was significantly lower at all loci from U125 to D150, within which there was a 
central core ofU75 to D30.2 of consecutive markers where diversity was 
significantly lower than on the sensitive chromosomes. However, diversity does not 
return gradually with increasing distance from the selected site, rather a substantial 
jump in gene diversity occurs only a relatively short distance from dhps. 
Contrasting this selective sweep with that around the dhji~ triple mutant allele in the 
same population in 1999 there are two notable differences; firstly, the selective sweep 
on the dhps double mutant chromosomes is considerably larger with the statistically 
significant drop in diversity covering approximately 275kb as compared to 
approximately 50kb on the dhfr triple mutant chromosome. The larger size of the 
dhps double mutant chromosome selective sweep is because of the shorter history of 
this allele in the population. The frequency of the dhfr triple mutant allele in 1995 
was 22% while the dhps double mutant was absent. 
Secondly, there is not such pronounced asymmetry to the selective sweep present on 
the dhps double mutant chromosome,althoug h there are more significant differences 
upstream than downstream as was found with dhfr. We explained the asymmetry of 
the dl?fr triple mutant sweep as a reflection of the stochastic pattern of recombination 
over time. The direction of asymmetry is the same in both cases and in the absence 
of a better explanation we assume this is due to chance. 
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chromosomes sampled from KwaZulu Natal. Shading indicates the following levels of significance Light grey = p<O.05; dark 
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d Deterministic modelling of the selective sweep on KwaZulu Natal double 
mutant chromosomes 
To examine differences in the contribution of various factors that influence sweep 
dimensions, we used the Wiehe model (Wiehe 1998), modified by Nair et aI. (2003) 
to generate the expected dimension of a selective sweep, using the parameters defined 
in the methods section. 
Using the Wiehe model it is possible to estimate either the selection coefficient acting 
on the selected site or the initial frequency of the allele in the popUlation, through 
describing a line of best fit to the observed data. In the case of the KwaZulu Natal 
population, a selection coefficient for the dhps double mutant has been estimated 
from direct observation of the change in allele frequencies between 1995 and 1999 
where the frequency in the samples taken from cross-sectional surveys rose from 0% 
to 15% (Roper et aI. 2003). Roper et al (2003) calculated an upper estimate of the 
initial frequency of the dhps double mutant of 0.03 based on binomial statistical 
probability. Based on this a conservative estimate of the selection coefficient, 's' was 
calculated as 0.13 assuming 3 parasite generations per annum. 
The initial starting frequency (e = mINe) of the double mutant allele in the KwaZulu 
Natal parasite population is unknown. We can infer that it was introduced by 
migration rather than de novo mutation since there are reports of the dhps double 
mutant at other sites in southeast Africa which precede its first appearance in 
KwaZulu Natal (Plowe et aI. 1997; Jelinek et aI. 1998). The number of migrants 
moving into KwaZulu Natal can be estimated from an FST calculated from 8 unlinked 
microsatellites (Chapter 3). The number of migrants between Tanzania and South 
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Africa per generation in one direction is approximately (m=) 20. This is comparable 
to an estimate of the number of migrants between the east African populations of 
Zimbabwe and Uganda (Anderson et al. 2000a). 
Using s = 0.13 and m = 20 we find that the shape and size of the modelled selective 
sweep follows closely the line of the observed data (Figure 6-5). However, even if 
these parameters were varied, it was not possible to generate a theoretical sweep that 
had achieved fixation at the two sites closest to the selected site and a return to 
diversity to the more distant sites at the same rate as that in the observed dataset. 
e The extent of the chromosome covered by the selective sweep may be 
obscured by inbreeding 
It could be argued that the large size of the region of reduced diversity on the resistant 
chromosomes was because we had sampled related individuals in a resistant malaria 
epidemic. Such a scenario would artificially lower diversity among all resistant 
chromosomes. The presence of "siblings" in the data set is a risk of sampling within 
populations of low transmission intensity where epidemic expansions of parasite 
lineages are not uncommon. We tested the entire KwaZulu Natal resistant and 
sensitive chromosome dataset for the presence of siblings. Neighbour joining trees 
were constructed using the distance measure 1- Ps where Ps is a measure of similarity 
between two isolates calculated as 'the proportion of alleles shared summed over 
loci/2 x number of loci compared' (Bowcock et al. 1994). As the majority of the loci 
on the resistant chromosomes share alleles the, differentiation between samples was 
effectively only tested on a minimum of 5 loci i.e. those which were not 
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Figure 6-5: Detenninistic prediction of the size and shape of the selective sweep 
8 
around the dhps double mutant allele at equilibrium between recombination, mutation 
and selection. The parameters used are given in the text, however: selection 
coefficient s = 0.13, m=20. The grey line represents the observed diversity with the 
dashed grey lines representing the 95% CI. The black line represents the model 
predication. Asterisks above indicate loci at which the modelled line fell within the 
95%CI 
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significantly different from the diversity on the sensitive chromosomes. The dataset 
was bootstrapped 100 times in Microsat (Minch et al. 1997) and a consensus 
neighbour joining tree drawn using the PHYLIP packages Neighbor and Con sense 
(Felsenstein 2004) (Fig 6-6). 
The majority of the pooled sensitive and resistant dataset were unrelated and equally 
dissimilar. Four lineages of near identical chromosomes were identified, three 
consisting of two isolates and one of 6 isolates. Only one lineage contained sensitive 
alleles. When the lineage of six isolates were examined at dhfr and microsatellites 
on chromosome 4, only three matched indicating that these three are siblings; the 
remaining three carried different alleles. The other two resistant lineages which 
consisted of pairs of isolates were found to be unrelated at chromosome four. 
f A selective sweep present on double mutant chromosomes sampled in 
Mpumalanga in 2001 
A key observation of the selective sweep on the triple mutant chromosome observed 
in KwaZulu Natal was the reduction in size from 70kb in width to 50kb between 1995 
and 1999. By describing the region of reduced diversity on a second South African 
population at a later time point we hoped to examine whether the same thing had 
happened. KwaZulu Natal stopped using SP in 2000 so we used a sample from 
Mpumalanga which is a neighbouring province in South Africa. It is likely that there 
is considerable gene flow between KwaZulu Natal and Mpwnalanga (Chapter 3). 
Use ofSP began in only 1997. In 2001 the frequency of the dhps double mutant 
allele in Mpumalanga was 10% ranging between 2 and 22% in the populations 
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Figure 6-6: 'Neighbour joining' tree of relatedness using the measure of I-Ps of 
sensitive and double mutant chromosomes sampled in KwaZulu Natal. Bootstrap 
values are given on the nodes of the expanding lineages 
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sampled. This frequency was broadly equivalent to 15% in KZN in 1999 (Roper et 
al. 2003). 
g Gene diversity across the Mpumalangan sensitive chromosomes is high 
The effective recombination rates for both populations are similarly low, which is 
important in considering the rate of breakdown of the selective sweep although the 
entomological inoculation rate, a measure of transmission intensity is lowest in 
Mpumalanga (Table 6-1). Low transmission intensity reduces gene diversity in a 
parasite. A sample of 24 sensitive chromosomes were typed at 19 micro satellites 
covering 250kb of sequence flanking the selected site; the same four loci, namely 
V40.2, D20, D30, and D40 were monomorphic or had very low diversity on the 
sensitive chromosomes, as observed in the KwaZulu Natal population. The diversity 
at each locus on the sensitive chromosome was plotted against distance from the 
midpoint of dhps in Figure 6-7. We found that the low transmission intensity in 
Mpumalanga had not affected the levels of diversity on the chromosome. 
With the exception of the VI 0 and D20.2 there were high levels of diversity across 
the entire region of the chromosome. The observed gene diversity was tested for 
either a significant excess or deficiency using WiIcoxons' rank test through 
comparison with expected diversity generated under lAM or SMM mutation models 
(Cornuet and Luikart 1996). It was found that under lAM there was a significant 
excess of gene diversity but under SMM there was neither a significant deficiency nor 
excess of gene diversity. 
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Figure 6-7: Gene diversity at microsatellite loci at increasing distances upstream and 
downstream from the midpoint of dhps on drug sensitive chromosomes sampled from 
Mpumalanga. 95% confidence limits calculated from variance in gene diversity 
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h The selective sweep present on double mutant chromosome in Mpumalanga is 
smaller than that in KwaZulu Natal 
Gene diversity at each of the 19 loci in a sample of 24 double mutant resistant 
chromosomes was plotted against distance from the midpoint of dhps in Figure 6-8. 
The selective sweep present on the double mutant chromosomes sampled from 
Mpumalanga was smaller than that in KwaZulu Natal. Comparing 95% confidence 
intervals between sensitive and resistant chromosomes it was determined that the core 
of the selective sweep covered approximately 80kb from loci U50.2 to D30.2. Whilst 
this is smaller than the 275kb dhps in KwaZulu Natal, it was larger than the 70kb 
selective sweep present on chromosome 4 in Mpumalanga in 2001 and KwaZulu 
Natal in 1999. It is asymmetrical with diversity having returned quicker on the 
downstream side. Paired comparison of the sensitive and resistant chromosomes in 
Mpumalanga are summarised in Figure 6-9. 
Curiously, the deepest part of the region of reduced diversity is not centred on the 
selected site, but upstream of the gene itself. The overall shape of the sweep is also 
asymmetrical extending much further upstream. This was also the case when we had 
observed asymmetry in the selective sweep present on the dhJi" triple mutant 
chromosome. In the case of the dhjr we concluded that the stochastic pattern of 
recombination breakpoints was the cause (Kim and Stephan 2002) and this may well 
be the case for dhps too. However with dhfr the deepest part of the selective sweep 
was most proximal to dhjr,wher eas with dhps the deepest part of the selective sweep 
is upstream of dhps. This suggests a second site linked to dhps is also subject to 
selection. 
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Figure 6-8: Gene diversity at microsatellite loci at increasing distances upstream and 
downstream from the midpoint of dhps on drug sensitive/ancestral chromosomes 
(dashed line) and dhps double mutant chromosomes (solid line) sampled from 
Mpumalanga. 95% confidence limits calculated from variance in gene diversity 
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Figure 6-9: The direction and extent of significant differences in gene diversity between ancestral and double 
mutant chromosomes sampled from KwaZulu Natal and Mpumalanga. Shading indicates the following levels 
of significance Light grey = p<O.05; dark grey = p<O.OOl; black = p<O.OOOl. 
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i Comparing the double mutant lineages of Mpumalanga and KwaZulu Natal 
Before committing to any further comparison of the selective sweeps present on 
double mutant chromosomes from KwaZulu Natal and Mpumalanga it was first 
necessary to address the question of shared ancestry. Archetypal resistant 
chromosomes were constructed using all loci where significantly reduced diversity 
was found. The allele with the highest frequency at every locus was considered the 
most likely archetype (Figure 6-10). Comparing KwaZulu Natal and Mpumalanga 
allelic archetypes it is clear that they are identical within the U 50-D 10 region; only 
U40, D20.2 and D30.2 were different. As the KwaZulu Natal sample was taken at an 
earlier time point, we considered that the alleles at the three loci are the original 
hitchhikers associated with the mutation event at dhps and that the variants are 
Mpumalanga specific. At a few loci there were two alleles that could be classified as 
archetypal alleles and these were not solely restricted to the outer portions of the 
selective sweep (U60, D125) but were also found at loci proximal to the selected site 
(U20). It is likely that these differences are products of recombination between other 
allelic chromosomes that have subsequently increased in frequency. In chapter 3 of 
this thesis we showed that epidemic like expansions of lineages had occurred in 
Mpumalanga and it is reasonable to assume that the differences between the 
archetypal double mutant chromosomes from both populations were formed in this 
way. 
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Figure 6-10: The archetypal haplotypes of flanking sequence loci for sites within the region of reduced diversity 
defined on the dhps double mutant chromosome. See text for method of definition of archetype alleles. 
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j Deterministic identification of the cause of the difference in size of the region 
of reduced diversity between the two populations 
The Wiehe (Wiehe 1998) model of a selective sweep at equilibrium between 
recombination, selection and mutation was used to determine the differences in 
selection and required migration between the selective sweep present in the two 
populations. Unlike in KwaZulu Natal, no directly observed selection coefficient for 
the double mutant allele was available. We input parameters identical to those used 
for KwaZulu Natal; inbreeding coefficient (F=0.7) based on the number single 
genotypes present at dhps and effective population size (Ne =51 OO)~ and altered 
selection coefficient to find the line of best fit to the observed data. Assuming an 
initial frequency of the allele in the population of 20, the same as used in K waZulu 
Natal, it was determined that the line of best fit occurs when s=0.08 (Figure 6-11). 
This is a reduction in the magnitude of the selection coefficient from that directly 
observed in KwaZulu Natal where s = 0.13. When s = 0.13, the number of migrants 
establishing the initial starting frequency of the double mutant allele was one, much 
less than the m=20 used for KwaZulu Natal. 
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Figure 6-11: Deterministic prediction of the size and shape of the selective sweep 
8 
around the dhps double mutant allele at equilibrium between recombination, mutation 
and selection. The parameters used are given in the text however: selection 
coefficient s = 0.08, m=20. The grey line represents the observed diversity with the 
dashed grey lines representing the 95% CI. The black line represents the model 
predication. Asterisks above indicate loci at which the modelled line fell within the 
95%CI 
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V Discussion 
In this thesis we have described selective sweeps around the key dhfi" resistance 
allele, the triple mutant, and now around the dhps double mutant allele. Selection 
operating on these two loci must be equivalent at any given point in time as the two 
drugs which target these enzymes are co-administered. Therefore, it is interesting to 
compare the selective sweep around the dhps double mutant allele with that around 
the dhfr triple mutant allele. We have described the selective sweeps around both the 
dhfr and dhps alleles in two populations, KwaZulu Natal and Mpumalanga. By 
comparing sweeps around dhfr and dhps within a population, the effective 
recombination rate and selection pressures are effectively standardised, as are the 
other factors contributing to the dimensions of selective sweeps. 
The selective sweep present on resistant chromosomes from K waZulu Natal in 1999 
extended from approximately 125kb upstream to 150kb downstream with a central 
core of 125kb of unbroken significantly low gene diversity. This 275kb region far 
exceeded the 50kb region of reduced gene diversity present on dhfr triple mutant 
chromosomes also sampled in KwaZulu Natal in 1999 (Chapter 4). In Mpumalanga 
in 2001 ,a smaller se lective sweep was found around the resistant dhps allele. In this 
case the region of significantly reduced diversity covered a 80kb region similar, but 
slightly larger than the 70kb around dhfr triple mutant alleles sampled 
contemporaneously. 
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a Why is the selective sweep around the dhps double mutant wider than that 
around dhfr: Time? 
The difference in the size of the selective sweeps around the two genes is notable, but 
consistent with our observation that selective sweeps reduce in size over time. The 
appearance of the resistant dhps allele was much more recent than dhfr. In 1995 the 
dhfr triple mutant allele had a frequency of 22%, whilst the dhps double mutant allele 
was absent. The longer that an allele has existed in a population the greater the length 
of time that recombination will have had to act to reduce the size of a selective sweep, 
and as neither of the alleles discussed have reached fixation in the population, there 
are still opportunities for recombination, with sensitive chromosomes. 
b Why is the selective sweep around the dhps double mutant wider than that 
around dhfr: Migration and startingfrequencies? 
One of the most striking observations of the work describing the selective sweeps 
present on the resistant dhfr chromosomes was the role of migration in determining 
the size and shape of the region of reduced gene diversity (Chapter 4). Using a 
deterministic model of a selective sweep (Wiehe 1998; Nair et al. 2003), we found 
that rather than an initial starting frequency of lINe in the population, the model 
predicted that multiple migrants carrying the resistance allele were involved in 
establishment of the allele in these populations. 
Using constant parameters for mutation and recombination in addition to a directly 
observed selection coefficient, we observed in KwaZulu Natal that an estimation of 
an initial frequency of the dhfr triple mutant allele in the population generated by 20 
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migrants generated a good fit to the observed data. Neutral markers indicate 
extensive gene flow between sites in the southeast Africa region (Chapter 3), so this 
value seems reasonable. Applying the selection coefficient observed in K waZulu 
Natal to Mpumalanga the model indicated that 200 migrant triple mutant 
chromosomes founded the initial starting frequency. Since SP use began in 
Mpumalanga nine years later than in KwaZulu Natal, the regional frequencies of the 
dhfr triple mutant allele were very probably a lot higher. Chapter 3 showed that the 
frequency of the resistance alleles in Mozambique in 2001 was high. This country 
had very little SP use so the high frequencies suggests passive diffusion gene flow 
into the popUlation. Of course the selection coefficient directly observed in K waZulu 
Natal may be an underestimate of that in Mpumalanga but both populations have a 
similar malaria epidemiology and treatment policy and treatment seeking behaviour 
are similar in the two provinces. 
In the case of the dhfi~ resistance allele, the shape of the selective sweep that we 
observed is a product of migration and a low selection coefficient. How migration 
performs this role will be discussed in the following chapter, however, to briefly 
summarise, it is evident that the moderately high starting frequencies of an allele in a 
new population places the allele in the new population at frequency closer to fixation 
than a low starting frequency. If the allele had an initial frequency in the population 
equivalent to lINe the directly observed selection coefficient would take longer to 
reach the current allele frequency in the population and thus greater opportunity for 
recombination reducing the size of the selective sweep. 
Using the selection coefficient estimated from the dhps double mutant allele 
frequency change, we found that in KwaZulu Natal the initial starting frequency will 
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have required 20 migrants into the population carrying the double mutant allele. This 
estimate of 20 is, however, an upper boundary as the selection coefficient calculated 
and used in the model makes the assumption that the double mutant allele appeared in 
1995 (and therefore that 12 generations have passed), whereas in reality it was 
undetected at this time point and may have appeared subsequently. If so, the 
selection coefficient would have been higher. Applying the same selection 
coefficient to Mpumalanga identified that the initial starting frequency of the allele in 
the population was approximately lINe. 
Thus we have observed that the initial starting frequencies of the dhps double mutant 
allele in KwaZulu Natal and Mpumalanga were lower than those estimated for the 
dhfr triple mutant allele, and this was most pronounced in Mpumalanga. What 
underlies this difference in initial starting frequencies? In Chapters 2 and 3 we 
described heterogeneity in the dhfr and dhps allele frequencies between populations 
across southeast Africa and in all these populations the frequencies of the dhps 
resistance alleles were lower than that of the dhfr resistance alleles, which given the 
recent emergence of dhps in the population is unsurprising. We would expect that 
this difference in the resistance allele frequencies between loci would extend to the 
proportions of the total number of migrants occurring through natural levels of gene 
flow that carry either of these resistance alleles. The high starting frequencies 
estimated for the triple mutant alleles in Mpumalanga reflects the high frequencies of 
the allele in neighbouring populations when use of SP selection began in the South 
African province, whereas the lower estimate of migrants with the dhps double 
mutant allele reflects its lower frequency in neighbouring populations. 
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c Why is the selective sweep around the dhps double mutant wider than that 
around dhfiA: Selection coefficients? 
The final major difference between the resistant dhps and dhfr alleles is the size of the 
selection coefficient operating on them. Roper et al estimated the selection 
coefficients for both the dhfr triple mutant and the dhps double mutant alleles from 
frequency changes in KwaZulu Natal between 1995 and 1999 (Roper et al. 2003). 
The magnitude of the selection coefficient for the dhps allele, estimated over 12 
generations, was notable for being almost three times larger than that estimated over 
the time period at dhfiA (0.13 vs. 0.048). As we have stated earlier the selection 
pressure applied by SP use is simultaneously applied on both loci so at first sight the 
difference in selection coefficients is curious. 
However, we know that the dhps allele arrived into the population when the resistant 
dhfr allele was already established. The combination of the dhfr triple mutant and the 
dhps double mutant together is predictive of survival of treatment doses of SP (Omar, 
Adagu, and Warhurst 2001; Kublin et al. 2002; Dorsey et al. 2004), whereas dhfr 
alone is not (Alifrangis et al. 2003). 
Clearly the two locus resistant genotype has higher fitness than other genotypes as 
evidenced by observation in chapters 2 and 3 that there is strong linkage 
disequilibrium between the dhfr triple mutant and the dhps double mutant (Omar, 
Adagu, and Warhurst 2001; Pearce et al. 2003). It can be postulated that the 
measurable association of the dhfiA triple mutant and the dhps double mutant in the 
field and post treatment is what is observed in the high selection coefficient. To test 
this hypothesis would require a second population where a resistant dhps allele had 
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appeared in the population first. Such populations can be found in west Africa where , 
alleles at dhps other than the A437G+K540E double mutant can be found in high 
frequencies (Eberl et al. 2001; Marks et al. 2005) although the association of the west 
African dhps alleles with sulphadoxine resistance is not as clear cut as the east 
African double mutant described here. 
d Effects on the dhps selective sweep of the presence of the dhfr triple mutant 
allele 
In addition to speculating whether the observed association between the dhfr and 
dhps resistant alleles has had an effect on the selection coefficient of the dhps double 
mutant allele, it is interesting to speculate what effect the association of the two 
alleles would have on the selective sweep around the dhps double mutant allele over 
time. 
The dhfr triple mutant can survive treatment with SP, but addition of the dhps double 
mutant allele increases the survival of the parasite. However, as the frequency of the 
dhfr triple mutant allele increases in the population, it would have the effect of 
reducing the fitness differential between the dhps double mutant and dhps sensitive 
allele, as arguably both dhps alleles would survive SP treatment if present in a 
parasite with the dhfr triple mutant. The reduction in fitness differential would 
increase the time to fixation for the dhps double mutant allele, increasing the time that 
recombination would have to reduce the selective sweep flanking the allele. 
We observed in Mpumalanga that the selective sweeps present on the dhfr and dhps 
resistant chromosomes were 70kb and 80kb respectively. The dhps double mutant 
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allele was at a lower frequency in the population than the dhfr triple mutant allele 
(l0% vs. 52%) and thus more prone to outcrossing decaying the selective sweep. 
Yet it had existed in the population for a shorter period of time and thus less time for 
recombination to occur. 
It is interesting to speculate whether the rate in reduction of the size of the selective 
sweep on the dhps resistant chromosomes would be quicker than observed on the dhfr 
triple mutant chromosomes despite both being subject to the same underlying 
effective recombination rate. It may be expected that both selective sweeps would 
reach a unity when there is equilibrium in the population genetic parameters. Yet, the 
effect of a reduced fitness differential would lead to the selective sweep on the dhps 
resistant chromosome being smaller at fixation than that present on the dhfr resistant 
chromosomes. 
However a more probable explanation for the similarity in size between the selective 
sweeps observed in Mpumalanga around the dhfr triple mutant allele and dhps double 
mutant allele, despite the difference in age of the alleles, is the instability of large 
selective sweeps over smaller ones. The larger a region of reduced diversity is the 
greater the length of sequence within which stochastic recombination breakpoints can 
occur. In Mpumalanga these would occur rarely and larger sequences have a greater 
probability of crossover. It would be interesting to describe the sweep on resistant 
chromosomes sampled in Mpumalanga at a later time point to observe the rate of 
decay of the sweep from this starting point similar sized sweeps. 
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VI Concluding remarks 
Watkins et al have argued in the past that sulphadoxine plays no role in the killing 
effect of SP and that the variety of point mutations at dhps is argument against its role 
in resistance (Watkins et al. 1997; Watkins et al. 1999). This is disputed by a number 
of lines of evidence such as the proven role of dhps through allelic replacement and 
gene knock out transfection studies (Triglia et al. 1997; Triglia et al. 1998; Wang et 
al. 2004b) and the predictive association of dhps mutations with treatment failure 
(Omar, Adagu, and Warhurst 2001; Kublin et al. 2002; Dorsey et al. 2004). 
We have shown the presence of a large selective sweep around the dhps double 
mutant allele in two South African populations. In conjunction with the fact that 
these resistant alleles increased in frequency under SP drug pressure, the presence of 
a selective sweep is clear indication that the dhps double mutant allele is under 
positive directional selection. The role of this double mutant allele and the 
importantance of sulphadoxine resistance to parasite survival is very clear. 
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Chapter 7 M etadiscussion 
This final section of this thesis is divided into two parts. The first part will bring 
together the conclusions of the five chapters of experimental work. The second part 
discusses the conclusions in the wider context. 
I Part 1: 
a Local and regional heterogeneity in haplotype frequencies and the 
relationship with selection pressure 
We began by developing a novel technique for the high throughput detection of the 
point mutations associated with sulphadoxine/pyrimethamine (SP) resistance at the 
loci encoding the drug targeted enzymes dihydrofolate reductase, dhfr, and 
dihydropteroate synthetase dhps (Pearce et al. 2003). Based on the sequence specific 
oligonucleotide probing dot blot (SSOP-dot blot) hybridisation method (Conway et 
al. 1999), we developed an approach that enables the detennination of "allelic 
haplotypes" of the different SNPs coding for amino acid substitutions. Each allelic 
haplotype confers known differences in drug tolerance, as detennined by in vitro 
studies, for example the triple mutant allele comprised of substitutions 
N51I+C59R+SI08N is 1600 times less sensitive to pyrimethamine than the sensitive 
allele (Wu, Kirkman, and Wellems 1996). Using the SSOP-dot blot approach we 
described the frequencies of the different SP resistance alleles present in field samples 
collected as dried bloodspots from infected patients in three sites 150 miles apart in 
northern Tanzania. We found that there were a small number of alleles (5 at dhfr and 
3 at dhps - see figure 7-1) and these were common to each population. 
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Figure 7-1: Scheme of dhji~ and dhps alleles found within in this study. Shaded 
blocks indicate the site at which the constituent SNPs of each haplotype arise. Names 
of the alleles are composed of the amino acids present at each of the sites, in 
consecutive order of the codon number, described as having a role if SP resistance. 
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The dhfr triple N5II+C59R+SI08N mutant and the dhps double A437G+K540E 
mutant were the most highly resistant alleles identified. The frequencies of these 
were high and differed significantly between the three sites strongly suggesting 
regional heterogeneity in the strength of selection. 
The high frequencies of the resistance alleles in northern Tanzania suggested a history 
of drug selection operating on the population. To gain a broader picture of the region 
we used the SSOP-dot blot approach to determine the frequency of dhfr and dhps 
alleles in samples from three populations with widely different selection histories. In 
Tanzania in 2000, SP had been used as second line antimalarial treatment after 
chloroquine for 18 years. In Mozambique in 2001, there was officially no use of SP 
in malaria treatment and in Mpumalanga, South Africa in 2001, SP had been firstline 
antimalarial since 1997. Given that the histories of drug treatment policy were 
different, we expected heterogeneity in the frequencies of resistance alleles between 
the populations. In all three populations the same five alleles at dhfr and three at dhps 
described in the earlier northern Tanzania study were observed. As expected we 
found significant differences in the population frequencies of each allele, but 
surprisingly Mozambican populations had the highest frequencies of the highly 
resistant alleles. It was clear that past national policy was not a good indicator of the 
resistance status of the parasite populations. We speculated that selection had 
occurred through unofficial use; there is anecdotal evidence of Mozambicans crossing 
the border seeking treatment in nearby border clinics in South Africa, where SP is 
used for treatment of their infections. 
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b The shared ancestry of resistance alleles sampled across a wide region 
suggests significant gene flow 
Microsatellite loci in the immediate flanking region of the dhfr and dhps genes have 
been used to infer the ancestry of these point mutation haplotypes (Roper et al. 2003). 
Comparison of South African and northern Tanzanian samples showed that alleles 
comprised of multiple mutants were monophyletic in origin and had dispersed 
throughout the southeast African region. The exception was the dhji'" double mutant 
N 51 I -S 1 08N allele, for which two ancestral lineages were identified; a common 
widely dispersed lineage and a rare independent lineage in South Africa. 
To quantify the extent of regional gene flow we examined allele frequencies at 8 
unlinked neutral microsatellite loci in Tanzania, Mozambique and South Africa. 
Nesting tests of population differentiation by scales of distance we found high 
amounts of gene flow both between local populations and across the region, despite 
the regional and local differences in the frequencies of resistance alleles. The 
evidence of strongly homogenising gene flow across a region, but strong 
differentiation between populations in the frequencies of resistance alleles is evidence 
of the heterogeneity in selection intensity across the region. The observation of a 
high level of gene flow explains the common ancestry of the resistance alleles region 
wide and is consistent with early reports of highly mobile pyrimethamine resistance 
(Clyde 1967). Pyrimethamine resistance was selected by intense prophylactic use of 
pyrimethamine in the Muheza district of Tanzania in the 1950s. Diffusion of 
resistance up to 100miles from the original focus was described. Such a pattern of 
diffusion outwards from the initial site of intense selection to populations where 
selection was absent as observed in the 1950s and the low population differentiation 
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between sites described here, is strongly suggestive of a diffusion of resistance genes 
through a parasite population that is continuous over a great geographical distance in 
southeast Africa. 
c Transcontinental gene flow 
As a source of gene flow, the movement of people particularly across large distances 
through aviation has also contributed to the spread of SP resistance. Through 
comparison of the flanking markers around triple mutant dhfr alleles sampled from 
southeast Africa and numerous dhfr resistance alleles from southeast Africa, we 
identified the southeast African triple mutant allele as a transcontinental migrant from 
Asia (Roper et al. 2004). This reinforces the view that de novo development of SP 
resistance mutants in southeast Africa has occurred rarely. The lineages of the double 
mutant C59R+SI08N and the two N5II+SI08N alleles present in southeast Africa are 
highly likely to be "home grown" as their flanking haplotypes were different. 
d Selective sweeps around the dhfr triple mutant allele in Africa 
dhfr is found on chromosome four; dhps is found on chromosome 8. By comparing 
diversity at micro satellites the length of chromosomes carrying sensitive and 
resistance alleles at both these loci, we showed a loss of diversity specifically around 
mutant alleles at both loci. 
We compared selective sweeps around the dhfr triple mutant allele on chromosomes 
sampled from Tanzania, and the KwaZulu Natal and Mpumalanga provinces of South 
Africa. The inner part of the sweep shared identity with the selective sweep present 
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on southeast Asian dhfr resistance chromosomes confirming previous data (Roper et 
al. 2004). The width of the selective sweep in African populations was reduced 
relative to that described in Asian populations (Nair et al. 2003). The sweep was 
widest in KwaZulu Natal in 1995 where the region of significantly reduced gene 
diversity covered a smaller region of 70kb, smaller than that recorded in southeast 
Asia (> 1 OOkb) (Nair et al. 2003). This difference in size is even more striking when 
one considers that at the time of sampling in southeast Asia, SP selection pressure had 
been absent for at least ten years (Nosten et al. 2000). 
e Interaction between recombination and selection and the additional role of 
gene flow 
Between the three southeast African populations we observed significant differences 
in the sizes of the selective sweeps around the triple mutant allele. The key factors in 
explaining these differences were the intensity of drug selection operating in the 
region and the effective recombination rate, which varies according to transmission 
intensity (Paul et al. 1995; Dye and Williams 1997). Recombination acts to limit the 
distance from the favourable allele that hitchhiking flanking alleles persist, whereas 
selection by increasing the frequencies of both favoured alleles and hitchhikers acts to 
cement these associations into the population by fixation (Smith and Haigh 1974; 
Kaplan, Hudson, and Langley 1989). The opposing effects of these parameters mean 
that neither recombination nor selection can be treated independently. 
We observed that the effect of recombination over time was to narrow considerably 
the selective sweep around the dhfiA triple mutant allele. In KwaZulu Natal the region 
of reduced gene diversity was narrowed from 70kb in 1995 to a region of 50kb in 
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1999, despite ongoing selection through the use of SP as first line treatment. 
Sampling from the same population standardises the effective recombination rate 
between the two time points, and highlighted how selection for the triple mutant 
allele in the population was insufficient to counter the high recombination rate. 
Recombination reduces the size of a selective sweep when derived chromosomes 
recombine with ancestral chromosomes. This occurs when drug coverage in the 
population is not absolute. In African populations absolute drug coverage is rare as a 
significant proportion of infections are asymptomatic, disease recognition is poor 
(von Seidlein et al. 2002) or other forms of treatment are used; Knowledge-Attitude-
Practice studies show that in the marketplace a number of alternatives to SP including 
non antimalarials are widely available and are used in malaria treatment (Djimde et 
al. 1998). 
Description of selective sweeps present on triple mutant chromosomes sampled from 
Tanzania and Mpumalanga, suggested that there is a limit to the variability in the size 
of selective sweeps despite differences in selection histories and transmission 
intensities. This may imply stability to the selective sweep even when resistance 
alleles are not at fixation. The region of reduced gene diversity on the triple mutant 
chromosomes sampled from Tanzania was expected to be very small as the 
population has a high effective recombination rate and selection in the population was 
at the time of sampling was by second line only. However, it was 50kb wide, the 
same as that found in KwaZulu Natal in 1999 after 11 years as firstline. This 
suggested that another factor was involved that compensated for the weak selection 
pressure and maintained the region of reduced diversity in the face of the high 
effective recombination rate. This factor was gene flow as determined by its 
incorporation into a deterministic model (Wiehe 1998; Nair et al. 2003) within the 
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parameter of the initial starting frequency of the selected allele. Using estimates of 
selection based on measured frequency change and recombination rate adjusted for 
intrapopulation inbreeding rates, we showed that the initial starting frequency was a 
key variable reinforcing the importance of gene flow in the evolution of SP resistance 
in this region. 
The deterministic model used (Wiehe 1998; Nair et al. 2003) predicts a selective 
sweep at equilibrium between the parameters of selection, mutation and 
recombination. If this is not the case then the initial frequency required to 
compensate for the low selection coefficient may be an over estimate. However it is 
doubtful that the values for the initial frequency in the population would ever have 
been equal to l/Ne,bec ause we know that de novo mutations giving rise to the 
resistance alleles occurred in Asia (Roper et al. 2004) and subsequently starting 
frequencies will always have been determined by gene flow. It makes sense that the 
selective sweep often requires an initial starting frequency greater than l/Ne. 
f The selective sweep present on C59R+S018N dhfr double mutant 
chromosomes 
Having described the selective sweep around the most highly pyrimethamine resistant 
allele in the region, we carried out the same analysis of selective sweeps around the 
dhfr C59R+S108N double mutant allele in two populations, South Africa and 
southern Tanzania. The observation that the level of resistance to SP conferred by 
this allele is insufficient to survive treatment doses of pyrimethamine in the hosts' 
plasma and selection for this allele over the sensitive allele is reliant on infection of a 
host, or emergence from the liver stages into the bloodstream within a specific 
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window of sub therapeutic drug levels that occurs 7-15 days after treatment (Watkins 
et al. 1997), led to the expectation that the size of the selective sweep on the double 
mutant chromosomes would be smaller than on the triple mutant chromosome. We 
used the deterministic model (Wiehe 1998; Nair et al. 2003) to determine the size 
based on a directly observed selection coefficient from Tanzania and found that the 
real sweep was much larger than predicted. It is probable that this allele was present 
in the southeast African parasite population prior to the triple mutant allele and 
perhaps dates from the earliest reports ofPyr resistance in the 1950's (Figure 7-2) 
(Peters 1970). If that is the case the recombination rates and the irregularity of 
selection would reduced the extent of the region of reduced gene diversity. Thus it 
was surprising to find that in the two study populations a substantial selective sweep 
was still detectable. 
g Comparing the selective sweeps around the dhfr double mutant and triple 
mutant alleles 
In Tanzania the width of the selective sweeps present on the double mutant (U30-
DI0) and triple mutant chromosomes (U40-DI0) sampled from the same time point 
were similar. In Mpumalanga we found that the difference was more pronounced, 
with a wider selective sweep around triple mutant alleles (U60-DI0) than double 
mutant alleles (U30-DI0) probably reflecting the greater relative fitness of the former 
over the latter. 
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1952 1954 1957 
1958 1960 1961 
1962 1963 
Figure 7-2: The emergence of pyrimethamine resistance on continental Africa 
between 1952 - 1963 adapted from (Peters 1970) 
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The differences in size of sweep around the triple mutant allele between Mpumalanga 
and Tanzania probably reflects the fact that SP was first line there, while in Tanzania 
it was second line at the time. 
The similarity in size of the selective sweeps present on the double mutant 
chromosomes from Mpumalanga and Tanzania is curious. The sweeps have 
converged on a stable size despite heterogeneity in selection and recombination rates. 
This is particularly curious as the selected allele and hitchhiking alleles were not at 
fixation in the population and thus are vulnerable to break up by recombination. 
Once more high initial starting frequencies could explain the similarity in the size of 
the selective sweep despite differences in population genetic parameters. 
h Co selection of the dhfr triple mutant and the dhps double mutant 
The two locus combination of the dhfr triple mutant and the dhps double mutant is 
statistically associated with treatment failure (Omar, Adagu, and Warhurst 2001; 
Kublin et al. 2002). We observed linkage disequilibrium between these two alleles in 
P. falciparum populations Hai and South Pares (Chapter 2; (Pearce et al. 2003). 
Interestingly the dhfr double mutant alleles were not in linkage disequilibrium with 
dhps double mutant but were with sensitive dhps alleles. 
The linkage disequilibrium between the dhfr triple mutant and dhps double mutant 
alleles is indicative of the co selection by the drug components ofSP. It shows that 
combined the two alleles confer greater fitness than each separately supporting the 
view that they both have a role in the survival of SP treatment in the field. 
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The appearance of the dhfr triple mutant allele preceded emergence of the dhps 
double mutant allele. In KwaZulu Natal in 1995 the dhps double mutant allele was 
absent from the population, and by 1999 it had achieved a frequency of 15%, an 
estimated selection coefficient of 0.13, assuming 3 generations per annum (Roper et 
al. 2003). This was greater than the selection coefficient estimated for the dhfr triple 
mutant over the same time period. It is worth considering that the larger selection 
coefficient for the dhps allele is a reflection of this advantage of the temporary 
association. Any advantage conferred on the dhfr triple mutant allele through 
association with the dhps double mutant allele is not clear from its selection 
coefficient estimated over the same period as the dhps allele was absent at the earlier 
time point. 
One of the original questions we were to attempt to address in this thesis when first 
designing the study, was whether we could use the width of a selective sweep present 
on a selected chromosome as a proxy for the strength of selection occurring in that 
population. Clearly for such a measure to be made the effective recombination rate 
between the two popUlations would need to be standardised, hence use of a 
longitudinal dataset from KwaZulu Natal. However, it soon became apparent with 
the observation of the important role of gene flow in the formation of the selective 
sweeps, that it would be impossible to distinguish between selection occurring in the 
study site and selection occurring in neighbouring populations. 
Therefore we propose that a better proxy for the intensity of selection occurring in the 
population would be the linkage disequilibrium between the two locus dhfrldhps 
combination of the dhfr triple mutant and dhps double mutant as we would expect 
that if there was no selection these two alleles would be rapidly uncoupled. 
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The selective sweep present on the dhps double mutant chromosomes 
In KwaZulu Natal in 1999, it was notable how much larger the selective sweep 
around dhps was than around the dhfi~ triple mutant allele population in 1999 (>275kb 
vs. 50kb). In neighbouring province of Mpumalanga where the effective 
recombination rate and selection coverage is similar the selective sweep on double 
mutant chromosomes sampled in 2001 was narrowed to 80kb and dhfi~ was 70kb. 
The reduction in size of the selective sweep is due to disequilibrium between 
recombination and selection pressure. Deterministic modelling (Wiehe 1998; Nair et 
al. 2003) of the predicted size of the selective sweep at equilibrium between known 
effective recombination and microsatellite mutation rates and directly observed 
selection coefficients, found that as with sweeps described on chromosome 4, there 
was a requirement of an initial frequency of the allele in the population greater than 
liNe. The value for the number of migrants estimated by the model was 20, but as the 
selection coefficient used was the minimum estimate this number of migrants could 
be lower. In Mpumalanga the initial starting frequency of the allele was closer to liNe. 
As the frequency of the double mutant allele in the region is low the low initial 
starting frequencies of the allele predicted by the model are unsurprising, particularly 
as selection was operating at the time, whereas arguably dhfr resistance alleles 
accumulated passively in some populations prior to selection. 
The de novo origin of the dhps SGEAA double mutant allele is unknown, however 
it's probably of African origin, being found in high frequencies throughout east 
Africa, but very low prevalence in southeast Asia and South America, where the 
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SGKGA and the SGEGA resistance alleles are the common types. Thus, the initial 
frequency of the allele in perhaps Tanzania or Malawi will have reflected the de novo 
mutation event (I /Ne). Since then gene flow has clearly played the important role in 
establishing the mutation in the KwaZulu Natal and Mpumalanga populations. 
j Features common to the three selective sweeps described 
None of the three resistance alleles,dhfiA triple, dhfr double or dhps double have 
achieved fixation in the populations studied. The rate that the frequency of the allele 
increases has implications for the size of the sweep size because it determines the 
opportunities for outcrossing. In African populations the expectation is that selective 
sweeps present around the drug selected alleles will always tend towards a smaller 
size reflecting the high rate of recombination and the weaker selection. It might also 
be expected that selective sweeps in African parasite populations will be less 
permanent than in malaria populations elsewhere. 
One recurring observation was the asymmetrical nature of the regions of reduced 
gene diversity around all three alleles. In each case, diversity was consistently 
returned more quickly on the downstream side of the selected site. This was 
particularly pronounced on the dhfr triple mutant chromosomes. On the dhfr double 
mutant chromosomes the asymmetry identified could be secondary, occurring 
through recombination with the expanding popUlation of triple mutant chromosomes. 
On the dhps double mutant chromosomes the asymmetry was clear, with the deepest 
part of the region of reduced gene diversity being maintained on the upstream side 
consistently over two time points. 
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In the absence of a better explanation we argue that the stochasticity of recombination 
breakpoints was to blame (Kim and Stephan 2002), with more recombination events 
occurring on the downstream side of the selected site. Other causes of the asymmetry 
could be recombination hot/cold spots or an additional site such as a compensatory 
mutation under selection (discussed below), but we observed that in the case of the 
dhfr triple mutant chromosome where the asymmetry is most pronounced, over time 
the deepest part of the selective sweep condenses onto dhfr. 
Curiously, the same asymmetry was found in the southeast Asian selective sweep 
around dhfr. The triple mutant allele was introduced from Asia to Africa (Roper et al. 
2003). The common asymmetry to sweeps in the two continents supports the view 
that the introduction involved multiple migrants. If a single migrant had entered the 
population, the asymmetry would happen by chance to be on the same side of dhfiA as 
in southeast Africa. By contrast if a larger number of migrants entered the African 
parasite population, and undergone a rapid expansion, the same asymmetry as 
southeast Asian chromosomes would be transferred. 
II Part 2: 
a Why do dhfr and dhps multiple mutants emerge so rarely? 
Prior to recent discoveries, the predominant hypothesis explaining the evolution of 
resistance to SP suggested that resistance conferring mutations had occurred de novo 
frequently (reviewed in (Hastings 2004)). The argument for multiple de novo origins 
is a numerical one. The mutation rate of dhfiA, for example, is sufficiently high 
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(2.5x10-9 mutationsldhfrlgeneration) that at least one mutation would arise at dhfr per 
patent infection (101°_1012 parasites). 
One explanation for the difference between empirical evidence and theoretical 
prediction is that the probability of survival of a new mutation in the population is 
low (Hastings 2004). If a beneficial allele arises during the course of a drug treated 
infection, for it to survive in the population it must be transmitted to other hosts. 
Only a small proportion of blood stage parasites develop into gan1etocytes «1 %) 
(Taylor and Read 1997; Anderson and Roper 2005), and it is possible that the new 
mutation can be lost. Furthermore, the transmission of the de novo mutant is 
dependant on the parasites survival against the hosts' immune defence. Plasmodium 
falciparum can perform antigenic switching, conferred by expressing different var 
genes and thus avoid immune destruction. (Gatton, Martin, and Cheng 2004) showed 
that parasite lineages that had only recently switched the var gene being expressed 
survived and went on to be transmitted. So while mutations may occur frequently, 
they would need to coincide with var gene switching to evade host immunity and be 
ingested in a mosquito blood meal. It is perhaps then not surprising that the majority 
of high level drug resistance has occurred in places where the majority of individuals 
are semi immune or non-immune. 
It is argued that high transmission intensities would greatly assist in the establishment 
of the allele in the population (Mackinnon 1997), as in low transmission regions there 
is a lower chance of transmission to other hosts. However, high transmission 
increases the challenges to the hosts' immune systems, speeding up the development 
of clinical immunity in the host (Snow et al. 1997). 
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A second explanation for low rate of emergence of de novo mutations observed is 
that additional adaptations are required to alleviate or compensate for a fitness cost of 
the resistance mutation itself. There is strong evidence of fitness costs associated 
with dhfr mutations as identified in growth rate transfection experiments comparing 
dhfr sensitive and double mutant alleles in the presence and absence of 
pyrimethamine selection (Fohl and Roos 2003). In the case of chloroquine resistance 
the observed drop in the frequency of the Pfcrt chloroquine resistance allele in 
Malawi dropped after SP replaced chloroquine as first line antimalarial suggesting 
that fitness costs of resistance Pfcrt alleles still remain (Kublin et al. 2003). 
However, in bacteria compensatory adaptations to alleviate the cost of the antibiotic 
resistance have been shown to exist (Schrag, Perrot, and Levin 1997). 
b Evidence for compensating adaptations 
A compensatory mutation is one which alleviates the fitness cost of the mutations 
occurring at the drug targeted site. This may occur through a variety of mechanisms 
such as intragenic mutations in RNA or protein molecules, intergenic mutations 
altering the interaction between cofactors, bypass mechanisms or emergence of a new 
function and, finally, increased expression of the mutated protein (Maisnier-Patin and 
Andersson 2004). 
Of the first of these compensatory mechanisms, there has been no descriptions of 
intragenic mutations other than those already described as associated with SP 
resistance, although substitutions at codons 51 and 59 could be argued to be 
compensatory as they enhance the substrate binding of enzymes with substitutions at 
codon 108 (Warhurst 2002). 
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In terms of compensatory overproduction of the mutated protein, it is interesting to 
note that DHFR binds its own mRNA as post transcriptional control of protein 
production (Goldberg 2002; Zhang and Rathod 2002). The mRNA is bound within 
the joining region between DHFR and thymidylate synthase, preventing production of 
excess protein. If a mutation blocking mRNA binding occurred in the joining region, 
over expression of dhJr could have the effect of swamping out the drug through 
producing excess target. I undertook a brief project sequencing the joining region of 
a small number of pyrimethamine sensitive and resistant parasites sampled from the 
field, but did not identify any polymorphism. Subsequently, it has been shown that 
there is no evidence for over expression of dhfr in resistant parasites (Wang et al. 
2004a). 
There is potential for compensatory adaptations in form of folate salvage, bypassing 
the function of dhps. The human host is incapable of de novo synthesis of folate, and 
all its folate is derived from the diet. P. Jalciparum carries out folate synthesis but is 
also capable of scavenging folate from the host, although the concentration of folate 
in the blood of the host is particularly low in populations suffering from malnutrition 
(Wang et al. 1997b; Wang et al. 1999; Wang et al. 2004a). Resistance substitutions 
in dhfr and dhps interfere with the normal interactions with the substrate molecule 
and the production of folate and in this situation the ability to scavenge folate is 
advantageous to the parasite. If exogenous folate is limited (such as in the case of 
malnutrition of host) the ability to synthesise folate from precursor molecules would 
be more efficient. Therefore it is interesting to speculate whether P. Jalciparum has 
evolved a compensating mechanism for actively accumulating folate. 
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Recent work describing the activity of the drug Probenecid on P.Jalciparum, suggests 
that the parasite may indeed have such a mechanism. Probenecid, is an inhibitor of 
drug efflux mechanisms and folate salvage, and has been shown in vitro to 
chemosensitise drug resistant P. Jalciparum to SP (Nzila et al. 2003). It is possible 
that probenecid inhibits the uptake of exogenous folate into the parasite, either 
through blocking parasite specific folate carrier proteins, similar to its action in 
blocking folate transporters in mammalian cells, or through blocking the 
accumulation of PABA, an essential precursor of the folate biosynthesis 
pathway(Nzila et al. 2003). Field studies testing the efficacy of SP in combination 
with probenecid in Nigerian children found that the addition of probenecid increased 
the treatment efficacy ofSP (Sowunmi et al. 2004). As yet a target of probenecid 
activity remains unidentified. 
The asymmetry of the selective sweeps present around the dhfr mutant and dhps 
mutant alleles could indicate the presence of compensatory adaptations. At the latter 
time point in the description of the selective sweep on the dhps double mutant 
chromosome (Mpumalanga 2001), the deepest part of the selective sweep seemed not 
to be on dhps but slightly upstream of it. Diversity had returned quicker on the 
downstream side. Bioinformatic analysis of the region within the deepest part of the 
selective sweep identified a function unknown open reading frame (PF08 _0093), 
which had some homology to a mitochondrial folate carrier proteins in other systems. 
However, the homology was only between conserved mitochondrial signalling motifs 
rather than to specific functional motifs and so this protein may not actually have a 
folate specific function. 
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Similarly the selective sweep around the dhfr triple mutant allele was asymmetrical 
favouring reduced diversity on the upstream side of the gene. Interestingly, (Wang et 
al. 2004a) mapped the ability to salvage folate and escape the lethal effects of 
sulphadoxine damaged dhps,to a 48kb re gion of chromosome 4 containing 7 open 
reading frames (ORPs) including dhfr. If there were a compensatory mutation within 
this 48kb region, we would expect to see reduced diversity around it and the 
asymmetry could be evidence of this. The position of dhfi" in this 48kb region is with 
the majority of sequence downstream of the gene, and the asymmetry points to the 
shorter upstream arm of the region, where three additional ORPs are located, of 
which two are function unknown and the closest to dhfiA has homology to an RNA 
binding protein. However, in KwaZulu Natal the selective sweep reduced in size to 
be more condensed on dhfr suggesting that stochasticity of recombination was the 
more likely a cause of asymmetry than one of the three ORFs identified on the 
upstream portion of the 48kb region. 
c The emergence of dhfr double mutant alleles 
The establishment of the 'home-grown' dhfr double mutant alleles and there 
widespread distribution in the southeast African population is a curiosity, mainly 
because of their inability to survive treatment concentrations of SP (Watkins et al. 
1997). We found supporting evidence in the lack of LD between the dhfiA and dhps 
double mutant alleles, suggesting that combination conferred insufficient fitness to 
maintain the association of the alleles through drug selected assortative mating. The 
dhfiA double mutant allele has at most a 45 day window within treated people during 
which they enjoy a positive selective advantage over sensitive alleles (Watkins et al. 
1997). Only chance infection post treatment would favour the dhfr double mutant 
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allele over the sensitive allele. In KwaZulu Natal the triple mutant displaced the 
double mutant allele over the 4 year period (Roper et al. 2003). 
Our analysis of the selective sweep around the C59R+SI08N double mutant allele 
clearly demonstrates the action of selection. Yet it is hard to see what advantage they 
have in the face of SP use. Intense use of SP treatment will increase the number of 
hosts in the population with the 45 day selective window, but equally the expansion 
in numbers of resistant parasites will be limited by chance infection of hosts with 
lethal SP concentrations. 
It is possible that the double mutant allele became established in a population where 
pyrimethamine rather than SP selection was operating. The earliest reports of 
pyrimethamine resistance in Africa came from regions where pyrimethamine alone 
was used prophylactically in community wide treatment programmes in the 1950s-
1960s summarised by (Peters 1970) (Figure 7-2). It is possible that the double mutant 
alleles date from this era. If the C59R+SI08N double mutant allele has existed since 
the 1950s this would have implications for the expected size of the selective sweep 
around the double mutant allele described in Chapter 5, because we would expect that 
120 generations of recombination would remove the selective sweep, particularly as 
the allele has never achieved fixation. 
d The emergence of the dhfr triple mutant 
The dhfr triple mutant allele in southeast Africa has been shown to have shared 
ancestry with the clade of dhfr resistance alleles found in Southeast Asia. It is 
tempting to speculate that the triple mutant allele was introduced into African 
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populations at the same time as the Pfer! resistance allele, also of Asian origin 
(Wootton et al. 2002). Certainly pyrimethamine resistance was well established in 
Thailand in the 1980s (White 1992), which is when chloroquine resistance first 
appeared in Africa (Payne 1989). It can be speCUlated that the triple mutant allele 
'hitch-hiked' with chloroquine resistant Pfer! for sufficient generations to increase the 
frequency of the dhfi~ triple mutant allele even in the absence of pyrimethamine 
selection (Roper et al. 2004). However, recombination would rapidly uncouple the 
association unless selection for the dhfr triple mutant resistance allele was occurring 
concomitantly with chloroquine use. This might have occurred once chloroquine 
treatment failures were treated with SP. SP became second line antimalarial in the 
majority of southeast African countries after 1982 (Mutabingwa et al. 2001). 
It is probable that the dhfr triple mutant allele entered continental Africa through 
southeast Africa, as it is here that the earliest reports of high numbers of SP treatment 
failures were made (Ronn et al. 1996; Trigg et al. 1997; Wang et al. 1997a). It is not 
known how the southeast Asian triple mutant allele made its' way into southeast 
Africa; it can be speculated that having expanded out of southeast Asia into the 
Indian subcontinent and migration between southeast India and Africa had introduced 
the resistance allele into southeast African parasite populations. Alternatively it may 
have come directly from Thailand. In either case the amount of gene flow into Africa 
would be restricted by the proportion of travellers infected. 
A recently published model (Santiago and Caballero 2005) describes the effects on 
genetic hitchhiking when a favourable mutation arises in only one population but 
enters the other through migration. The major prediction of the model is that the 
more restricted the gene flow between the two subpopulations, the narrower the 
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region of reduced gene diversity around the favourable allele in the second 
population. Where migration is low this causes an increase in diversity within the 
selective sweep and only at loci very close to the selected site does gene diversity 
remain at levels in the population of origin. It is likely that the source of higher 
diversity is recombination between the migrant sweep and the local population. As 
population differentiation approaches panmixia the very high number of migrants into 
the second population maintains the reduced diversity around selected alleles. Only 
at panmixia does the diversity flanking the beneficial allele in each 'population' 
become equivalent. 
What does this model tell us about the effects of gene flow in the populations 
described in this thesis? In the first scenario, the dhfi" triple mutant allele came 
directly from southeast Asia. Using unlinked micro satellites, a FST value of ~0.1 was 
estimated for comparisons between Southeast Asian and African parasite populations 
(Anderson et al. 2000a). This gives an estimate of2.25 effective migrants per 
generation, or assuming symmetrical migration, 5-7 migrants per year, given 4-6 
generations per year (Anderson and Roper 2005). Using the model described above 
to predict the effects on the selective sweep of migration between southeast Asia and 
southeast Africa, we find that there was likely to be an approximately 8% increase in 
diversity levels along the chromosome. Figure 7-3 shows the modelled diversity at 
increasing distance from dhfr along the chromosome in '"Asia" where the favourable 
allele arose, then in "Africa" into which the allele migrated. 
Note that even with these low rates of migration the width of the selective sweep is 
predicted to be only marginally narrowed. The level of diversity on the selected 
chromosomes in the "African" population returns to the pre selective sweep levels of 
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diversity approximately 10kb closer to the selected site than in the population of 
origin. This indicates that there is no theoretical basis to expect loss in the 
dimensions of the selective sweep due to migration to southeast Africa from southeast 
Asia. It is more likely that the difference in the size of the selective sweeps measured 
in southeast Asia and in Africa are due to events that have occurred within the 
African populations. Regrettably we do not have descriptions of the size of the 
selective sweep around the triple mutant allele in Africa immediately after its 
introduction from Southeast Asia and therefore can not directly verify the prediction 
from the model. 
In the second scenario, namely that the triple mutant allele entered continental Africa 
via the Indian subcontinent, introduced into east Africa by numerous migrants 
travelling to and from Indian ex pat communities or as a result of flourishing trade 
links. As such the effect on the size of the selective sweep around the triple mutant 
allele in Africa would be even less than that resulting from migration from southeast 
Asia to Africa. 
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Figure 7-3: The predicted variation as a proportion of variation prior to hitchhiking 
on selected chromosomes present in subdivided populations. The parameters used in 
the model were as used by (Nair et al. 2003) in the (Wiehe 1998) deterministic model 
prediction of the shape of the selective sweep present in southeast Asia; population 
size N=l 0000, selection coefficient s=O.l, recombination rate r=0.000588 
Mlkb/generation FST = 0.1; Diamonds "Asia" where the favourable allele first arose, 
and Squares "Africa" to which the allele migrated. See text and (Santiago and 
Caballero 2005) 
243 
Metadiscussion 
III Generalisable conclusions about the selective sweeps around SP 
resistance alleles in southeast Africa 
a Movement of SP resistance alleles with in southeast Africa 
A recurring theme in this thesis is the role of gene flow in the evolution of SP 
resistance in African populations. Firstly, microsatellite analysis of three parasite 
populations in Mozambique, South Africa and Tanzania found that there was little 
population differentiation between them, and thus heterogeneities in resistance allele 
frequencies were due to differences in the intensity of selection in these populations. 
Secondly gene flow was identified as passively disseminating and establishing the 
resistance alleles in populations throughout the region. We observed that the starting 
frequencies of an allele in the population as predicted by the model broadly reflected 
it frequency in neighbouring populations and the history of selection in the 
population. Passive accumulation of pyrimethamine resistance alleles in the absence 
of drug selection explaining the higher starting frequencies compared to the initial 
starting frequencies of the later emerging dhps double mutant allele. 
The role of gene flow in the evolution of SP resistance has clear implications for the 
policy approach to maintaining the useful treatment lifetime (UTL) of antimalarial 
drugs as it is evident that unilateral national approaches to the use of antimalarials are 
detrimental. Whilst not making the drug unusable, large scale gene flow ensures that 
resistance alleles are present throughout the region when selection occurs, limiting 
the usefulness of the drug for neighbouring states. If the next generation of 
antimalarial treatments are to be protected it is key that the importation of parasites 
into Africa is limited to prevent migration of resistance alleles and secondly 
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multilateral antimalarial treatment policies need to be adopted to maximise the UTL 
of the drug in a region. 
The gene flow between the southeast African populations described in this thesis is 
sufficiently high that the model of (Santiago and Caballero 2005) would predict no 
effect on the diversity levels of a selective sweep as it moved from one population to 
another. The numbers of migrants are sufficiently high that associations between 
hitchhiker and selected site are maintained. This is particularly pertinent considering 
our observation of the similarity in the sizes of the selective sweeps across southeast 
Africa despite very different effective recombination rates and selection histories. 
For example, a 50kb region of reduced gene diversity was described on the dhji- triple 
mutant chromosomes sampled from both Tanzania, where the effective 
recombination rates is high and KwaZulu Natal in 1999 where it is low. The 
similarity in the dimensions of the selective sweeps in the two populations despite 
different recombination and selection parameters, was deterministically modelled 
(Wiehe 1998; Nair et al. 2003) as due to the 100 times greater initial starting 
frequency of the allele in Tanzania. These high initial frequencies of the allele in 
Tanzania in the absence of selection slow the breakdown of associations between 
selected site and hitchhiker in the absence of selection by increasing the proportion of 
'recombining' resistant chromosomes where there is minimal effect on diversity in 
the selective sweep. 
b Detection of drug selected loci in African Populations 
If there is an additional locus involved in SP resistance, describing patterns of 
diversity in the genome would be a reasonable method of detection (Anderson 2004), 
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although in the light of the findings in this thesis, African populations are a double 
edged sword. Whilst we identified selective sweeps around known sites under 
selection, they were smaller in the African populations described here than in 
populations in southeast Asia. Thus identifying unknown sites after an unknown 
period of selection in African populations would require a greater coverage of 
markers than on chromosomes sampled from southeast Asian populations. We would 
expect that to identify a novel resistance allele in African populations by description 
of patterns of diversity in the genome of parasites with a resistance phenotype, one 
would need a high coverage of genetic markers spaced approximately 10kb apart 
(which would have captured the 40kb sweep around the dhfr double mutant allele). If 
the resistance phenotype was only recently observed approximately 2S-30kb apart 
would be sufficient (and would capture the dhps double mutant sweep). 
The high recombination rate and weaker level of selection maybe a disadvantage of 
using African populations, but it also provides the advantage of condensing the region 
of reduced gene diversity to a smaller region of the chromosome than in other 
populations, for example South American populations where the entire genome can 
be in linkage disequilibrium (Cortese et al. 2002). Thus if additional novel mutations 
are involved they maybe more easily identified in Africa than in other populations. 
Another advantage of using African populations is that resistance alleles and their 
phenotypes are more easily distinguished because their origin in the population is 
limited, either to a single de novo mutation event or a migration event. This is true 
for both SP resistance and chloroquine resistance and arguably will hold for future 
resistance to novel antimalarials. In other global locations, whilst also occurring 
rarely, there can be more variation in the number of resistance alleles that arise, that 
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whilst composed of different substitutions would all have a resistance phenotype. For 
example in southeast Asia the description of the selective sweep on the resistant dhps 
chromosomes is hampered by the presence of at least three origins of dhps resistance 
alleles, each with separate flanking haplotypes that show evidence of having 
recombined (Anderson and Roper 2005). 
IV Final Remarks: Future ,vork and the future of antimalarials 
This thesis is not a comprehensive description of the evolution of SP resistance in 
southeast Africa and there are a number of avenues that could be explored with 
reward: 
1.1 n West Africa, the frequency of SP resistance alleles are much lower than 
found in east Africa (Wang et al. 1997a; Eberl et al. 2001; Marks et al. 2005) 
C. Roper personal communication), as SP selection histories in west African 
countries are for the majority shorter than those in east Africa. Whereas at 
dhfr the substitutions found in west Africa are the same as in east Africa, at 
dhps the double mutant allele common to southeast Africa is very rare, and 
other substitutions are more common (Wang et al. 1997 a; Eberl et al. 2001; 
Marks et al. 2005) C. Roper personal communication). Having now 
described the selective sweeps around the common southeast African SP 
resistance alleles, it is essential to do the same around the common west 
African alleles, particularly so at dhps. A mapping study identifying the 
distribution of the dhfr triple mutant allele across continental Africa, 
describing both allele frequencies and flanking haplotypes is currently in 
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progress (Pota and Roper). This work has yet to be extended to the alleles 
present at dhps. 
2.Ha ving made one longitudinal description of the selective sweep on dhfr triple 
mutant chromosomes in southeast Africa, it would be of interest to do an 
equivalent study in an additional population, particularly one where effective 
recombination rates are high. This would address the question of the apparent 
stability in size of the selective sweeps around drug-selected alleles regardless 
of recombination or selection history. In southern Tanzania the samples used 
in this thesis were taken prior to the national policy switch to SP in 2001. 
Samples taken at two further time points would address two questions. Firstly 
is there any effect on the region of diversity around the resistance alleles in 
this population when selection is eventually applied? Given that transmission 
intensity in this population is high and drug use generally lower, it is doubtful 
that the application of selection would result in an epidemic expansion of 
resistant parasites that would increase the size of the selective sweep. A 
second time point a few years after selection in the popUlation had begun, 
when presumably there will have been an increase in the frequencies of the 
resistance allele, could be used to address the question of the interaction 
between recombination and selection as presumably the rate of breakdown of 
the sweep will have been greater prior to selection occurring, unless gene flow 
from neighbouring populations had sufficiently stabilised size of the selective 
sweep. 
3.To attempt t 0 address the role of gene flow in the size of the selective sweep 
on resistant chromosomes, it would be of interest to describe the region of 
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reduce diversity on chromosomes taken from specific geographical areas, with 
sufficient power that comparisons could be made between them. If we were 
able to longitudinally sample populations where selection was ongoing and 
neighbouring populations where selection was absent, between which a 
known amount of gene flow was occurring, we would comparatively test the 
theoretical role of gene flow in the size and shape of the selective sweeps in 
the populations where selection was absent. As with Clyde's observation of 
pyrimethamine resistance 100 miles from the initial foci of selection, would 
we observe that the selective sweep around an allele narrowed more in 
populations of greatest distance from the population where selection was 
initially applied? Clearly southeast African populations where SP resistance 
alleles and use of SP is widespread, would not be the most applicable such an 
investigation. 
4.As a related point to that made above, finer resolution of the parasite 
population structure could be made if more microsatellites or other markers 
such as SNPs were used, which are less likely to overestimate population 
differentiation. Whilst there is unlikely to be much deviation from the 
conclusion of low population subdivision, it may illuminate more minor 
differences. With sufficient coverage it maybe possible to detect the 
introgression of non African drug resistant parasites into African populations 
shedding light on the route of spread. Clearly to do this on SP resistance 
would require good historical data. Furthermore, as gene flow is likely to be 
occurring in all directions all the time, homogeny across the region in neutral 
allele frequencies could make this difficult to determine. 
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246 0.96 0.82 1.26 
249 1.92 0.82 
n=46 n=41 n=87 n=42 n=34 n=104 n=122 n=159 
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TA87 Komatipoort Mangweni Steenbok E. Mozambique W. Mozambique Ulanga Morogoro Rufigi "tI 0 
-0 
73 2.17 2.27 2.42 c a-
80 2.22 2.08 o· ::l 
84 1.22 C) ~ 
::l 
87 2.22 8.33 5.56 2.17 2.27 0.81 1.96 0.61 ~ o· 
90 2.22 2.08 2.17 1.61 0.65 2.44 > ::l 
93 4.44 4.17 8.89 4.35 2.27 3.23 0.65 3.66 Ql ~ 
'" 96 15.56 18.75 12.22 26.09 31.82 20.16 15.69 24.39 in· 0 
99 20.00 20.83 20.00 4.35 18.18 13.71 20.92 15.24 
...., 
> 
102 22.22 18.75 20.00 15.22 9.09 16.13 21.57 15.24 
g g; 
105 13.33 10.42 10.00 13.04 15.91 15.32 14.38 20.73 iii" Cb 
108 13.33 6.25 16.67 17.39 6.82 12.90 13.73 9.15 :;:t) ~. 
111 2.22 2.08 3.33 4.35 4.55 5.65 5.23 1.83 g 
114 6.25 2.22 2.42 2.61 1.83 C"l ~ 
117 1.11 8.70 4.55 4.03 2.61 3.66 :i" 
'"tl 
120 2.22 0.81 tr 
'" :::: 
123 0.81 is ~ 
131 2.27 ;::: ;: 
n=45 n=48 n=90 n=46 n=44 n=124 n=153 n=164 ~ f) 
ij. 
~ 
i1 
:s 
s· 
'" 0 c go 
~ 
Ql 
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N > 
0\ I~ -....J 
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00 
TAI02 KomatiQoort Mangweni Steenbok E. Mozambigue W. Mozambigue Ulanga Morogoro Rufigi 
111 2.22 0.69 
114 0.77 
117 2.22 8.70 ]4.29 6.67 9.76 3.45 3.47 3.08 
120 15.56 17.39 10.71 13.33 ]7.07 ]8.10 18.75 ]8.46 
123 11.11 10.87 13.10 6.67 9.76 15.52 19.44 9.23 
126 15.56 17.39 22.62 10.00 14.63 22.41 14.58 17.69 
129 33.33 21.74 19.05 40.00 31.71 26.72 28.47 27.69 
132 6.67 8.70 ]4.29 10.00 4.88 2.59 7.64 ]] .54 
135 6.67 4.35 4.76 6.67 6.03 5.56 8.46 
138 4.44 6.52 1.19 6.67 9.76 2.59 1.39 0.77 
141 2.22 4.35 2.44 0.86 2.31 
144 1.72 
n=45 n=46 n=84 n=30 n=41 n=116 n=144 n=130 
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Primer Name Seguence Re~eat Unit Name Distance from codon 108 of dhfr Size Range 
dhfr350kbU3F CACATACTATGATCTACCC AAT U350 -349402 288-303 
dhfr350kbUF -lab CAGAAGATGTGCAACAAG 
dhfr350kbUR CTTCGCAATTGAGTTGGT 
dhfr250kbU3F GAGCAAATCCGTATGATCG AAT U250 -249083 261-287 
dhfr250kbUF-Iab ATGGACGCATTTAACCCGA 
dhfr250kbUR TCATAGGAGCGACTAGGTT () >-
dhfrl50kbU3F ATGCATACCTGTGAAGAA AAAAT U150 -143768 162-210 ~ 
'" ""1 0 dhfrl50kbUF-Iab TGCCCTTTTAATCAGAAC 0 "0 3 s:: 
dhfrl50kbUR CTACAGTTTTGTGAGTTAT ~ 0 0 CI) ::I 
dhfrl25kbU3F TAAATTTCCTTCACATAGGCC AT U125 -125163 158-198 0 a 3 (1) dhfrI25kbUF-Iab CGTTGCAAATATACCATCTTG ::I ('1) ~ 
dhfrI25kbUR GGATGAATCCAAGTAACCAAT ~ 0" 
dhfr 1 00kbU3F AACTTGTATCACACACCCAA AT UI00 -100618 309-338 3 ~ III A) ~ 
dhfr 1 OOkbUF -lab CCTGAGCATAAGATTGCAAAG til r;;" 
dhfrlOOkbUR AACTGAATCAGAAGTCATATTGG 0 ...., 
>-dhfr90kbUF GTAATAGCAAATTAGAGGTGtt AT U90 -89100 n/a ::I 3 ~ dhfr90kbU3R GAACACCAGATGGCCCTC 0' ~ dhfr90kbUR-Iab CAAATGGTATGAACGTGATTC ""1 0 ;::t:I CI) ~ dhfr80kbUF AAGAGGTTGCACAAGATC AT U80 -80048 258-277 A) 
--
~" 
dhfr80kbU3R CATATCGTATGTATGCCAC ~ ::I () 
dhfr80kbUR-lab GAGATGCTCTTACAATCG 
--
(1) 
('1) ::i" 
dhfr75kbU3F CGAGGTGAATTATGGGAA AT U75 -76185 247-273 
CI) 
"t! 0.. ts' 
dhfr75kbUF-Iab CATACGGCAAAATGAGATa ('1) ~ CI) 
dhfr75kbUR TATGTGCGAACGGTAAAA 
() c 
""1 ~ ~ ::: dhfr70DDkbUR ACCTTTAAATACGACTAGCG AT U70DD -70352 480-521 :§ ('1) ~ dhfr70DDkbU3F GGCTGTTGTCGCTACTCG 0.. 5' f)' ~" dhfr70DDkbUF -lab GTATGATCACCTAAATCGAC tl 
--
t! ::r dhfr70kbUF TACACACATATGTGCACATATAA AAAG U70 -69219 301-395 til' ~ :r dhfr70kbU3R CCTTATTCTTATGTCCCGCG CI) til 
--
0 
dhfr70kbUR-lab CTTACGTTCTTACTTTCTTACG c s:: 0.. So (1) 
dhfr60kbUF CGGTCTATATAGGAAATTTATC AT U60 -60113 193-242 ~ 
N dhfr60kbU3R CGGTTCTGTGTAAACCCATG >-=t> 
0\ dhfr60kbUR-lab CCCCAGCCTTAGACATATGC 0" \0 po 
Primer Name Seguence Re12eat Unit Name Distance from codon 108 of dhfr Size Range 
dhfr50kbU3F CTTCCTTTGTATATCATATC AT U50 -51037 212-219 
dhfr50kbUF -lab TGATATTCTTATATGTTCATC 
dhfr50kbUR GAACATTTCATATAGTTACAT 
dhfrii40kbU3F GTTGCCTTGGCGTATAAG AT U40 -39464 200-242 
dhfrii40kbUF -lab aaGCAACATATGCAAGTTAAt 
dhfrii40kbUR TTTATCAAAGGGACACTCC 
dhfr30kbU3F GTGACAGTGAACAGGTAATA AT U30 -29895 133-173 
dhfr30kbUF-lab GAACGTACATAGGTTTATAC > 
dhfr30kbUR CTTCATAATTGTCGCACGTA '0 '0 ~ 
dhfr20kbU3F GCTTCATATCTTATATCATT AT V20 -20182 197-222 ::;, 0. x· 
dhfr20kbUF -lab CAAATTAACACTTCATAATC w 
dhfr20kbUR tTTCT AAAATGCTTATCCc ~ 
dhfriil OkbU3F CAGAAGGGTTATAATAAGAT ATTT VI0 -7415 245-265 g. 
dhfriilOkbUF-Iab CGACATACATACATTTATCA a 3 
dhfrii I OkbUR TACAAATGAAGGTCGATTTT ~ 0 
dhfr 3 ~ 
dhfrlOkbD3F AGTAAAGAAACAGAAACAAGTACA AT DIO 11450 130-153 .j:>.. 3 
dhfrIOkbDF-lab ATCAGGAGGAATAAGAAATGAAC Dl '0 
'0 
dhfrIOkbDR GTTAACATACTATCCATATGAATG :r (fQ 
dhfr20kbD3F GATGAAAATTTGCTTACTTAC ATG D20 19605 280-296 3 (i. 
dhfr20kbDF -lab TGTGCACATGAAATTTGTTC ~ 
Dl dhfr20kbDR TGGTTCAATAAACGAGACC ~ 
dhfr30kbD3F TCATCATCTGGATCGATA AT D30 30199 126-166 ~. 
dhfr30kbDF-lab ACAAATTGTGTGTATCAC 0. ~ 
dhfr30kbDR ATGCTGTACACAAATTGG Q c: 
dhfr40kbD3F ACGATAAGGATGATACTC AT D40 40874 297-336 ~ 0. 
dhfr40kbDF -lab TTGTGTTCATCTTCATCC :i" .... 
:r dhfr40kbDR TAACAAGCGAAAGAGGTA en· 
tI> 
dhfr50kbD3F AATGTACTACAGTAAAACAGA AT D50 50176 142-175 2 0. 
dhfr50kbDF-lab AGCATATATGATGTAATAAGG '< n 
dhfr50kbDR AATACAAGTGGAAAGTTACC :r Dl 
'0 
dhfr60kbDF GTGCATGTTGCACAGAAATG TAA D60 60946 242-272 Fb ;;l 
N dhfr60kbD3R GTCCTTCCCATTACAAGTTTC .j:>.. 
......:J dhfr60kbDR-lab Ro 0 GGTAAATAGGCCAACAACTC ~ 
Primer Name Seguence Re~eat Unit Name Distance from codon 108 of dhfr Size Range 
dhfr70kbDF GTTATCACCAAAATGAGTTCG TAT D70 70672 215-232 
dhfr70kbD3R CAAATGCTCACTATGTGAAG 
dhfr70kbOR-lab GTGCAGATAGGAATAACATG 
dhfr75kbD3F ACAAATCACCACACCAAA AT 075 75424 177-199 
dhfr75kbOF -lab AACAAACACACACGTTCT 
dhfr75kbDR TACATGTAAGAAAGAACGT »-
dhfr80kbD3F GGCTATTTGTTCATAATGTTC AT D80 80215 272-295 "'C 0 
"0 
dhfr80kbDR GTGGACAGGTAAAACATATTA c: ~ 
dhfr80kbDF -lab GCAAACATCCAATGGTATCA o· :::s 
dhfr90kbDF ACAAATATCATGTTAGTAATACA AT D90 91191 246-264- a ~ 
:::s 
dhfr90kbD3R AGGACGTTAAAATGACGGC ~ o· 
dhfr90kbDR-Iab CTTTCCCATAGACACTTGAA »-:::s 
dhfrl00kbD3f TGACAAATTAAATGTAGG TAAA DI00 101466 107-139 e?. ]. 
dhfrl00kbDF-lab CCTATAAGAAAAGATGAG 0 
dhfrl00kbOR GCACATCATTCTAACAA 
....., 
»-
dhfrl25kbD3F ATATATGCTGAAATGTGG AT 0125 126196 nla a g; 
dhfrl25kbDF-lab AGACAAAGGTACAAATAC ;-ft 
dhfrl25kbOR TTCAATCCTAACAACAAC :;0 ~ 
dhfrl50kbD3F TTTCATCTTCTCCTCTTGA ITA D150 148016 220-253 iii· fit 
dhfrl50kbDF-lab CCTTTGATTCGTTCATGC :::s ~ 
dhfr150kbDR CAACGAACATACTGAAGAA :r 
"tI 
dhfrii250kbD3F GGTGACAAGAAAAAGGCGAC ATA D250 250856 221-275 ~ ~ dhfrii250kbDF-Iab GAATGCAAATGATAATGTGAATG 0 ~ 
dhfrii250kbDR CATCGTCTTCAGCATTCATCT ;:: :ii 
dhfr350kbD3F GAAATGAATTTGTCTACC AAT D350 348652 166-181 'is' i)' 
dhfr350kbDF-Iab CTGCAATAAACATACAAC il· I:) 
dhfr350kbDR TAACCACATTTACAGCTA t! :ii 
s· 
til 
0 
c: go 
~ 
~ 
N »-
-....) I~ I--l 
A Population Genetic Analysis of Anti fol ate Resistance in Plasmodiumfalciparum in southeast Africa. 
A1212endix 4: Allele freguencies (%) at each microsatellite locus on dhfr sensitive and 
tri12le mutant chromosomes 
KZN CIRN KZN CIRN Mpu Tanz 
U350 Sensitive 1995 1999 CIRN CIRN 
288 65.00 53.85 64.71 42.86 
291 10.00 5.88 
294 10.00 7.69 17.65 42.86 
297 10.00 30.77 11.76 14.29 
303 5.00 7.69 
n=20 n=13 n=17 n=7 n=O 
KZN CIRN KZN CIRN Mpu Tanz 
U250 Sensitive 1995 1999 CIRN CIRN 
261 23.81 23.08 11.76 25.00 
264 30.77 
267 14.29 30.77 41.18 50.00 
270 9.52 7.69 29.41 12.50 
273 19.05 5.88 
276 4.76 7.69 5.88 12.50 
279 19.05 5.88 
285 4.76 
287 4.76 
n=21 n=13 n=17 n=8 n=O 
KZN CIRN KZN CIRN Mpu Tanz 
UI50 Sensitive 1995 1999 CIRN CIRN 
162 4.76 5.88 
166 19.05 15.38 35.29 25.00 
168 14.29 7.69 5.88 
170 9.52 7.69 5.88 
172 9.52 30.77 12.50 
174 7.69 5.88 
176 19.05 12.50 
178 9.52 
180 4.76 5.88 
184 5.88 
192 11.76 
200 7.69 
202 5.88 
208 9.52 23.08 5.88 50.00 
210 5.88 
n 21 n-13 n=17 n-8 n 0 
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Appendix 4: Allele frequencies (%) at each microsatellite locus on dhfr sensitive and triple mutant chromosomes 
KZN CIRN KZN CIRN Mpu Tanz 
U125 Sensitive 1995 1999 CIRN CIRN 
158 5.26 
164 10.53 7.69 
168 5.26 15.38 14.29 
170 21.05 14.29 
172 10.53 15.38 12.50 14.29 
174 10.53 15.38 
176 5.26 6.25 28.57 
178 10.53 15.38 28.57 
180 5.26 6.25 
182 15.38 25.00 
184 5.26 7.69 ] 8.75 
190 7.69 6.25 
192 6.25 
194 12.50 
196 5.26 
]98 5.26 6.25 
n=19 n=13 n=16 n=7 n=O 
KZN CIRN KZN CIRN Mpu Tanz 
U]OO Sensitive 1995 1999 CIRN CIRN 
309 4.76 7.69 
311 4.76 
313 12.50 
315 19.05 23.08 7.69 62.50 
317 14.29 15.38 7.69 
319 7.69 
321 23.81 23.08 
323 4.76 23.08 15.38 
325 15.38 15.38 12.50 
327 9.52 7.69 
330 7.69 
332 9.52 
334 4.76 15.38 12.50 
338 4.76 7.69 
n-21 n-13 n=13 n-8 n 0 
KZN CIRN KZN CIRN Mpu Tanz 
U75 Sensitive 1995 1999 CIRN 
CIRN 
247 25.00 
255 20.00 6.25 
257 30.00 7.69 
259 10.00 92.31 93.75 100.00 
261 10.00 
265 5.00 
n 20 n-13 n-16 n 8 n 0 
273 
A Population Genetic Analysis of Antifolate Resistance in Plasmodiumfalciparum in southeast Africa. 
KZNCIRN KZN CIRN Mpu Tanz 
U70DD Sensitive 1995 1999 CIRN CIRN 
480 42.86 76.92 26.67 57.14 57.14 
483 4.76 13.33 3.57 
499 4.76 
SOl 33.33 15.38 53.33 21.43 17.86 
503 7.69 2.38 3.57 
521 14.29 6.67 19.05 17.86 
n=21 n=13 n=15 n=42 n=28 
KZN CIRN KZN CIRN Mpu Tanz 
U70 Sensitive 1995 1999 CIRN CIRN 
301 7.55 
304 9.09 1.89 
310 5.26 9.09 1.89 15.38 
312 5.26 7.14 1.89 3.85 
314 5.26 9.09 7.69 
320 1.89 3.85 
322 5.26 14.29 
323 1.89 3.85 
327 3.77 
328 5.26 3.77 
329 7.69 
331 3.77 
335 21.05 14.29 9.43 11.54 
337 5.26 
339 10.53 
341 9.09 3.77 
347 5.26 14.29 11.32 
349 9.09 3.85 
351 10.53 36.36 14.29 22.64 23.08 
356 5.66 3.85 
360 5.66 
362 3.85 
363 9.09 14.29 
364 3.77 
371 5.26 5.66 
373 10.53 1.89 
375 14.29 3.85 
379 9.09 3.85 
383 5.26 
387 1.89 
389 7.14 
395 3.85 
n-19 n-ll n=14 n-53 n 26 
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Appendix 4: Allele frequencies (%) at each microsatellite locus on dhfr sensitive and triple mutant chromosomes 
KZNCIRN KZNCIRN Mpu Tanz 
U60 Sensitive 1995 1999 CIRN CIRN 
193 17.65 
220 3.57 4.35 
222 4.76 5.88 7.14 
224 4.76 8.33 7.14 
226 14.29 5.88 1.79 6.52 
228 23.81 29.41 16.07 17.39 
230 28.57 83.33 29.41 55.36 39.13 
232 4.76 8.33 5.88 17.39 
234 4.76 6.52 
236 4.35 
238 14.29 5.88 3.57 2.17 
240 2.17 
242 5.36 
n=21 n=12 n=17 n=56 n=46 
KZN CIRN KZN CIRN Mpu Tanz 
U40 Sensitive 1995 1999 CIRN CIRN 
202 2.08 
204 5.26 3.64 
206 2.08 
208 5.26 6.25 
209 1.82 
210 21.05 83.33 71.43 70.91 60.42 
212 5.26 4.17 
214 5.26 
215 1.82 
216 31.58 7.14 5.45 10.42 
218 10.53 4.17 
220 1.82 4.17 
222 5.26 14.29 7.27 2.08 
224 10.53 16.67 7.27 4.17 
242 7.14 
n-19 n-12 n-14 n 55 n 48 
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KZN CIRN KZN CIRN Mpu Tanz U30 Sensitive 1995 1999 CIRN CIRN 
137 1.82 
140 4.76 
142 14.29 
145 4.55 
147 4.76 18.75 1.82 2.27 
149 19.05 9.09 13.64 
151 9.52 18.75 14.55 15.91 
153 4.76 3.64 2.27 
155 1.82 4.55 
157 4.76 1.82 4.55 
159 19.05 6.25 
161 14.29 6.25 6.82 
163 4.76 92.31 50.00 56.36 43.18 
165 5.45 
167 7.69 3.64 
173 2.27 
n=21 n=13 n=16 n=55 n=44 
KZN CIRN KZN CIRN Mpu Tanz 
U20 Sensitive 1995 1999 CIRN CIRN 
199 10.00 
201 92.31 56.25 60.38 78.72 
203 5.00 7.69 12.50 16.98 6.38 
205 20.00 12.50 1.89 
207 15.00 12.50 5.66 2.13 
209 15.00 3.77 6.38 
211 10.00 1.89 2.13 
213 1.89 2.13 
215 6.25 5.66 
217 10.00 1.89 
219 15.00 
222 2.13 
n-20 n=13 n=16 n=53 n=47 
KZN CIRN KZNCIRN Mpu Tanz 
UI0 Sensitive 1995 1999 CIRN CIRN 
245 25.00 
253 20.00 6.25 
255 25.00 7.69 12.50 1.82 
257 15.00 92.31 81.25 89.09 93.02 
259 10.00 6.98 
261 1.82 
263 5.00 
265 7.27 
n 20 n-13 n-16 n-55 n 43 
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Appendix 4: Allele frequencies (%) at each microsatellite locus on dhfr sensitive and triple mutant chromosomes 
KZN CIRN KZNCIRN Mpu Tanz 
MAl Sellsitive 1995 1999 CIRN CIRN 
197 15.79 
199 10.53 
203 21.05 100.00 91.67 
205 21.05 
207 5.26 8.33 
209 15.79 
211 10.53 
n=19 n=7 n=12 n=O n=O 
KZN CIRN KZNCIRN Mpu Tanz 
MA2 Sensitive 1995 1999 CIRN CIRN 
159 5.56 
170 16.67 
172 22.22 
174 11.11 
175 5.56 18.18 6.25 
177 16.67 81.82 87.50 
179 11.11 
183 5.56 
187 6.25 
189 5.56 
n=18 n=ll n=16 n=O n=O 
KZN CIRN KZN CIRN Mpu Tanz 
DHFR Sensitive 1995 1999 CIRN CIRN 
88 80.00 7.69 
99 5.00 
100 5.00 
108 100.00 92.31 
110 10.00 
n=20 n=7 n=13 n=O n-O 
KZN CIRN KZN CIRN Mpu Tanz 
DI0 Sensitive 1995 1999 CIRN CIRN 
130 4.76 1.85 
133 4.76 5.88 1.85 2.17 
136 47.62 92.31 76.47 83.33 78.26 
139 33.33 7.69 17.65 5.56 13.04 
143 4.76 3.70 4.35 
147 2.17 
150 3.70 
153 4.76 
n 21 n-13 n-17 n-54 n 46 
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KZN CIRN KZNCIRN Mpu Tanz 
D20 Sensitive 1995 1999 CIRN CIRN 
280 23.08 5.88 5.45 5.41 
283 90.48 61.54 94.12 87.27 91.89 
286 9.52 7.69 7.27 
290 2.70 
296 7.69 
n=21 n=13 n=17 n=55 n=37 
KZN CIRN KZN CIRN Mpu Tanz 
D30 Sensitive 1995 1999 CIRN CIRN 
126 4.76 2.38 
130 11.76 9.09 9.52 
132 14.29 8.33 5.88 3.64 9.52 
134 25.00 29.41 21.82 26.19 
136 9.52 8.33 5.88 9.09 2.38 
138 4.76 8.33 3.64 14.29 
140 9.52 5.88 3.64 7.14 
142 14.29 5.88 7.27 4.76 
144 4.76 16.67 5.88 
145 9.09 2.38 
147 4.76 16.67 17.65 12.73 4.76 
149 4.76 8.33 5.88 9.09 7.14 
151 4.76 2.38 
154 3.64 
155 9.52 
156 5.45 
157 4.76 8.33 5.88 
159 9.52 
160 1.82 7.14 
n=21 n=12 n=17 n=55 n=42 
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Appendix 4: Allele frequencies (%) at each microsatelIite locus on dhfr sensitive and triple mutant chromosomes 
KZN ClRN KZN ClRN Mpu Tanz 
D40 Sensitive 1995 1999 CIRN ClRN 
299 9.52 15.38 14.29 14.55 30.77 
301 7.14 
303 1.82 2.56 
307 9.52 7.27 5.l3 
309 7.69 2.56 
311 7.27 2.56 
313 9.52 7.69 5.45 7.69 
315 5.45 12.82 
317 19.05 7.14 5.45 5.l3 
319 4.76 30.77 7.14 5.45 2.56 
321 9.52 7.69 9.09 2.56 
323 9.52 15.38 14.29 7.27 10.26 
325 4.76 7.69 14.29 3.64 5.l3 
327 4.76 7.69 14.29 5.45 5.l3 
329 4.76 7.14 
331 4.76 3.64 
332 2.56 
333 9.52 14.29 
334 7.27 2.56 
336 10.91 
n=21 n=l3 n=14 n=55 n=39 
KZN ClRN KZN CIRN Mpu Tanz 
D50 Sensitive 1995 1999 CIRN ClRN 
142 1.89 2.38 
144 2.38 
147 4.76 15.38 3.77 7.14 
149 7.55 2.38 
151 4.76 18.75 5.66 9.52 
153 33.33 15.38 25.00 5.66 21.43 
155 14.29 7.69 15.09 7.14 
157 4.76 15.38 12.50 5.66 11.90 
159 4.76 15.38 3.77 2.38 
161 4.76 18.75 7.55 2.38 
163 23.81 15.38 12.50 22.64 14.29 
165 5.66 4.76 
167 7.69 6.25 1.89 9.52 
169 6.25 9.43 
171 4.76 1.89 
173 7.69 
175 1.89 2.38 
n 21 n 13 n=16 n-53 n 42 
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KZNCIRN KZN CIRN Mpu Tanz 
D60 Sensitive 1995 1999 CIRN CIRN 
242 13.33 2.13 6.25 
245 20.00 4.26 6.25 
248 11.11 ]0.64 9.38 
251 13.33 33.33 60.00 40.43 46.88 
254 53.33 30.00 25.53 ]8.75 
257 22.22 10.00 2.13 3.13 
260 11.11 4.26 3.13 
263 11.11 4.26 6.25 
269 6.38 
272 11.11 
n=15 n=9 n=lO n=47 n=32 
KZN CIRN KZN CIRN Mpu Tanz 
D70 Sensitive 1995 1999 CIRN CIRN 
215 5.56 9.09 20.00 1.82 8.33 
2]8 22.22 36.36 6.67 5.45 ]6.67 
221 5.56 20.00 18.18 ]6.67 
224 66.67 54.55 53.33 60.00 37.50 
227 7.27 ]4.58 
229 7.27 6.25 
n=18 n=1 ] n=15 n=55 n=48 
KZN CIRN KZN CIRN Mpu Tanz 
D80 Sensitive 1995 ]999 CIRN CIRN 
272 5.88 
273 14.29 
274 5.00 11.76 
275 5.00 7.69 14.29 
276 5.00 
277 5.00 7.69 
280 20.00 15.38 23.53 42.86 
281 15.00 7.69 
282 5.00 7.69 11.76 14.29 
283 5.00 5.88 
284 10.00 30.77 23.53 
285 5.00 5.88 
286 5.00 15.38 
287 5.00 
288 5.00 11.76 
289 7.69 14.29 
293 5.00 
n-20 n==13 n=17 n-7 n-O 
280 
Appendix 4: Allele frequencies (%) at each microsatellite locus on dhfr sensitive and triple mutant chromosomes 
KZN CIRN KZN CIRN Mpu Tanz 
D90 Sensitive 1995 1999 CIRN CIRN 
246 12.50 
249 7.69 
252 5.88 
255 9.52 7.69 5.88 12.50 
258 61.90 61.54 52.94 50.00 
261 28.57 23.08 29.41 12.50 
264 5.88 12.50 
n=21 n=13 n=17 n=8 n=O 
KZN CIRN KZN CIRN Mpu Tanz 
DI00 Sensitive 1995 1999 CIRN CIRN 
107 20.00 
115 7.69 20.00 9.09 
117 7.69 
121 7.69 20.00 
123 23.08 27.27 33.33 
125 30.77 9.09 
127 15.38 9.09 
129 20.00 9.09 
131 7.69 18.18 33.33 
133 20.00 
135 18.18 33.33 
n=13 n=5 n=11 n=3 n=O 
KZN CIRN KZN CIRN Mpu Tanz 
D150 Sensitive 1995 1999 CIRN CIRN 
220 8.33 13.33 
232 5.56 14.29 
235 8.33 20.00 
238 33.33 25.00 40.00 14.29 
241 38.89 8.33 26.67 71.43 
244 16.67 8.33 
247 5.56 33.33 
250 8.33 
n 18 n-12 n-15 n 7 n 0 
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KZN CIRN KZN CIRN Mpu Tanz 
D250 Sensitive 1995 1999 CIRN CIRN 
221 21.05 11.76 
227 12.50 
230 5.26 
233 15.79 7.69 23.53 12.50 
236 5.26 23.08 5.88 
239 5.88 
242 7.69 29.41 
245 15.79 23.08 5.88 25.00 
248 7.69 
251 21.05 7.69 25.00 
254 5.26 
257 5.26 15.38 25.00 
260 5.26 7.69 
263 11.76 
266 5.88 
n=19 n=13 n=17 n=8 n=O 
KZN CIRN KZN CIRN Mpu Tanz 
D350 Sensitive 1995 1999 CIRN CIRN 
166 7.69 12.50 
169 76.19 30.77 58.82 50.00 
175 14.29 46.15 35.29 37.50 
178 9.52 
181 15.38 5.88 
n=21 n=13 n=17 n=8 n=O 
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Almendix 5: Allele freguencies (%} at each microsatellite locus on dhfr double 
mutant chromosomes 
U70DD M:QuCNRN TanzCNRN U70 M:QuCNRN TanzCNRN 
480 57.89 52.63 310 8.33 6.25 483 5.26 314 6.25 499 5.26 320 4.17 
501 15.79 3l.58 323 6.25 
503 5.26 335 16.67 18.75 
521 15.79 10.53 337 4.17 
n=19 n=19 339 4.17 6.25 
341 12.50 
345 6.25 
347 8.33 6.25 
349 4.17 
351 8.33 6.25 
356 8.33 
360 20.83 6.25 
362 8.33 
364 4.17 
371 6.25 
375 6.25 
381 6.25 
n=24 n=16 
U60 M:QuCNRN TanzCNRN U40 M:QuCNRN TanzCNRN 
220 7.69 200 6.67 
222 7.69 20.00 208 8.00 
224 3.85 10.00 210 36.00 60.00 
226 3.85 15.00 214 4.00 
228 11.54 10.00 216 16.00 6.67 
230 30.77 15.00 218 13.33 
232 30.77 20.00 220 32.00 
234 5.00 222 13.33 
236 3.85 5.00 224 4.00 
n=26 n=20 n=25 n=15 
U30 M:QuCNRN TanzCNRN U20 M:QuCNRN TanzCNRN 
133 3.70 197 6.25 
137 11.11 14.29 201 19.23 6.25 
140 4.76 203 38.46 62.50 
147 4.76 205 6.25 
149 3.70 207 6.25 
151 25.93 52.38 209 6.25 
153 7.41 4.76 211 19.23 
155 3.70 9.52 213 23.08 
161 4.76 222 6.25 
165 37.04 4.76 n=26 n=16 
167 7.41 
n=27 n=21 
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UI0 MpuCNRN TanzCNRN MAl MpuCNRN TanzCNRN 
253 4.76 195 10.53 4.76 
257 76.00 66.67 199 78.95 80.95 
259 24.00 28.57 201 5.26 
n=25 n=21 203 5.26 9.52 
207 4.76 
n=19 n=21 
MA2 MpuCNRN TanzCNRN DI0 MpuCNRN TanzCNRN 
170 5.26 133 14.81 
177 13.33 36.84 136 85.19 90.00 
185 6.67 143 10.00 
187 80.00 42.11 n=27 n=20 
189 15.79 
n=15 n=19 
D20 MpuCNRN TanzCNRN D30 MpuCNRN TanzCNRN 
280 14.81 28.57 126 3.70 5.00 
283 77.78 66.67 128 3.70 
286 3.70 4.76 130 5.00 
296 3.70 132 3.70 15.00 
n=27 n=21 134 7.41 10.00 
136 3.70 10.00 
138 15.00 
D40 MpuCNRN TanzCNRN 140 11.11 
297 4.35 142 5.00 
299 4.35 5.56 145 25.93 10.00 
303 4.35 16.67 147 11.11 15.00 
311 4.35 5.56 149 5.00 
313 16.67 151 3.70 
317 17.39 5.56 154 3.70 5.00 
319 4.35 156 14.81 
321 8.70 11.11 160 3.70 
323 26.09 166 3.70 
325 4.35 5.56 n=27 
n=20 
327 16.67 
329 4.35 5.56 
334 17.39 11.11 D50 MpuCNRN 
TanzCNRN 
n=23 n=18 149 8.33 
11.76 
151 16.67 5.88 
153 16.67 17.65 
155 16.67 11.76 
157 8.33 17.65 
159 8.33 5.88 
163 12.50 5.88 
165 5.88 
167 8.33 17.65 
169 4.17 
n=24 n=17 
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Name Sesuence Re12eat Unit Marker Position relative to dh12s Size Ran~e ('> dhps450kbU3F TACATGTATAGTGCAAAGCCC TA U450 -432403 n/a ~ (D 
.-+::s dhps450kbUF -lab GCAAAGCCCTTCGGGTCC (D 0-
'"1 -. 
dhps450kbUR GTGTAATAAGCGTGCACACG 0'1>:: 
dhps350kbU3F TGAGTCTTGCACACTACTA CAT U350 -327070 n/a 0'1 
dhps350kbUF-lab CCAGAATGGACAAGCTTC » 
dhps350kbUR GTGATTGCCATCGGTCG = (') ;I> 
dhps250kbU3F GCTAAAAGGATAAGGATAT TAT U250 -232209 nJa Ef '"0 0 
0 "0 dhps250kbUF-lab GCGGTTTATAATGACATG c 3 ;-
dhps250kbUR TGGAAAAGGTGTACATTC 0 r=o 0 CIl ::s 
dhps150kbU3F GAAATATTGTGAGCATTGG TA U150 -151317 nJa 0 0 3 ~ dhpsl50kbUF-lab AATAAACCCCGATCTGTC ::s (D ~ 
dhpslS0kbUR GCATAACAGGGTTATCAC 00 
c;o 
3 ;I> dhps125kbU3F TGTAATATACACATGCTG TA U125 -124300 334-360 ::s 
'" ~ ~ dhps12SkbUF-lab AACATTGTACAAGTAAGG iii ° 
dhps125kbUR CTGAGGATTAAATTAAGAA 5· 0 ....., q ;I> 
dhpsl00kbU3F GTGAAGACATACGTTCACT TA DIOO -100502 227-319 3 a dhpslOOkbUF-lab CATAGAAAGAGTTAAGAATAC o· S; ;-
dhpslOOkbUR GCTATTACCTGCTATTAATC '"1 ~ 0 ;;0 CIl 
dhps90kbUF CTACACTAATAGGTAGTTAG ATITT U90 -91246 nJa ~ ~ 
.-+ En' 
dhps90kbUR-lab CGTTTATGTATGTAGAATAAAT (D s ~ ::s n 
dhps90kbU3R TCATGGATTTTATGAATGCTA .-+ ~ (D so 
dhps80kbUF GACGACGCAATTTCACTG ATT U80 -77874 229-247 CIl '"t:l 0- is"' 
dhps80kbUR-lab GGATTTTTACTTCAGTATATG (D '" CIl :::s 
dhps80kbU3R CAGCCTTATGTAATGATGTA (') 5 '"1 ~ ;: s::: dhps7SkbU3F CGTATATACGTTTATCAT CIllllll U75 -74856 258-3]6 ::! (D ~ dhps75kbUF-lab TATTAAACCATTCAACTG 0-
-. 
f)' 
-e' dhps75kbUR CCAATGCATATATGAAAA ::s t:) 
.-+ t! 
dhps70kbUF GGAATATTCAATATTCATGC ATT U70 -67216 n/a e: ::! CIl so 
dhps70kbUR-lab CGTTTAATAAGAACCAAGG CIl til 
Z 0 dhps70kbU3R GATTGTGACGAAGAATGG c 0- s-
dhps60kbUF CTGCATATAATTATGTAAATTG ATT U60 -59750 296-330 ~ ~ 
N dhps60kbR-lab TCAAGACGAAAACGTATTAG ;I> ::;> 
00 dhps60kb3R CAAGAATGTGCAGAAGTG c;o Vl p:> 
Name Sesuence Re2eat Unit Marker Position relative to dh2s Size Range 
dhps50kbU3F TAAGTCATATATCATTGG TA U50 -50542 109-137 
dhps50kbUF-lab GAAATTGAAAAATATGCC 
dhps50kbUR TATTTAGGAGATATACAC 
dhps50.2kbUF CCTGTAGTATTTCCTCCT TA U50.2 -49173 211-247 
dhps50.2kbUR-lab GGCAACTAACAGAGGAAT 
dhps50.2kbU3R CCGAACCTTAGAATCCAA 
dhps40kbU3F CGATATCGTTCGAATGTG TA U40 -40411 153-199 
dhps40kbUF-Iab TGGACATATAACTGCACC 
dhps40kbUR ACTCTCCCACATTCAACA 
dhps40.2kbUF GGGATTTGTCATTTCTTCC ITA U40.2 -37676 nla » "0 
"0 
dhps40.2kbUR-lab GAAAGGGTCCTAGGAAAC (D :l 0-
dhps40.2kbU3R GGGGTATAGACGATACTA )(' ~ 
dhps30kbU3F CATCATGCTTTATTCGTA TA U30 -30534 177-197 ~ dhps30kbUF-lab ATTCTCATGATGTTTATGT (") 
dhps30kbUR TACATGTGTGTTATTTCC ::r a 
dhps30.2kbUF GAGTACGTTAGCATCATC TAA U30.2 -26958 218-239 3 0 en 
dhps30.2kbUR-lab CCACGTTTATATTGTTCG 0 3 
(D 
dhps30.2kbU3R GCATAGTTCGTTCTCATC 00 
dhps20kbU3F CTTTTGTTACATCAAATTCG TA U20 -19600 396-420 3 s:>l 
"0 
dhps20kbUF-lab GGTATAATGTACATTTTCAC "0 :j' 
dhps20kbUR ATAAAGACAGAGAAAATTATC fIQ 3 
dhps20.2kbU3F CGTCCAAATATAACGAATTAA TA U20.2 -18014 85-105 n' ~ dhps20.2kbUF-lab CTCTTTATAAGGTTGTCCC s:>l 
dhps20.2kbUR GACTTTTTATATTTGCCTGTG ~ ~ 
dhpsl0kbU3F CTCCCTTTTGTAAAATGTA TA UIO -10749 107-115 en 0-
dhpslOkbUF-lab CGTTTCACATATGGTCAA ~ !4 
dhpslOkbUR GAAATAAAACTTAGCTATTTG 0 c;: (D 
dhps 
0-
S' 
dhpsiOkb03F TTTCTCCTTTTCTTACGGA TA 010 10721 142-166 [. 
dhpslOkbDF-lab TACGGATTCATTGTGCAC en 2 
dhpslOkbDR CTGTAGCTCAATCTTAAGA 0-'< 
dhps20kbD3f CCCTAAATTAGATGATCA TAA 020 18810 nla 0 ::r 
dhps20kbOF-lab AGATATCACAACCATCAC s:>l N "0 
00 dhps20kbOR GTGACTATGATGACTATT ~ 0\ ~ 
Name Sesuence Re12eat Unit Marker Position relative to dh12s Size Range 
dhps20.2kbD3F GAAAGCATCGGGTGATAA TAA D20.2 21596 394-448 
dhps20.2kbDF-lab CGAACCTGATTATAAGGAA 
dhps20.2kbDR TGTATTCATGTTCCCATGT 
dhps30.2kbD3F TATCATATTGTTCTTGACATAAA TA D30.2 29011 187-234 
dhps30.2kbDF-lab CTGTAATCTCTTGTTAATAATC 
dhps30.2kbDR GAGCTGAATATTAAAATGATAA >-
dhps30kbD3F AATAGTAACAAGTTTGTG TAA D30 31957 nla ""C 0 
"0 
dhps30kbDF-Iab ATTTTGACTGCTTATTTG t: ~ dhps30kbDR CTGTTCATTCAAATTTAC 0 
:: 
dhps40.2kbD3F TATCTCGTGGGAAGGAGC TA D40.2 39849 nla a C1I 
dhps40.2kbDF-lab AATACCTGGAAGGATAAATTT :: ~ 
dhps40.2kbDR GAGGAAGAATCATTTTGAATA n' >-
dhps40kbD3F TGGTTTAGATGATAAGTC TAA D40 42075 nJa :: III 
dhps40kbDF-lab TATAATAGGGCATACAAC ]. 
dhps40kbDR CATTTTGAATACCACCAT 0 .... 
>-dhps50.2kbD3F GGAACCTAGAGGATGATG TA D50.2 50028 159-183 ;a 
dhps50.2kbDF-lab CTCCCACTCAAAGTTCTC §i [ 
dhps50.2kbDR TTACGGAATATCAGTGGTC C1I ;;0 
dhps60kbDF GGGGAATATATTTCCGATC ATA D60 61522 256-273 ~ [ii' 
dhps60kbDR-lab ATTATCAGAATAATGTATATCC s-:: 
n 
dhps60kbD3R GTAAAGGGCACAATATTGAT C1I s' 
dhps70kbDF GTCCTACACATTAAGTTGTTC TA D70 71248 121-160 '"t! is" 
dhps70kbDR-lab GGTTATATATTGTTCACCATG c.. ~ 
dhps70kbD3R TTGAAACATACTAAAGAAGCTAT 0 ~ 
s:: 
dhps75kbD3F CTTGTGTCATCACAATTC TA D75 73587 189-203 ~ ~ dhps75kbDF-lab TCTCCTATCCATTTTTGC f)' 
dhps75kbDR CCTCAAIIII I IATGTTTAC 'E' ~ 
dhps80kbDF CAACTGTTTTATATGAATGGG D80 80791 nJa ~ 
dhps80kbDR-lab TTGTCTACATTTTGTAGAACG :j' CIl 
0 
dhps80kbD3 R CATATTATTCATAATGTGGGG t: go 
dhps90kbD3F AAGGACAATTCACTGGGC TAAA D90 91767 nla C1I ; 
N dhps90kbDF-lab GCGTATGTCAATATATGGAG :> =t> 
00 dhps90kbDR ATTAGACTTTGCATGGCCTT n' 
-......l p 
Name Sesuence Re,Eeat Unit Marker Position relative to dh,Es Size Range 
dhpsl00kbD3F CGATACAGATTTATATAAC TA DIOO 100542 113-145 
dhpsl00kbDF-lab AATATGCCACATACATAAT 
dhpslOOkbDR GTCACATTTTATGATATATG 
dhps125kbD3F TTCACCGTCATGGACTT TA D125 126314 364-400 > 't:I 
't:I 
dhpsl25kbDF-Iab CTTGAAGTCTTCTATGCT ~ :: 0. 
dhps125kbDR CTTGTCCTGTTATTCCG 5(' ~ 
dhps150kbD3F TCGTCTTCTACCTTTACG CATA D150 147878 108-221 ~ 
dhps150kbDF-Iab ATTTTCACGCGCTTTTCC 9-
dhpsl50kbDR TTATAAGGAATTGCCCTGA a 3 
dhps250kbD3F GTTCGTATGCTCTTTTGT D250 250699 nla 0 til 0 
dhps250kbDF-Iab GAAAAAAGCTAGCCATGA 3 ~ 
00 
dhps250kbDR CCTATTACAACATATGTTG 3 
III 
dhps350kbD3F GACAGCGAGCTATTACGA ATI D350 352476 263-337 't:I 't:I 
:r 
dhps350kbDF-Iab GAGGGTTGCTTTGGTTCA {JQ 
3 
dhps350kbDR GGGAATGAGGAAAAACGTT n' a 
dhps450kbD3F TATTCAGATAATGCAACG ATf D450 451061 nJa til ~ dhps450kbDF-Iab TTTTTCACATTATCACCC ~. 
dhps450kbDR ATCTGAAGATCTTGTGGA til 0. 
dhps550kbD3F ATTTTATTCGTGTTCTAC AT D550 530114 100-124 ~ Q 
dhps550kbDF-Iab TAGTATACTCAGCATAAG 0: ~ 
0. 
dhps550kbDR CACATACCCAATATGTTA 5' 
~ 
til 
2 
0. 
'< 
n 
:r 
III 
N I! 00 00 
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AQl2endix 7: Allele freguencies (%) at each microsatellite locus on dh12.s double 
mutantchromosornes 
KZN 
U125 KZN Sensitive '95 KZN Sensitive '99 Meu Sensitive SGEAA Meu SGEAA 
334 4.17 
336 8.33 4.35 
338 5.00 8.70 
340 5.00 4.35 7.69 
342 4.17 20.00 4.35 
344 4.17 5.00 17.39 20.83 
346 16.67 20.00 8.70 25.00 
348 45.83 30.00 43.48 92.31 33.33 
350 4.17 
352 4.17 4.17 
354 8.33 10.00 8.70 12.50 
356 5.00 
360 4.17 
n=24 n=20 n=23 n=13 n=24 
KZN 
UIOO KZN Sensitive '95 KZN Sensitive '99 Meu Sensitive SGEAA Meu SGEAA 
227 21.74 31.58 4.17 16.67 
229 4.35 5.26 12.50 8.33 33.33 
231 13.04 10.53 16.67 16.67 12.50 
233 4.35 
237 4.35 5.26 
239 4.35 5.26 4.17 
241 5.26 
243 5.26 4.17 8.33 
245 13.04 16.67 8.33 
249 16.67 
251 4.35 
259 5.26 
269 4.17 
271 5.26 8.33 
273 4.17 
275 5.26 8.33 
277 8.70 5.26 4.17 12.50 
283 4.35 4.17 
287 5.26 8.33 16.67 4.17 
289 4.35 41.67 
292 4.17 
297 4.35 
301 5.26 
319 8.70 
n 23 n-19 n-24 n 12 n 24 
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KZN 
U80 KZN Sensitive '95 KZN Sensitive '99 Mpu Sensitive SGEAA Mpu SGEAA 
229 45.83 30.00 57.14 
235 5.00 
241 50.00 60.00 42.86 
244 5.00 
247 4.17 
n=24 n=20 n=O n=7 n=O 
KZN 
U75 KZN Sensitive '95 KZN Sensitive '99 Mpu Sensitive SGEAA Mpu SGEAA 
258 14.29 5.26 4.76 
260 16.67 4.35 
262 9.52 
264 4.76 
266 10.53 4.76 
268 23.81 26.32 23.81 25.00 34.78 
276 15.79 
284 14.29 8.33 
286 5.26 9.52 
288 5.26 
292 23.81 15.79 28.57 21.74 
296 9.52 5.26 4.76 8.70 
300 4.76 5.26 14.29 4.35 
3]6 4.76 5.26 50.00 26.09 
n=21 n=19 n=21 n=12 n-23 
KZN 
U60 KZN Sensitive '95 KZN Sensitive '99 Mpu Sensitive SGEAA MpuSGEAA 
296 15.79 15.79 
299 5.26 
302 5.26 26.32 
305 5.26 11.11 
308 5.26 10.53 33.33 
311 21.05 15.79 11.11 
314 15.79 5.26 
317 15.79 44.44 
320 5.26 10.53 
324 10.53 
327 5.26 
330 5.26 
n 19 n-19 n-O n-9 n 0 
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KZN 
U50 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
109 5.00 
111 4.55 5.00 
115 4.76 
117 31.82 10.00 
119 4.55 35.00 10.00 
121 13.64 15.00 20.00 58.33 80.95 
123 31.82 20.00 30.00 16.67 
125 4.55 5.00 10.00 8.33 4.76 
127 9.09 5.00 5.00 9.52 
129 5.00 10.00 16.67 
133 5.00 
137 5.00 
n=22 n=20 n=20 n=12 n=21 
KZN 
U50.2 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
211 18.75 20.00 13.04 
213 15.00 8.70 
215 5.00 
217 12.50 60.00 75.00 
219 8.70 
221 12.50 5.00 13.04 
223 12.50 4.35 4.17 
225 18.75 20.00 8.70 20.00 8.33 
227 10.00 21.74 4.17 
229 12.50 8.70 20.00 
231 6.25 4.35 
233 10.00 8.70 8.33 
237 6.25 5.00 
243 5.00 
247 5.00 
n-16 n=20 n=23 n-IO n-24 
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KZN 
U40 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
153 5.26 
155 9.09 10.53 4.35 4.35 
157 10.53 
159 13.64 5.26 13.04 4.35 
161 10.53 4.35 
163 4.55 21.05 4.35 
165 13.64 5.26 
167 9.09 4.35 7.69 4.35 
169 13.04 
171 9.09 5.26 8.70 
173 5.26 4.35 
175 9.09 17.39 30.43 
177 9.09 5.26 17.39 
179 9.09 10.53 8.70 
181 9.09 53.85 4.35 
183 5.26 4.35 
185 4.35 
187 4.55 23.08 39.13 
199 15.38 4.35 
n=22 n=19 n=23 n=13 n=23 
KZN 
U30 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
177 4.35 
181 13.64 50.00 47.83 76.92 70.83 
183 31.82 15.00 17.39 7.69 8.33 
185 31.82 20.00 26.09 8.33 
187 9.09 5.00 4.35 4.17 
189 9.09 10.00 15.38 8.33 
197 4.55 
n=22 n=20 n=23 n=13 n=24 
KZN 
U30.2 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
218 4.17 4.17 
221 5.00 
223 29.17 25.00 16.67 4.17 
226 37.50 45.00 45.83 91.67 87.50 
228 4.17 
230 20.83 20.00 16.67 8.33 4.17 
233 8.33 4.17 
235 8.33 4.17 
239 5.00 
n=24 n=20 n=24 n-12 n-24 
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KZN 
U20 KZN Sensitive '95 KZN Sensitive '99 M:Qu Sensitive SGEAA MQu SGEAA 
396 8.33 
398 4.35 5.56 
400 8.70 5.56 8.33 
402 30.43 27.78 16.67 46.15 100.00 
404 4.35 5.56 8.33 7.69 
406 21.74 8.33 46.15 
408 11.11 
410 16.67 
412 4.35 11.11 16.67 
414 13.04 16.67 8.33 
416 8.70 
418 11.11 8.33 
420 4.35 5.56 
n=23 n=18 n=12 n=13 n=8 
KZN 
U20.2 KZN Sensitive '95 KZN Sensitive '99 M:Qu Sensitive SGEAA MQu SGEAA 
85 5.00 4.35 
90 73.91 65.00 66.67 100.00 82.61 
95 21.74 15.00 29.17 13.04 
100 4.35 15.00 
105 4.17 
n=23 n=20 n=24 n=12 n=23 
KZN 
UIO KZN Sensitive '95 KZN Sensitive '99 M:Qu Sensitive SGEAA MQuSGEAA 
107 5.00 
109 41.67 65.00 87.50 100.00 100.00 
111 37.50 30.00 8.33 
113 8.33 4.17 
115 12.50 
n=24 n=20 n=24 n=13 n=24 
KZN 
DI0 KZN Sensitive '95 KZN Sensitive '99 MQu Sensitive SGEAA MQu SGEAA 
142 4.55 28.57 8.70 
144 13.64 20.00 4.76 7.69 
146 9.09 5.00 14.29 13.04 
148 4.55 10.00 9.52 
150 27.27 10.00 26.09 
152 13.64 25.00 28.57 92.31 52.17 
154 4.55 5.00 4.76 
156 4.55 5.00 
158 13.64 4.76 
160 5.00 4.76 
162 4.55 10.00 
166 5.00 
n 22 n-20 n=21 n-13 n 23 
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KZN 
D20.2 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
394 5.26 4.35 
397 10.00 5.26 4.17 
400 10.00 5.26 4.35 
403 5.26 4.17 
406 5.26 
409 20.00 15.79 4.17 58.33 8.70 
412 10.00 5.26 12.50 4.35 
415 10.00 21.05 20.83 25.00 47.83 
418 30.00 15.79 16.67 4.35 
421 15.79 4.17 4.35 
424 12.50 
427 4.17 
430 12.50 16.67 21.74 
436 10.00 
448 4.17 
n=lO n=19 n=24 n=12 n=23 
KZN 
D30.2 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
187 4.55 
189 4.55 
191 4.55 
193 22.22 21.05 18.18 
195 4.55 
197 22.22 5.26 4.55 
199 11.11 8.33 
201 11.11 13.64 18.18 
203 21.05 4.55 58.33 18.18 
205 11.11 21.05 9.09 
207 5.26 4.55 4.55 
209 11.11 5.26 22.73 
211 4.55 
213 11.11 
215 10.53 4.55 33.33 45.45 
217 4.55 
219 5.26 
227 5.26 
234 4.55 
n=9 n=19 n=22 n=12 n=22 
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KZN 
D50.2 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
159 20.00 10.53 
165 10.53 4.55 
167 10.00 22.73 39.13 
169 60.00 47.37 45.45 75.00 43.48 
171 15.79 4.55 8.33 8.70 
173 10.00 5.26 4.55 16.67 4.35 
175 5.26 13.64 
179 5.26 
181 4.35 
183 4.55 
n=10 n=19 n=22 n=12 n=23 
KZN 
D60 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
256 4.55 
258 6.67 
261 5.26 19.05 31.82 
264 33.33 31.58 33.33 77.78 27.27 
267 26.67 31.58 28.57 22.22 36.36 
270 20.00 26.32 19.05 
273 13.33 5.26 
n=15 n=19 n=21 n=9 n=22 
KZN 
D70 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
121 16.67 
124 16.67 
127 12.50 
138 12.50 14.29 
140 33.33 
143 7.14 
145 12.50 28.57 
147 21.43 
150 16.67 
152 14.29 
154 25.00 7.14 
156 37.50 
158 16.67 
160 7.14 
n=8 n=14 n=O n=6 n=O 
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KZN 
D75 KZN Sensitive '95 KZN Sensitive '99 M,Qu Sensitive SGEAA M,QuSGEAA 
189 10.00 
191 9.52 6.25 
193 4.55 
195 23.81 18.75 31.82 25.00 15.00 
197 47.62 56.25 40.91 75.00 50.00 
199 14.29 18.75 18.18 15.00 
201 4.76 5.00 
203 4.55 5.00 
n=21 n=16 n=22 n=12 n=20 
KZN 
DI00 KZN Sensitive '95 KZN Sensitive '99 M2u Sensitive SGEAA M2u SGEAA 
113 10.00 
119 5.00 21.74 
121 8.70 17.39 8.70 
123 13.04 15.00 4.35 46.15 34.78 
125 4.35 4.35 7.69 
127 17.39 10.00 17.39 
129 4.35 15.00 4.35 7.69 21.74 
131 13.04 15.00 8.70 15.38 17.39 
133 30.43 10.00 17.39 4.35 
135 7.69 8.70 
137 4.35 10.00 4.35 
139 4.35 5.00 7.69 
141 7.69 4.35 
145 5.00 
n=23 n=20 n=23 n=13 n=23 
KZN 
D125 KZN Sensitive '95 KZN Sensitive '99 M,Qu Sensitive SGEAA M,Qu SGEAA 
364 4.35 5.26 9.09 4.17 
366 4.35 
368 4.55 7.69 
370 13.04 26.32 13.64 
372 10.53 4.55 
374 13.04 15.38 8.33 
376 17.39 18.18 23.08 20.83 
378 4.35 5.26 13.64 4.17 
380 10.53 4.55 
382 8.70 26.32 13.64 16.67 
384 16.67 
386 4.35 5.26 13.64 46.15 12.50 
388 17.39 5.26 7.69 8.33 
390 5.26 4.55 
396 4.35 
398 
399 
4.35 8.33 
400 4.35 
n 23 n 19 n 22 n 13 n 24 
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KZN 
D150 KZN Sensitive '95 KZN Sensitive '99 M2u Sensitive SGEAA MEuSGEAA 
108 4.35 5.56 
112 5.56 
116 4.35 
120 5.56 
124 8.70 5.56 23.08 
128 17.39 15.38 
132 13.04 16.67 7.69 
136 4.35 11.11 7.69 
140 4.35 
145 13.04 5.56 7.69 
150 8.70 11.11 
154 4.35 11.11 
158 4.35 5.56 
170 4.35 
174 5.56 
178 5.56 
182 4.35 
186 4.35 
201 5.56 
221 38.46 
n=23 n=18 n=O n=13 n=O 
KZN 
D350 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
263 9.52 8.33 
281 14.29 6.25 
284 4.76 
300 19.05 31.25 25.00 
303 6.25 50.00 
319 23.81 31.25 
322 9.52 16.67 
337 19.05 25.00 
n=21 n=16 n=O n=12 n=O 
KZN 
D550 KZN Sensitive '95 KZN Sensitive '99 MEu Sensitive SGEAA MEu SGEAA 
100 11.76 
104 5.88 17.65 
106 11.76 
108 5.88 41.18 20.00 
110 11.76 20.00 
112 52.94 5.88 
116 5.88 5.88 
120 5.88 40.00 
122 10.00 
124 5.88 11.76 10.00 
n-17 n-17 n=O n=10 n-O 
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Appendix 8: Publications arising from, or fonning an integral part of the thesis. 
Contribution to published work by candidate 
Pearce et a12003, Antimicrobial Agents and Chemotherapy: 
I participated in the design of the study. I was the lead investigator in the adaptation 
and refinement of the SSOP dot blot technique for use in typing point mutations at 
dhfr and dhps. I carried out the point mutation typing and the population genetic data 
analysis. I wrote the paper, in consultation with Dr C. Roper. 
Roper et a12003, The Lancet 
I participated in the design and execution of the molecular genetic analysis of the dhfiA 
and dhps SNPs and micro satellites flanking dhps. I was involved in the analysis of 
both the SNP and microsatellite data. 
Roper et al 2004, Science 
I participated in the design and execution of the SNP and micro satellite genetic 
analysis. 
Endorsement by supervisor, Dr C. Roper: 
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Molecular Determination of Point Mutation Haplotypes in the 
Dihydrofolate Reductase and Dihydropteroate Synthase 
of Plasmodium Jalciparum in Three Districts 
of Northern Tanzania 
Richard J. Pearce,h Chris Drakeley,l,2 Daniel Chandramohan,l 
Frank Mosha,2,3 and Cally Roperl 
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, 
London, WCIE 7HT, United Kingdom,l and Kilimanjaro Christian Medical Centre3 and 
The Joint Malaria Programme (JMP)2 Mashi, Tanzania 
Receivt!d 24 St!plt!mber 2002/Retumed for modification 12 November 2002/Accepted 28 January 2003 
The antimalarial combination of sulfadoxine and pyrimethamine (SP) was introduced as first-line treatment 
for uncomplicated malaria in Tanzania during 2001 following 18 years of second-line use. The genetic deter-
minants of in vitro resistance to the two drugs individually are shown to be point mutations at seven sites in 
the dihydrofolate reductase gene (dlifr) conferring resistance to pyrimethamine and five sites in the dihydro-
pteroate synthase (dhps) gene conferring resistance to sulfadoxine. Different combinations of mutations within 
each gene confer differing degrees of insensitivity, but information about the frequency with which allelic hap-
lotypes occur has been lacking because of the complicating effects of multiple infection. Here we used a novel high-
throughput sequence-specific oligonucleotide probe-based approach to examine the present resistance status 
of three Plasmodium Jaiciparnm populations in northern Tanzania. By using surveys of asymptomatic infections 
and screening for the presence of all known point mutations in dlifr and dhps genes, we showed that just five 
dhJr and three dhps allelic haplotypes are present. High frequencies of both triple-mutant dhJr and double-
mutant dhps mutant alleles were found in addition to significant interregional heterogeneity in allele frequency. 
In vivo studies have shown that the cooccurrence of three dlifr mutations and two dhps mutations in an infection 
prior to treatment is statistically predictive of treatment failure. We have combined data for both loci to 
determine the frequency of two-locus genotypes. The triple-dhJr/double-dhps genotype is present in all three 
regions with frequencies ranging between 30 and 63%, indicating that treatment failure rates are likely to be high. 
sulfadoxine-pyrimethamine (SP) has now replaced chloro-
quine as the first-line curative antimalarial in much of East 
Africa. The earliest reports of emerging SP resistance in Africa 
were from Muheza district in Tanzania during 1994 and 1995 
(32, 37). SP remains in use throughout Tanzania and was re-
ently officially adopted as the national first-line treatment for ~onse"ere Plasmodium falciparum malaria. It is now a priority 
to learn how widespread genet!c determinants of SP re~istance 
rreotIy are in the larger regIons of northern Tanzama. 
eu . d I . To investigate this issue, we have carne out a popu atJOn-
b sed genetic analysis of P. falciparum in the North and South 
p:re Mountains and Hai di~trict,.which are di~tinct geograph-
. I areas with their own mlcrochmates and tnbes. There had ~a 0 ]10 malaria research in these districts since 1965 until 
ee ot work showed relatively low levels of transmission, with 
rece . f 24 . f . estimated entomological inoculatIon rate 0 In ectlve 
b
a? s/person/year in Hai district (c. Drakeley and D. Chan-
lte . hI· I drarnohan, unpublished data) compared ~It a~ en~omo oglca 
. ulation rate in the range of 34 to 405 mfectlve bltes/person/ 
InoC d· . (14) ar io Muheza Istnct . 
ye I t is widely understood that people self-treat with antima-
'" ~responding author. Mailing address: D~partment of l.nfectious 
'Tropical Diseases, London School of HygIene and TropIcal Med-?~d J<eppel St., London WC1E 7HT, United Kingdom. Phone: (44) 
~~~e927 2416. Fax: (44) 2076368739. E-mail: Richard.Pearce@lshtm 
.ac.uk. 
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larial drugs, which can be freely purchased (24); as a conse-
quence, a proportion of people attending health facilities with 
signs and symptoms of malaria may have had recent prior 
exposure to drugs. In this study we have analyzed material 
from community surveys of asymptomatic infections. These 
data, we believe, are less subject to bias due to prior drug 
selection and are therefore representative of the parasite pop-
ulation at large. 
Resistance to SP is associated in vitro with a series of sub-
stitutions within the active site of target enzymes of the folate 
biosynthesis pathway, dihydropteroate synthase (DHPS) (~, 
38) and dihydrofolate reductase (DHFR) (9, 29, 36), and thiS 
has been demonstrated through laboratory-based in vitro sen-
sitivity tests and transfection experiments with DHFR with 
respect to pyrimethamine (43, 44) and DHPS with respect to 
sulfadoxine (39, 40, 42). The sequence changes coding for 
substitutions that are naturally occurring worldwide are sum-
marized in Table 1. A Ser-to-Asn substitution at codon 108 of 
DHFR decreases sensitivity to pyrimethamine 100-fold (43) 
Additional substitutions at codons 51 (N51I), 59 (C59R), and 
164 (I164L) progressively increase levels of resistanc~ to. py~ 
rimethamine (15,43). Isolates containing all four substIt~tJOn 
have been found in South America and southeast Asia but 
have yet to be reported in Africa (21, 25, 41). A total of 14 
DHPS substitutions at five sites have been characterized world-
wide, of which 6 have been recorded in Africa, with A437G and 
1348 PEARCE ET AL. 
TABLE 1. Summary of each of the sites at which an SNP occurs 
which is known to be associated with SP resistance and the 
oligonucleotide probe designed to detect it 
Probe Amino acid Probe sequenceD 
DHFR 
Codon 16 
A-b Ala CC ATA TGT GCA TG T TGT A 
S Ser CC ATA TGT TCA TG T TGT A 
V Val CC ATA TGT GTA TG T TGT A 
Codons 50 and 51 
CN* Cys Asn TGG AAA TGT AAT TCC CTA 
CN2* Cys Asn TGG AAA TGT AAC TCC CT A 
RN Arg Asn TGG AAA CGT AAT TCC CT A 
RN2 ArgAsn TGG AAA CGT AAC TCC CT A 
RI Arg J1e TGG AAA CGT ATT TCC CT A 
CI Cys J1e TGG AAA TGT ATT TCC CT A 
Codon 59 
C* Cys AA TAT 1Tf TGT GCA GTT A 
R Arg AA TAT 1Tf CGT GCA GTT A 
Codon 108 
N Asn A AGA ACA AAC TGG GAA AG 
S* Ser A AGA ACA AGC TGG GAA AG 
T Thr A AGA ACA ACC TGG GAA AG 
Codon 140 
V* Val AT GAA GAT GTT TAT ATC A 
L Leu AT GAA GAT CTT TAT ATCA 
Codon 164 
1* J1e GT 1Tf A TT ATA GGA GGT T 
L Leu GT 1Tf AIT TTA GGA GGT T 
DHPS 
Codons 436 and 437 
SA* Ser Ala GAA TCC TCT GCT CCT TIT 
SG Ser Gly GAA TCC TCT GGT CCT TIT 
FA Phe Ala GAA TCC TIT GCT CCT TIT 
FG Phe Gly GAA TCC TIT GGT CCT TIT 
AA Ala Ala GAA TCC GCT GCT CCT TIT 
AG Ala Gly GAA TCC GCT GGT CCT TIT 
CA Cys Ala GAA TCC TGT GCT CCT TIT 
Codon 540 
K* Lys ACA ATG GAT AAA CTA ACA 
E Glu ACA ATG GAT GAA CTA ACA 
Codon 581 
A* Ala A GGA 1Tf GCG AAG AAA CA 
G Gly A GGA TIT GGG AAG AAA CA 
Codon 613 
A* Ala GA TIT A IT GCC CAT TGC 
T Thr GA TIT ATT ACC CATTGC 
S Ser GA TIT A IT TCC CAT TGC 
Q Entries in column 3 indicate the amino acid changes that occur at the 
relevant codons following the point mutation. The sequences in bold represent 
the codon within which the point mutation occurs. 
b *, wild-type sensitive codon. 
K540E mutations being the most frequently reported (12, 41, 
42). 
The role of the point mutations at each locus in conferring 
resistance to SP in vivo has been inferred from studies showing 
predictive association of particular mutations with treatment 
failure (21, 28) and from overrepresentation of mutations in 
recrudescent infections after treatment (2, 3, 8, 10, 11, 13, 
16-18, 20, 26). Such studies are complicated by mixed infec-
tions. As the blood-stage parasites are haploid, the cooccur-
renee of two or more genotypes in an infection means that 
variation at multiple sites cannot be assigned to an individual 
parasite line within the infection and, accordingly, that the 
predictive association with treatment outcome is rendered less 
straightforward. 
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To study the frequency of alleles at a population level, we 
have designed a PCR high-throughput approach which uses 
sequence-specific oligonucleotide probes (SSOP) for detection 
of known single nucleotide polymorphisms (SNP) to identify 
and construct haplotypes. Haplotypes are combinations of SNP 
that are in the same gene in the same parasite, as distinct from 
associations of point mutations that cooccur because there is a 
mixture of parasites of different genotypes within a single in-
fection. Haplotypes are biologically meaningful, since they de-
termine the resistance properties of parasites that are exposed 
to drugs at the time of treatment. For example, a triple-mutant 
dhfr haplotype of N51I+C59R+S108N has 1.5- to 3-fold-
higher pyrimethamine resistance in vitro than either the 
N51I +S108N or C59R +S108N double-mutant haplotype (35). 
A mixed infection containing these two double-mutant alleles 
is less resistant to pyrimethamine than an infection containing 
the triple-mutant allele, despite all three mutations being pres-
ent in either case. When comparing populations, it is important 
to measure the frequency of haplotypes rather than the prev-
alence of each point mutation separately, because haplotypes 
are the determinants of resistance levels. 
The method we have employed involves the peR amplifica-
tion of sequences from the coding regions of dhfr and dhps 
genes, which are fixed onto membranes and probed with SSOP 
(7) designed to detect each of the single base pair substitutions 
at all positions summarized in Table 1. The SSOP method has 
advantages for high throughput, while retaining sensitivity and 
specificity equivalent to those of other methods used for de-
tection of dhfr and d/zps SNP (1, 31). We used tetramethylam-
monium chloride (TMAC) to standardize the melting temper-
ature of digoxigenin-labeled oligonucleotide probes, thus 
enabling duplicate membranes to be probed and washed at a 
standard temperature and sequence variants at all SNP sites to 
be detected simultaneously. Chemifluorescent signals from the 
detection of probes for differing SNP at the same site were 
compared quantitatively using a Storm phosphorimager. This 
high-throughput method allowed us to command data from 
large sample sizes. 
MATERIALS AND METHODS 
The study area and the samples. P. faiciparnm-positive samples were collected 
from two separate studies within the same area of northeast Tanzania; one was 
a study of infants and young children in Hai district, and the second was a study 
of people up to 45 years of age in the North and South Pare sites. Both studies 
were cross-sectional malariometric surveys across an altitude band of 550 to 
1,600 m, and most of the study subjects were asymptomatic. 
For the villages in Hai district, samples were collected in May 2001. All 
children less than 5 years old from 16 randomly selected villages were invited to 
attend the survey clinic at a central clinic. A finger-prick blood sample for blood 
slides and a filter paper blood sample were collected from each participating 
child. The filter paper blood samples were air dried and stored at 4°C with 
desiccant. Bloodspots from blood film-positive children were selected retrospec-
tively for genotyping. 
Samples from the North and South Pare Mountains were collected in Novem-
ber 2001 during malariometric cross-sectional surveys. A random sample of 1,250 
individuals (250 per village) under 45 years of age was recruited, and a finger 
blood sample was taken into EDTA Microtainer tuhes. Filter paper bloodspots 
were made with 10 ILl of packed cells from samples of individuals found to be 
parasite positive. 
Ethics. Scientific and ethical clearance for both studies was granted from the 
National Institute of Medical Research in Tanzania and the London School of 
Hygiene and Tropical Medicine. Consent was obtained from all individuals or 
their guardians prior to enrollment in the surveys. 
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TABLE 2. Table of PCR primer sequences and reaction conditions for the nested amplification of dhfr and d/zps 
Gene and primer 
dhfr 
Outer, Ml 
650 bp, M7 
Inner, M3b 
594 bp, M9 
d/zps 
Outer, Nt 
770 bp, N2 
Inner, R2 
711 bp, R 
Primer sequence 
5' TITATGATGGAACAAGTCfGC 3' 
5' CfAGTATATACATCGCfAACA3' 
5'TGATGGAACAAGTCfGCGACGTT3' 
5' CfGGAAAAAATACATCACATTCATATG3' 
5' GATTCTTTTTCAGATGGAGG 3' 
5' TTCCfCATGTAATTCATCfGA 3' 
5' AACCfAAACGTGCfGTTCAA 3' 
5'AATTGTGTGATTTGTCCACAA3' 
DNA extraction. DNA extraction from bloodspots on filter paper was carried 
out in a 96-well plate format. A segment of the bloodspot was first soaked in 
0.5% saponin-IX phosphate-buffered saline overnight and was then washed 
twice in 1 ml of 1 X phosphate-buffered saline. The segment was then boiled for 
8 min in 100 JJ.l of PCR-quality water-50 JJ.l of 20% Chelex suspension in distilled 
water (pH 9.5). 
PCR amplification of dhfr and dhps. A 711-bp fragment of dhps and a 594-bp 
fragment of dhfr containing the polymorphic codons were independently ampli-
fied by nested PCR in a 96-well plate format. PCR primer sequences and 
reaction conditions are indicated in Table 2. The 25-JJ.l PCR mix contained 
primers at 0.25 JJ.M final concentration, 2 mM MgCI2, 250 JJ.M each deoxynucleo-
side triphosphate. and IX Bioline Taq polymerase. Template DNA (1 JJ.1) was 
introduced to outer reaction mixtures. The d/zps outer PCR product (1 JJ.l) was 
introduced into a 25-JJ.l inner amplification mixture. Aliquots of 1 JJ.l of threefold-
diluted dhfr outer PCR product were introduced into a 25-JJ.l inner amplification 
reaction mixture. 
Use of SSOP for molecular genotyping of point mutations. Final-round PCR 
products were heat denatured (95°C for 2 min), cooled, and then spotted onto 
nylon membranes in I-JJ.l volumes in a 12 by 8 grid. A panel of four PCR samples 
of known sequences representing all common sequence variants was spotted on 
every blot to act as positive-negative controls for probe specificity. Replicate 
blots were made of each array so that simultaneous probing with the oligonu-
cleotide probes of the full panel for that gene could be conducted. After drying, 
cross-linking was performed with 1,200-1 UV light. Sequence-specific 18-bp 
oligonucleotide probes 3' end labeled with digoxigenin (DIG) (Roche Boehr-
inger Mannheim, Mannheim, Germany) were each designed to complement the 
known sequence polymorphisms in dlzfr and dhps listed in Table 1. SNP-specific 
hybridization was followed by high-stringency TMAC washes, and alkaline phos-
phatase-conjugated anti-DIG Fab fragments (Roche Boehringer Mannheim) 
were used to detect DIG-labeled probes as described by Conway et al. (7). 
Visualization was performed through the alkaline phosphatase-catalyzed break-
down of the fluorogenic substrate ECF (Amersham Pharmacia Biotech, Little 
Chalfont, Buckinghamshire, United Kingdom) and scanned on a Molecular 
Dynamics Storm 840 PhosphorImager (Amersham Pharmacia Biotech). 
Scoring. We scored the presence, absence, or relative abundance of the variant 
sequence polymorphism at each site separately. Images of blots probed with 
variant sequences for a single locus were transferred as TIF files to ImageMaster 
Total Lab software (Amersham Pharmacia Biotech). In the array analysis sub-
section of the software, a standard area of each spot was defined and the intensity 
of chemifluorescence in that area was measured. Background data were adjusted 
for by subtraction of the volume of the negative controls from the volume data. 
Thus, the volume of chemifluorescence for each spot was calculated as Volume 
= (maximum intensity X spot area) - background. To determine the threshold 
of detection per se, the presence-flagging option was employed. By this method, 
the faintest spot considered present and not background was selected to set the 
flagging threshold value. To compare SNP-specific probes at a single site, Mi-
crosoft Excel bar charts were drawn comparing the volume data for each probe 
on every sample to the presence-flagging result in each case. The following rules 
were used to determine whether a SNP was present or absent at each site. 
(i) An SNP was considered present in a peR product when the volume value 
with a particular probe was higher than that of the background. When volume 
values were low, presence flagging provided an internal control for avoiding 
possible biasing between probes or blots. 
(ii) An SNP was considered absent when all volume values below the first 
PCR conditions 
94°C X 3 min 
94°C X 1 min, 52°C X 2 min, 72°C X 1 min, 40X; 72°C X 10 min 
94°C X 3 min 
94°C X 1 min, 44°C X 2 min, 72°C X 1 min, 4x; 94°C X 1 min, 
44°C X 1 min, 72°C X 1 min, 34X; 72°C X 10 min 
94°C X 3 min 
94°C X 1 min, 51°C X 2 min, 72°C X 1 min, 40X; 72°C X 10 min 
As described above for dIJps outer primer sequence 
gridline on the chart were rejected. No set value can be given for this criterion, 
as volume value comparison is relative and differs depending on the strength of 
the probe labeling and binding. 
Samples were categorized into the single. majority, or mixed category at each 
site as follows. Samples were considered to be of mixed haplotypes when the 
volume value of the minority SNP was more than half the volume value of the 
majority SNP. Samples were considered to be mixed but containing a majority 
SNP when the minority SNP value was less than half of the majority value but 
higher than that represented by the first gridline on the chart. Samples were 
considered to be single when only one SNP was present at a site according to the 
rules given above. 
To combine data from all sites in a gene and construct haplotypes, it was 
necessary to discard samples in which a mixture was found but which did not 
contain a majority SNP. Thus. for the purpose of generating frequency data, one 
haplotype was scored from each sample; this was either a single or majority type, 
because haplotypes from mixed infections cannot be constructed. 
Following the same principle, for measuring the frequency of two-locus geno-
types, a subset of samples in which a single or majority allelic haplotype was 
found at both dhfr and dhps was used. 
Statistical analysis. Statistical analysis of population differences in haplotype 
frequencies (Wright's F.t [fixation index)) (6) and linkage disequilibrium (LD), 
given as D' coefficient, was carried out using Arlequin software (33). Statistical 
analysis of contingency tables of the association of haplotypes within two-locus 
combinations was performed using a X:! test. 
RESULTS 
Of the 165 bloodspots that yielded peR products, 10.3% 
were mixed at dhps and 1.2% were mixed at dhfr; no majority 
haplotypes were found. The low number of mixed infections 
was a reflection of the low level of transmission in the area. On 
stratification of the populations of the North Pare and South 
Pare Mountains into the age ranges of 0 to 4 and 5 to 45 years, 
no significant difference was found in the frequencies of dhfr 
and dhps allelic haplotypes, allowing comparisons to be made 
between the samples from those sites and those from Hai 
district, where samples were taken exclusively from subjects <5 
years of age. 
The dhfr and dhps allelic haplotypes present in each region 
are shown in Fig. 1. Three point mutations were found in dhfr, 
and of the eight possible haplotypic conformations, five were 
found; this matches well with findings of point mutations pres-
ent in single-genotype infections elsewhere in East Africa that 
have been described previously (26, 41). Three point mutations 
were likewise found in dhps, and of the eight possible haplo-
types, only three were found in dhps. 
Regional haplotype frequencies are summarized in Fig. 2. 
Not all alleles at dhfr and d/zps were present in each of the 
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FIG. 1. Scheme of dhfr and dhps alleles found in this study. Shaded 
blocks indicate the sites at which the constituent SNP of each haplo-
type arise. Names of the alleles are composed of the amino acids 
present at each of the sites, in consecutive order by codon number, that 
are described as having a role in SP resistance. Substitutions are in 
boldface characters. 
districts. The sensitive dhfr allele was not present in Hai district 
or the South Pare Mountains. The frequency of the dhfr triple-
mutant allele was high in all districts and was highest in Hai 
(84.1 % ). The North Pare Mountains region had the lowest 
frequency of dhfr triple-mutant alleles; nevertheless, that fre-
quency was five times greater than the frequency of sensi-
tive dhfr alleles. We found no dhfr quadruple-mutant alleles 
(N51I + C59R + S108N + I164L). 
The frequency of the dhps double-mutant allele was also 
greatest in Hai (64.2% ) and lowest in the North Pare Moun-
tains (43.3% ); the frequency in the South Pare Mountains was 
intermediate (54.5% ). Unlike that of dhfr, the sensitive allele 
of dhps was found in all districts. Furthermore, there was a low 
frequency (4 to 7.4% ) of the single-mutant (S436A) allele in all 
districts. 
On calculation of the Wright's Fs t (fixation index), the pair-
wise difference in haplotype frequencies at both loci between 
regions was shown to be statistically significant in comparisons 
of Hai district with the North Pare Mountains (dltf,. Fs t = 
0.0733 [P < 0.05]; dhps FS ( = 0.0748 [P < 0.05]). Interestingly, 
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there was no significant difference in the remaining pairwise 
comparisons, despite the differences in haplotype frequencies 
between the North and South Pare Mountains. 
Two-locus combinations were derived from single infections 
for which only one haplotype was recorded in both dhfr and 
dhps. The map in Fig. 3 shows the spatial distribution of fre-
quencies of two-locus combinations. The reduction in sample 
size (n) reflects the Joss due to mixed infections. The frequency 
of the most highly resistant genotype triple-mutant dhfr/double 
mutant dltps (ACIRNVI-SGEAA; substitutions are under-
lined) was found to be extremely high. The frequency was 
63.2% in Hai district, 50% in the South Pare Mountains, and 
22% in the North Pare Mountains. In the North Pare Moun-
tains, there was more diversity at both loci and consequently a 
greater diversity of 2 locus genotypes. The Wright's FSI com-
paring the three populations at both loci further confirms the 
differences between the North and South Pare populations (Fs, 
= 0.0583 [P = 0.0054]) and between the North Pare Mountains 
and Hai district (Fsr = 0.149 [P < 0.00001]) . Pairwise compar-
ison of the South Pare and Hai district populations (Fst = 
0.011) showed no significant difference and were merged for 
subsequent analysis. Statistical analysis of observed and ex-
pected two-locus combinations was performed on the popula-
tion of the North Pare Mountains and the combined popula-
tions of Hai district and the South Pare Mountains. We found 
a significant departure from expected in the merged Hai-South 
Pare Mountains population (X 2 test [P = 0.0018, 6 df)) , 
whereas the distribution in North Pare was nonsignificant (X 2 
test [P = 0.835, 8 dt]). LD analysis was performed on the 
combined Hai and South Pare Mountain data set, and we 
found three two-locus combinations to be in LD, namely, 
ACICNVI-SAKAA (D' = 0.277, P = 0.01), ACNRNVI-AA 
KAA (D' = 1.0, P < 0.00001), and ACIRNVI-SGEAA (D' = 
0.229, P = 0.031) (substitutions are underlined). No other pair 
of alleles was found to be in LD. 
DISCUSSION 
We have described a new approach by which blood survey 
material was used to determine the frequency of point muta-
tion haplotypes in P. falciparum populations. This approach 
allows quantitation of resistance at the population level and 
enables direct comparison of population resistance levels even 
when they differ widely in the proportions of multiply infected 
individuals. The issue of multiple infections can be problematic 
when genotyping blood-stage parasites, because it causes hap-
lotypic conformations of point mutations to be obscured and 
rare mutations to be oversampled. By recording one genotype 
per infection and discounting minority genotypes, we were able 
to avoid the oversamp]ing of rare genotypes and to estimate 
the frequency of mutation haplotypes in the population in a 
manner which was standardized over all populations of differ-
ent transmission intensities. With this consideration in mind, 
the SSOP method employed is designed for high-throughput 
screening of blood-stage infections to derive haplotype fre-
quencies from survey material. 
We have shown that only a subset of point mutations re-
ported globally were present in North Tanzania in these pop-
ulations, confirming previous reports of analyses of natural 
P. falciparum populations of East Africa (26, 41). Using single-
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FIG. 2. (A) Frequencies of dhfr alleles found in the district of Hai and the regions of the North and South Pare Mountains. (B) Frequencies 
of dhps alleles found in the district of Hai and the regions of the North and South Pare Mountains. 
and majority-genotype infections, we were able to determine 
the point mutation haplotypes that were present in the three 
districts surveyed. We found five alleles at dhfr, and in review-
ing the single-infection data from other studies in Africa, it is 
Possible to see these same haplotypes in Kenya, Malawi, Tan-
zania, and Mauritania. We found three haplotypes in dhps , the 
sensitive-allele haplotype, the single-mutant allele S436A hap-
lotype, and the double-mutant allele A437G K540E haplotype 
which has been widely recorded in East Africa (18, 19, 21, 
25-27, 41) and not in West Africa (12, 30, 41). 
Regional variation in population resistance. Allelic haplo-
type frequencies in the three regions differed significantly. 
Those of the Rai district and South Pare populations were 
highly resistant at dhfr, with triple-mutant allele 
(N51I +C59R +S108N) frequencies of > 70% and dhps dou-
ble-mutant allele (A437G+ K540E) frequencies of >50%. 
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FIG. 3. Map of the three districts of northern Tanzania showing the frequencies and distribution of dhJr/dhps two-locus combinations. The 
genotype represented by the open symbol contains both sensitive alleles, and that represented by the black symbol contains the most resistant 
alleles. 
The same alleles were present in the North Pare population 
but at lower frequencies. Sensitive alleles at either locus were 
absent in the Rai district and South Pare populations but were 
present at low frequency in the North Pare population. The 
North Pare population was significantly distinct from the other 
two populations, with the most significant difference found 
between those of the North Pare and Rai district populations. 
These findings point to a slower development of SP resistance 
in the North Pare Mountains. Possible causes of weaker selec-
tive pressure are greater use of alternative antimalarials such 
as amodiaquine and reduced use of antimalarials per se due to 
pOor access to heaIthcare facilities or raised levels of acquired 
immunity. Such differences are maintained in the face of gene 
flow, which operates to make the parasite populations more 
homogeneous. Ongoing investigations into treatment-seeking 
behavior and overprescription by providers aim to further il-
luminate differences in drug use among the three study popu-
lations (T. Swarthout, D. Chandramohan, F. Mosha, A. Bell, 
G. Masuki, C. Drakeley, and H. Reyburn, Abstr. 3rd MIM 
Pan-African Malaria ConL, 2002). 
Recent work in real populations in Malawi has found statis-
tical association of the presence of all three dhfr mutations and 
both dhps mutations with failure to clear parasitemia after SP 
treatment (21). It is probable that in many cases this is due to 
the presence of the two most highly resistant alleles, triple dhfr 
and the double dhps-and this idea is supported by analysis of 
recrudescent infections following SP treatment (22). Here we 
directly measured the frequency of the highly resistant two-
locus genotype consisting of the ACIRNVI:SGEAA (substitu-
tions are underlined). We found that frequencies were twice as 
high in Hai district as in the South Pare Mountains and three 
times as high as in North Pare Mountains; hence, there is a 
clear and testable indication that SP treatment failure rates in 
these three regions are likely to differ. 
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Selection on dhfr and dhps by SP use. It has been observed 
that dhf,. mutations appear earlier than dhps mutations in the 
development of SP resistance within populations in Africa (23, 
26, 34). Our own data suggest the same sequence of events, 
with resistant dhfr being fixed in Hai and the South Pare 
Mountains yet with sensitive dJzps being relatively common. 
The observed LD between the ACICNVI-SAKAA and the 
absence of significant LD between the dhfr double mutants and 
the dhps double-mutant alleles supports the idea of an inter-
action between dhfr and dhps in the development of resistance. 
Furthermore, there was a statistically significant association 
between the triple dhfr mutant and the double dhps mutant in 
the combined Hai district and the South Pare populations. dhfr 
is on chromosome 4 and dhps is on chromosome 8, so the fact 
that LD was found between two highly resistant haplotypes at 
these unlinked loci is indicative of the nonindependence of SP 
selection. This relationship has been reported previously in 
Kenya (28) and Malawi (21). The same relationship was not 
apparent in North Pare, where the frequency of resistance 
alleles at both loci was also significantly lower; both this and 
the absence of statistically significant LD imply that drug se-
lection is weaker. This finding emphasizes the transient nature 
of linkage, particularly in areas of high transmission intensity, 
where recombination rapidly breaks down the linkage between 
dhf,. and dhps, and argues for caution in the use of indicator 
mutations as a proxy for resistance genotyping. While the cooc-
currence of all five mutations in an infection in the South Pare 
Mountains and Hai district was in fact a reliable indicator of 
the presence of a quintuple genotype, this was not the case in 
the North Pare Mountains. The widespread use of the antibi-
otic Septrin, which contains trimethoprim and sulfamethox-
azole, to treat other infections may indirectly select for dJzfr 
and dhps resistance mutations and further complicate the re-
lationship. 
Past, present and future of pyrimethamine and sulfadoxine 
use in northern Tanzania. The three districts described here 
are found in an area between 200 km and 400 km northwest of 
Muheza district, a region historically associated with excep-
tionally high levels of antimalarial drug resistance. Resistance 
to pyrimethamine alone was reported in 1954 in Mngeza in 
Muheza district, following mass administration of prophylactic 
doses of pyrimethamine monotherapy over a five-month pe-
riod during 1953 (5). Use of the SP combination began in 
Tanzania in 1982, when it was introduced as a second-line 
treatment for use in cases of chloroquine failure, and as early 
as 1984 it was the policy of the Muheza district hospital to use 
SP as a first-line antimalarial (25). Studies from the region 
report that SP was highly effective during the eighties, but 
resistance was recorded in Magoda village near Muheza in 
1994 (32) and was subsequently reported in villages in the 
surrounding area (18, 19,37). The emergence of resistance to 
SP in 1994 was attributed by the authors to he in part a result 
of the prophylactic intervention with weekly dapsone pyri-
methamine treatment to all children less than 10 years old. 
Resistance to SP in Muheza district hospital is now reported to 
be as high as 45% (25). 
Two explanations for the high frequency of resistance alleles 
in the three districts described here are the widespread use of 
SP or related drugs and the movement of resistance from 
Muheza. However, levels of resistance do not show a simple 
decline with distance from Muheza to Hai (Fig. 3), and drug 
use is clearly a very important factor. What is striking from the 
data presented here are the significant interpopulation differ-
ences, and it is probable that these differences have arisen from 
differing patterns of drug use in these communities. 
In this paper we have described a new technique for detec-
tion of resistance point mutations in dllf,. and dlzps. We have 
argued for the use of haplotype frequencies as a measure of 
resistance at the population level and as an appropriate tool 
for describing the spread of resistance. In displaying the power 
of this technique, we have shown significant regional hetero-
geneity and identified a region of northern Tanzania where 
resistance to SP is already unprecedentedly high. Since policy 
recently mandated a switch to use of this drug as the first-line 
treatment, we recommend that in vivo studies be performed to 
confirm that the high frequency of resistance alleles is indica-
tive of treatment failure, as is predicted on the basis of studies 
conducted elsewhere in Africa. 
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~ Antifolate antimalarial resistance in southeast Africa: a 
population-based analysis 
Cally Roper, Richard Pearce, Barry Bredenkamp, Jonathan Gumede, Chris Drakeley, Frank Mosha, 
Daniel Chandramohan, Brian Sharp 
Summary 
Background Sulfadoxine-pyrimethamine was first introduced 
for treatment of malaria in Africa during the early 1980s for 
cases when chloroquine treatment failed, and has since 
become the first-line treatment in many countries. Resistance 
to sulfadoxine-pyrimethamine is now increasing, especially in 
southeast Africa. 
Methods We characterised genetic change in dhfr and dhps 
genes in the Plasmodium falciparum population of KwaZulu-
Natal, South Africa, during 1995-99, a period of rapid 
deterioration of the effectiveness of sulfadoxine-pyrime-
thamine. We assessed the evolutionary origin of the 
resistance by analysing polymorphic microsatellite repeats in 
the flanking region of the dhfr and dhps genes, which show 
whether resistance alleles originated through shared or 
independent ancestral mutation events. We then assessed 
the current extent of dispersal of dhfr and dhps resistance 
alleles by doing the same analysis in P falciparum sampled 
from communities in the Kilimanjaro region of northern 
Tanzania in 2001. 
Findings The large genetiC change during 1995-99 in 
KwaZulu-Natal, South Africa, in both the health facility and the 
wider community surveys, was at the dhps locus, apparently 
because resistance at dhfr was established before 1995. The 
allelic determinants of resistance in this province share a 
common evolutionary origin with those found in Kilimanjaro, 
Tanzania, even though the two sites are 4000 km apart. 
Interpretation Three resistant dhfr alleles, and one resistant 
dhps allele, each derived from independent ancestral 
lineages, have been driven through through southeast Africa. 
The movement by the dhfr alleles (pyrimethamine resistance) 
preceded that of the dhps allele (sulfadoxine resistance). Our 
findings emphasise that gene flow rather than new mutations 
has been the most common originator of resistance in African 
countries. 
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Introduction 
Resistance to sulfadoxine-pyrimethamine is increasing, 
especially in southeast Africa, and the immense human 
cost of the successive failure of these two drugs in Africa 
was described in 1998 as a malaria disaster. I The search 
is on for ways to protect and extend the useful life of the 
next generation of antimalarials, and a clear research 
priority is to understand the dynamics underlying the 
emergence of drug resistance and the extent and rate of 
its spread. The genetic basis of resistance to sulfadoxine 
and pyrimethamine is point mutations in the genes 
encoding their target enzymes- dihydropteroate 
synthase (DHPS) and dihydrofolate reductase 
(DHFR), respectively. 2.1 These common mutations are 
assumed to have arisen independently on numerous 
occasions.1 
Pyrimethamine and sulfadoxine target two enzymes in 
the folate synthesis pathway of Plasmodium falciparum-
DHPS and DHFR. When the two drugs are 
administered together as sulfadoxine-pyrimethamine, 
they act synergistically to disrupt folate synthesis and kill 
the parasite. Resistance to sulfadoxine-pyrimethamine 
has evolved worldwide, and is caused by point 
mutations that accumulate at several sites in the dhfr and 
dhps genes Y In both genes, every successive mutation 
incrementally increases the parasite's tolerance to the 
drug in vitro. ~ 7 In Africa, each locus has just two or 
three point mutations that lead to resistance"·Q and these 
mutations are a subset of those found worldwide. 2,\ 
The rate at which point mutations occur in 
P falciparum is typical of eukaryotes, and a point 
mutation in dhfr that codes for a S 108N substitution 
occurs at between 2·5 X l 0 Q and 3 X l 0 II mutations per 
replication .lo Since patients with malaria generally have 
between lOR and 1012 haploid parasites circulating in 
their blood at the time of treatment, even at the most 
conservative estimate of mutation rate new resistance 
mutations could be expected to arise and be selected for 
within one patient. II For pyrimethamine and 
sulfadoxine, in which a few point mutations can directly 
confer resistance, resistance will probably arise rapidly 
and on many occasions ," 
To assess the evolutionary origins of dhfr and dhps 
resistance determinants we investigated polymorphic 
MICROSATELLITE REP EATS within an 8 kb flanking region 
of both genes. Such markers are a robust method to 
distinguish between resistance alleles that share ancestry 
and those that have arisen independently. Results of a 
study l 2 of microsatellite vanatlon flanking the 
chloroquine resistance determining locus pfcrt have 
shown that resistance alleles found worldwide all derive 
from four ancestral mutants. We have therefore 
compared dhfr and dhps resistance alleles from South 
Africa and Tanzania to determine the extent to which 
alleles of common origin are dispersed. We also assessed 
the stability of these alleles over time in a longitudinal 
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analysis of the P Jalciparum population of northern 
KwaZulu-Natal, South Africa. 
The province of KwaZulu-Natal in South Africa 
replaced chloroquine with sulfadoxine-pyrimethamine 
as a first-line therapy in 1988. The first African country 
to change, Malawi, did not do so until 1993, so the 
P Jalciparum population in KwaZulu-Natal was exposed 
to first-line sulfadoxine-pyrimethamine selection early. 
In 1996, results of a study based at Mosvold hospital in 
the Ingwavuma district of KwaZulu-Natal showed that 
20% of patients given sulfadoxine-pyrimethamine did 
not clear the parasites within 14 days of treatment. By 
2000 this proportion had increased to 70%, 13 whereon 
the province switched to using coartemether. 
Methods 
Patients 
In KwaZulu-Natal malaria is HYPOENDEMIC and 
transmission takes place during the second half of the 
rainy season Ganuary to June, with peak transmission in 
April). We obtained clinical samples from outpatients 
seeking treatment at Mosvold Hospital and its satellite 
clinic at Ndumu in April, 1996, and April, 1999. In 
1996, we recruited patients for an in-vivo clinical trial to 
test the effectiveness of chloroquine and sulfadoxine-
pyrimethamine, and in 1999, we compared 
immunochromatographic diagnostic tests for malaria. 
The patients all had positive bloodfilms for P Jalciparum 
and we excluded those who reported receiving 
antimalarial drugs in the previous 14 days. 
Procedures 
During February, June, and September, 1995, we 
surveyed the blood of 1200 people living within a 12 km 
radius of Ndumu clinic. Blood spots were dried on filter 
paper (Whatman 3MM, Whatman International, 
Maidstone, UK) and stored at - 20°C. The 1999 survey 
material was gathered by Department of Health 
personnel in routine active case detection in high risk 
areas of Ingwavuma district between January and 
March, 1999. ICT diagnostic test cards (Amrad ICT, 
Sydney, Australia) positive for P Jalciparum were 
retained and stored with desiccant. Parasite DNA was 
extracted from the paper blotter on which the 
fingerprick blood was introduced by the standard 
method. 
P Jalciparum positive samples were gathered in villages 
spanning 250 km and at altitudes of550-1600 min Hai, 
North Pare, and South Pare districts. Most study 
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parti.cipants were asymptomatic. In May, 2001, we 
obtamed samples . from .children aged younger than 
5 years from 16 Villages m the Hai District. The filter 
paper blood samples were air dried and stored at 4°C 
with desiccant. Samples from North and South Pare 
distri~ts were obt~ined in November, 2001 during 
malana cross-sectlOnal surveys. We recruited a 
consecutive sample of 1250 individuals (250 per village) 
younger than 45 ye.ars of age and obtained a finger 
blood sample, which was placed in an EDTA 
microtainer. Filter paper blood Spots were made with 
10 J.LL of packed cells from samples of individuals who 
were positive for the parasite and the samples were 
preserved as previously. 
We screened the parasite DNA for all known 
sequence variants at sites where point mutations are 
known- namely co dons 16, 50, 51, 59, 108, 140, and 
164 of the dhfr gene, and codons 436, 437, 540, 581, 
and 613 of the dhps gene. 2 The DNA was extracted from 
bloodspots on filter paper or from positive ICT 
diagnostic test cards using a standard preparation 
method. ~irst, we cut a segment of the dried blood spot 
or the excised paper blotter from the ICT diagnostic test 
card and (the site where the fingerprick blood is initially 
introduced to the test) using a sterile blade, and soaked 
the samples in 0'5% saponin-l X phosphate-buffered 
saline overnight. We then washed the sample in 1 mL 
1 X phosphate-buffered saline. The segment was then 
boiled for 8 min in 100 J.LL PCR quality water with 
50 J.LL 20% chelex suspension in PCR quality water 
(pH 9'5). 
We amplified a 594 bp fragment of dhfr and a 711 bp 
fragment of dhps, each of which contained the coding 
sequence where known sites of sequence POLYMORPHISM 
are found, using nested PCR. These PCR reactions were 
done independently with primers complementary to 
conserved sequence in these genes. 14 Amplification of 
the dhJr or dhps fragment was therefore independent of 
the allele-specific sequence polymorphism. The 
resulting PCR products were then fixed to nylon 
membrane and probed for known sequence 
polymorphisms by hybridisation to specific oligo-
nucleotide probes. 14 
Blood-stage P Jalciparum parasites are haploid, so 
when a patient was infected with a single parasite 
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genotype, we could determine unequivocally the 
haplotype of resistance point mutations of that parasite, 
which is not possible when a patient is infected with 
several genotypes at once. Fortunately KwaZulu-Natal 
has low rates of malaria infection compared with other 
regions of Mrica, so there are fewer mixed genotype 
infections than might be found elsewhere. Of 382 
KwaZulu-Natal samples typed at all dhfr and dhps loci, 
70% were infected by a single genotype. We included a 
further 8% of infections where a majority haplotype 
outnumbered the minority by greater than a two-to-one 
ratio, and excluded the remaining mixed infections. 
Likewise the cross-sectional surveys in Tanzania were 
across an altitude of 550- 1600 m, where transmission 
rates are low and the proportion of single genotype 
infections was 80- 90%. 
To assess the evolutionary origins of dhfr and dhps 
resistance haplotypes, we investigated polymorphic 
microsatellite repeats within 8 kb flanking regions of 
both genes. We analysed micro satellite sequences 
located 0·3 kb, 4·4 kb, and 5·3 kb upstream of codon 
108 of the dhfr-ts gene, which is on chromosome 4; and 
0·8 kb, 4,3 kb, and 7,7 kb downstream from codon 437 
of pppk-dhps gene, which is on chromosome 8. We 
amplified each locus by PCR then assessed the size of 
the fragments (reflecting the number of repeats) by gel 
electrophoresis. Alleles were PCR amplified and 
identified according to PCR fragment size, which was 
determined by electrophoresis on an ABI 377 and 
analysed with Genescan and Genotyper software 
(Applied Biosystems, Warrington, Cheshire, UK). We 
used a semi-nested PCR design, and primer sequences 
(panel) were designed from the 3D7 isolate genome 
PlasmoDb database 15 except DHFR.3R and DHFR.F 
which were described by Su and Wellems. ' 6 The primary 
reaction contained 1 IJ.L template, 3·0 mmol/L Mg2+, 
and 0·75 pmol/L each primer. Cycling conditions were: 
2 min at 94°C, and then 25 repeated cycles of 30 s at 
94°C; 30 s at 42°C; 30 s at 40°C; and 40 s at 65°C; 
followed by 2 min at 65°C. The third primer was 
fluorescently labelled and incorporated into a second 
round PCR reaction of total volume 11 IJ.L, introducing 
1·0 
0·8 
0·2 
o 
01996 
01999 
dhfr haplotypes 
1 IJ.L of product from the primary reaction, 2·5 mmol/L 
Mg2+, and 2 pmol/L of each primer. Cycling conditions 
were: 2 min 94°C, then 25 cycles 20 s at 94°C; 20 s at 
45°C; 30 s at 65°C, followed by a final step of 2 min at 
65°C. 
We used longitudinal analysis of the P falciparum 
population of KwaZulu-Natal to directly measure the 
RELATIVE FITNESS of resistant and sensitive alleles at dhfr 
and dhps while drug selection through use of 
sulfadoxine-pyrimethamine as firstline therapy was 
applied. We calculated relative fitness on the basis of 
frequency changes observed in the 1995 and 1999 
community surveys by 1 +s (the selection coefficient), 
where s was calculated from the formula: " Pn=PoXesn , 
where Pn=frequency after n generations, Po=frequency at 
start, and n=number of generations (we assumed three 
generations a year). The curves between the points were 
drawn with predicted frequency changes based on these 
relative fitness values. 
Statistical analysis 
We compared the allele frequencies of dhfr and dhps in 
the KwaZulu-Natal time-series samples using Fisher's 
exact test in STATA version 7.0. To test the 
significance of the changes in frequency of one allele 
alone, we used X2 test or Fisher's exact test as 
appropriate. 
Role of the funding source 
The sponsors of this study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. 
Results 
In all P falciparum samples investigated, either from 
KwaZulu-Natal or Tanzania, we identified point 
mutations only at co dons 108, 51, and 59 of the dhfr 
gene and at co dons 436, 437, and 540 of the dhps gene. 
Allelic haplotypes- the conformations of point 
mutations- in dhfr and dhps were recorded only from 
single and majority genotype infections. Figure 1 shows 
the frequency of allelic haplotypes at dhfr and dhps in 
dhps haplotypes 
Figure 1: Frequency of allelic haplotypes at dhfr and dhps In 1996 and 1999 In outpatients attending Mosvold Hospital and Its 
satellite clinic at Ndumu, Ingwavuma District, ZwaZulu-Natal, South Africa 
Frequency values are shown with 95% CI (bars) calculated by binomial exact method. 
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Figure 2: dhfr In 1995 and 1999 In Ingwavuma district, 
KwaZulu-Natal, South Africa 
(A) Changes in frequency of allelic haplotypes. Curves were drawn by 
computation of frequency changes based on relative fitness values. 
(8) Allele associated microsatellite polymorphism in the flanking region . 
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parasites sampled from outpatients attending Mosvold 
hospital and its satellite clinic at Ndumu in 1996 (n==50) 
and in 1999 (n==73). Allele frequencies at the dhfr locus 
did not change significantly between 1996 and 1999 
(p==0'07; figure 1), suggesting that pyrimethamine 
resistance had already been established. However, the 
frequency of the triple mutant dhfr N5II, C59R, S108N 
increased from 42% in 1996 to 62% in 1999 (p==0'04; 
figure 1). The frequency of the dhps double mutant 
A437G, K540E increased from 0% to 47% over this 
time (p<O'OOOl; figure 1). 
To assess changes in dhfr and dhps throughout a wider 
population we retrospectively analysed blood samples 
collected by active surveillance surveys in the 
Ingwavuma district in 1995 and in 1999. The cases we 
detected were sampled over a wider region than in the 
previous part of the study and most people were 
asymptomatically infected. The frequency, measured 
from single and majority genotype infections in 1995 
(n==50) and in 1999 (n== 125) are shown in figure 2 for 
dhfr and figure 3 for dhps. Changes in the frequency of 
alleles at dhfr were non-significant (p==0'09; figure 2), 
the frequency of the dhfr sensitive haplotype remained 
roughly the same: 36% in 1995 and 34% in 1999, 
whereas the frequency of the dhfr triple mutant 
increased from 22% to 38%, apparently displacing the 
dhfr C59R, S108N double mutant, which fell from 30% 
to 15%. 
Allele frequencies at dhps changed significantly 
between 1995 and 1999 (p==0·0006; figure 3) and the 
frequency of the double mutant rose from 0% in 1995 to 
15% in 1999 (p==0'002), which displaced the sensitive 
haplotype, mirroring the changes seen in the hospital. 
We identified four single mutants of dhps- A437G, 
S436C, S436F, and S436A- but they were rare. S436A 
was identified in three isolates, whereas the others were 
only in one. 
In 1999, the frequency of resistant alleles was 
significantly higher in the clinical isolates than in the 
community cases (dhfr p==0'002, dhps p<O'OOOI), but 
the frequency of the dhfr triple mutant did not differ 
between clinical and community cases in 1995- 96 
(p==0'052) and the frequency of the dhps double mutant 
was zero in each case. The dhps A437G, K540E and the 
dhfr N5II, C59R, S108N were also significantly higher 
in the clinical isolates than in the community cases. 
Such a trend would be expected if some patients had 
taken sulfadoxine-pyrimethamine before attending the 
hospital, but we excluded from the study any patients 
known to have received previous treatment. The 1999 
clinical samples were more likely to be simply related, 
having been drawn from a localised epidemic. 
We identified several polymorphisms at microsatellite 
loci around dhfr. The 0·3 kb locus had eight alleles sized 
90- 120 bp, the 4·4 kb locus 15 alleles of 157- 200 bp, 
and the 5·3 kb locus 17 alleles of 193- 226 bp. Of 102 
isolates, 43 had different microsatellite haplotypes, 
which were ranked according to allele size at the 0·4 kb 
locus, then at the 4·4 kb, and finally the 5·2 kb locus, 
and numbered 1- 43 (details of allele sizes for every 
haplotype are given in webappendix1; http://image. 
thelancet. com/extras/03art30 14webappendix 1.pdf). 
Figure 2 shows the characteristics of the haplotypes and 
how they are distributed between the dhfr alleles. 
Associated with the dhfr triple mutant was 
microsatellite haplotype 34 (110 bp/ 177 bp/203 bp), 
which was identified in seven samples in 1995; one in 
1996; and 35 in 1999, of which 22 were clinical and 13 
actively detected. The number of replicate samples for 
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KwaZulu-Natal, South Africa 
(A) Changes In frequency of allelic haplotypes. Curves were drawn by 
computation of frequency changes based on relative fitness values . (8) 
Allele associated mlcrosatellite polymorphism In the flanking region. 
each allele reflects the frequency of these haplotypes in 
the original sample. The dhfr C59R, S108N double 
mutant was associated with micro satellite haplotype 26 
(90 bpi 186 bpi 199 bp) consistently throughout the 
study (six in 1995, two in 1996, and four in 1999), 
although one recombinant 27 (90 bp/186 bp/212 bp), 
which had a new allele at the most distant 5·3 kb 
microsatellite site, was recorded in a 1999 clinical 
isolate. The dhfr N51I, S108N double mutant was 
associated with two micro satellite haplotypes- 23 
(90 bp/183 bp/193 bp): three samples in 1999, one in 
1995) and 9 (90 bpi 171 bp/217 bp): two samples in 
1999. The single mutant S108N was associated with 
various haplotypes (four in 1995, three in 1999, and one 
clinical in 1999) as was the sensitive haplotype (eight in 
1995, 11 in 1996, two in 1999, and 12 clinical in 1999). 
1178 
Microsatellite polymorphisms flanking the dhps gene 
were characterised at sites 0·8 kb, 4·3 kb, and 7·7 kb 
from codon 437 in 70 isolates. There were 16 alleles of 
104-142 bp at the 0·8 kb locus, seven alleles of 
105- 123 bp at the 4·3 kb locus, and 16 alleles of 110- 142 
bp at the 7·7 kb locus. Haplotypes were ranked according 
to allele size at 0·8 kb, then 4·3 kb, and finally 7·7 kb loci, 
and numbered 1-40 (full details of allele sizes for every 
haplotype are given in webappendix2; http://image. 
thelancet.com/extras/03art30 14webappendix2.pdf. 
Figure 3 shows how these flanking haplotypes are 
distributed among the dhps alleles. As with dhfr, there was 
a high level of polymorphism around the sensitive alleles. 
The dhps double mutant was associated with 
microsatellite haplotype 27- consisting of 132 bp/105 
bp/ 110 bp alleles at the 0·8 kb/4·3 kb/7·7 kb loci, 
suggesting a single origin. Of 29 double mutant A437G 
K540E isolates typed, three had recombined at the 7·7 kb 
locus, giving haplotypes of either 132 bpi 105 bpi 118 bp 
or 132 bp/105 bp/126 bp. By contrast with the dhps 
double mutant, the single mutant S436A alleles had 
unrelated flanking haplotypes 25 (128 bp/ 107 bp/ 132 
bp), 35 (134 bp/105 bp/130 bp), and 37 (136 bp/ 105 
bp/130 bp). 
We compared the flanking sequences described above 
with that around alleles from malaria surveys in the 
Kilimanjaro region of northern Tanzania. Blood samples 
positive for P fa/C£parum were obtained in 2001 in Hai, 
and in North and South Pare. '6 We characterised dhfr 
and dhps point mutations and found the same alleles as 
were present as in KwaZulu-Natal. We selected a subset 
of samples that were not mixed at any locus for 
micro satellite analysis. We could definitively 
characterise 86 samples that had the dhfr triple mutant 
haplotype and a single allele at each microsatellite 
locus- all of which had the identical 110 bp/177 bp/203 
bp micro satellite haplotype as the triple mutants in 
KwaZulu-Natal. The dhfr N51I, S108N double mutant 
was assessed in ten single genotype infections. Each of 
them had the same 90 bp/183 bp/193 bp flanking 
microsatellite haplotype as the more common of the two 
variants characterised in the KwaZulu-Natal population. 
Likewise the dhfr C59R, S108N double mutant, 
characterised in just two Tanzanian isolates, had the 
same flanking haplotype as the equivalent KwaZulu-
Natal mutant (90 bp/ 186 bp/ 199 bp). The pattern was 
repeated at dhps. Of 50 isolates with the A437G K540E 
double mutant allele, all had the characteristic 
132 kb/105 kb/l10 bp haplotype seen in the KwaZulu-
Natal isolates. 
At dhfr the relative fitness of the triple mutant N51 I 
C59R S 108N was standardised to 1·0 making the 
relative fitness of the sensitive allele 0·95 and the C59R, 
S108N double mutant 0·90. The frequencies of the 
N51I, S108N double mutant and the S108N single 
mutant were based on numbers fewer than ten at both 
time points and consequently measures of frequency 
change are prone to sampling error. We did not detect 
the dhps A437G K540E double mutant in 1995 or 1996. 
For fitness calculations an estimated initial frequency of 
0·03 based on binomial statistical probability (with 95% 
confidence) was used. The fitness of the dhps sensitive 
allele was 0·866 relative to the double mutant A437G 
K540E. 
Discussion 
Our results suggest that the escalation of sulfadoxine-
pyrimethamine resistance in KwaZulu-Natal during 
1999/2000 coincided with the emergence of sulfadoxine 
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resistance, the genetic basis of which was a double 
mutant form of the dhps gene. This escalation was 
preceded by establishment of pyrimethamine resistant 
dhfr in the population more than 5 years earlier. This 
pattern has been repeated throughout east Africa. In 
Kenya, pyrimethamine resistance was present in 1988 
but sulfadoxine resistance was not detected until 1993 
to 1995. 18 Reports of the emergence of the dhps double 
mutant date from the same period-in Kenya between 
1993 and 1995,19 in Tanzania in 1995/° and in Malawi 
from 1995 to 1996.21 The appearance of this allele on an 
background of pre-existing resistant dhfr coincides with 
intensified sulfadoxine-pyrimethamine resistance and 
outbreaks of severe drug failure in all these places. 
Results of in-vivo studies in Kenya8 and Malawi9 
confirm that the presence of all three dhfr mutations 
together with the two dhps mutations before treatment 
infection is an important predictor of sulfadoxine-
pyrimethamine failure. 
Analysis of microsatellites flanking the dhps gene has 
revealed that South African and Tanzanian double 
mutant A437G, K540E alleles have shared ancestry. It 
is therefore highly probable that the coincidence of 
sulfadoxine-pyrimethamine failure in these countries is 
related to the spread of this lineage. We did not detect 
the dhps double mutant in KwaZulu-Natal in 1995-96 
despite the fact that sulfadoxine-pyrimethamine was 
used as firstline therapy for the previous 7-8 years. Once 
established the frequency of the dhps double mutant 
increased rapidly under selection by use of sulfadoxine-
pyrimethamine. Results of laboratory studies7 have 
shown that the A437G, K540E substitutions raise 
sulfadoxine tolerance of sensitive DHPS by 200-fold, 
compared with just ten-fold for the A437G substitution 
alone. From the frequency changes seen at dhps we 
calculated relative fitness values which predict that if 
sulfadoxine-pyrimethamine use had continued at the 
same rate, the frequency of the double mutant would 
have reached 50% in just 12 more generations. Further 
research is needed to establish whether these relative 
fitness values are consistent in regions with different 
endemicities when a similar policy of firstline 
sulfadoxine-pyrimethamine treatment for clinical 
malaria is applied. Under high endemicity multiple 
genotype infections are more common, and drug use 
patterns will be affected by higher rates of acquired 
immunity. The potential confounders in such 
comparisons are factors not related to endemicity, such 
as drug availability and relative wealth. 
Sensitive dhfr alleles had a high degree of 
polymorphism in their flanking sequences, reflecting the 
ancestral state of the wild-type population. By contrast, 
alleles with several resistance mutations showed flanking 
sequence variation that was highly conserved. The dhfr 
triple mutant was always associated with the same 
microsatellite haplotype, indicating that it has arisen 
only once, whereas the dhfr N511, S108N double 
mutant was linked to two unrelated microsatellite 
haplotypes, suggesting that it has arisen twice, one of 
which was rare and found only in KwaZulu-Natal. The 
microsatellite haplotype flanking the dhfr C59R, S108N 
double mutant was different again. The distinctive 
flanking sequences of these double mutant alleles clearly 
show that none of them was ancestral to the triple 
mutant. Rather than arising many times, a few mutant 
alleles have been subject to positive drug selection, and 
been driven through the P falciparum population along 
with their flanking sequences. The fact that linked 
microsatellite alleles up to 5·3 kb away have been fixed 
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in the mutant population testifies to the strength of that 
selection. Meanwhile the single mutant S 108N was 
found on various flanking DNA backgrounds, 
suggesting either that the mutation has arisen on 
numerous occasions, or that the selection acting on it is 
too weak for the DNA sequences surrounding it to have 
become fixed, or both of these explanations combined. 
The frequency of the dhfr triple mutant increased with 
time, apparently displacing a double mutant allele. This 
is consistent with in-vitro studies examining the relative 
levels of resistance conferred by these allelic haplotypes. 
The triple mutant is the most resistant to 
pyrimethamine, increasing the parasite's tolerance 
1600-fold, whereas the S 108N single mutation increases 
pyrimethamine tolerance 1 OO-fold.' The double mutants 
C59R, S108N and N511, S108N share broadly similar 
tolerance22 between the single and triple mutants. 21 
Sequence analysis of dhfr and dhps in P falciparum 
sampled worldwide has shown that resistance alleles 
with multiple mutations predominate in regions of high 
drug use where sulfadoxine-pyrimethamine resistance 
problems are established. 2 Conversely they are rare, or 
absent, in places where the drug is used infrequently, 
showing that increasing resistance to sulfadoxine-
pyrimethamine is caused by a progressive accumulation 
of mutations. As a consequence, it is widely expected 
that as sulfadoxine-pyrimethamine resistance intensifies 
the number of point mutations in resistance alleles will 
increase stepwise. We found no evidence of such a 
process in our analysis of dhfr. Although the C59R, 
S 1 08N double mutant apparently preceded the triple 
mutant in KwaZulu-Natal and would theoretically be 
predicted to be replaced by it, it was not ancestral to it. 
Indeed none of the double mutant dhfr haplotypes gave 
rise to the triple mutant. This finding would suggest that 
new resistance mutations do not arise frequently and 
even constrain the rate at which the population can 
adapt to drug. Yet we did see rare single mutant 
resistance haplotypes in KwaZulu-Natal. And different 
versions of the dhfr S108N mutant or the dhps S436A 
mutant had unrelated flanking sequences, suggesting 
that they did arise independently, although it is possible 
that the selection acting on them is just too weak for the 
flanking sequences to have been conserved. Although 
single mutations seem to have arisen independently on 
multiple occasions, the fitness benefits they confer are 
perhaps too weak to overcome the associated fitness 
costs, and they do not seem to be strongly selected for. 
These alleles seem unlikely to spread throughout the 
population or to persist long enough to accumulate 
further mutations. On the rare occasions where a 
multiple mutant arises, it has high relative fitness and 
can spread rapidly throughout large geographic regions. 
Chloroquine and sulfadoxine-pyrimethamine have 
been the cornerstone of antimalarial treatment in Africa 
for the past 40 years. With the efficacy of these drugs 
diminishing, experts warn that "a health calamity looms 
within the next few years"! I For strategic planning of 
future resistance management the genetic analysis of 
flanking sequence around resistance genes is 
illuminating because it reveals the historical 
development of that resistance. A single allele of pfcrt, 
the chloroquine resistance determining locus, is found 
throughout Africa and flanking sequence has shown that 
it is a single lineage which first arose in southeast 
Asia. 24,12 We show here that the genetic determinants of 
sulfadoxine-pyrimethamine resistance in southeast 
Africa have also spread from a few ancestral mutants. 
Just one dhps and three dhfr alleles each of independent 
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and monophyletic ongm are the basis of widespread 
resistance in the region. These fmdings are consistent 
with those of an analysis of the genetic determinants of 
sulfadoxine-pyrimethamine resistance in the South 
American Amazon. 25•26 
During the historical period when chloroquine, 
pyrimethamine, and sulfadoxine resistance was selected, 
routine use of these drugs for treatment has been 
surprisingly inefficient at establishing new resistance 
mutations. In the normal course of events in Africa, the 
proportion of parasites exposed to any particular drug is 
particularly low because a large proportion of infections 
are asymptomatic and consequently untreated. 
Pyrimethamine resistance emerged rapidly in both 
Tanzania and Kenya after mass administration of the 
drug on its own27•28 the circumstantial evidence suggests 
that emergence of chloroquine resistance in southeast 
Asia and South America was associated with mass 
administration of that drug. 29 Therefore, drug coverage 
could be the most important driver of resistance 
evolution. 
There are important lessons here for future 
management of resistance in Africa. Once established, 
drug resistance determinants to chloroquine, 
pyrimethamine, and sulfadoxine are highly mobile. 
Gene flow has played a key part in the emergence of 
resistance to these drugs in southeast African countries. 
A very important threat to new drugs or drug 
combinations introduced in these countries could be 
posed by importation of resistant or multidrug resistant 
genotypes that have been previously selected elsewhere. 
A priority for future planning for management of 
resistance is further research into the spatial extent of 
spread of the genetic determinants of resistance, and the 
potential of combination therapy for arresting or slowing 
this process. 
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Cardiac denervation In amyloid polyneuropathy 
Tomoaki Nakata, Kazuaki Shimamoto 
" 
A 43-year-old woman with abnormalities 
in bone scintigraphy performed several 
times following resection of right breast 
cancer presented with electrocardiographic 
abnormalities to our cardiology laboratory. 
Her history and results of physical exami-
nation disclosed neurological signs of 
peripheral sensory and motor disturbances 
with severe orthostatic hypotension and 
neurogenic bladder, which had started 
6 months after the operation, but no 
symptoms or signs suggestive of myo-
carditis or an acute ischaemic event was 
documented. Massive 99mTc_MDP accum-
ulation in the heart (figure, left) strongly 
suggested cardiac amyloidosis. An echo-
cardiogram revealed cardiac hypertrophy 
but no wall motion abnormality; left 
ventricular wall thickness was 14 mm and 
left ventricular ejection fraction was 57%. 
There was no abnormality in myocardial 
perfusion imaging. Left ventricular 
diastolic function, however, was greatly 
depressed and cardiac sympathetic nerve 
imaging revealed a profound loss of cardiac 
uptake of i231-metaiodobenzylguanidine 
(figure, upper right); the heart-to-
mediastinum ratio of 1·62. Her heart rate 
variation was also markedly reduced. 
Biopsy specimens from the salivary gland 
and intestine revealed depositions of 
amyloid proteins (figure, lower right). 
These findings indicated that systemic amyloid deposition is related not only to 
denervation. The patient currently has no serious complications or cardiac symptoms. 
polyneuropathy but also to cardiac 
Graduate School of Medicine, Cardiovascular and Renal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan 
(T Nakata MO, K Shimamoto MO) 
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Intercontinental Spread of 
Pyrimethamine-Resistant Malaria 
cally Roper,'· Richard Pearce,' Shalini Nair,2 Brian Sharp,3 
Fran~ois Nosten," Tim Anderson2 
Here we present molecular evidence demonstrat-
ing that malaria parasites bearing high-level py-
rimethamine resistance originally arrived in Afiica 
from southeast Asia Chloroquine (CQ) is being 
replaced by sulfadoxine pyrimethamine (SP) for 
treatment of Plasmodium falciparum malaria in 
Afiica. Mutations in the dihydrofolate reductase 
(dhfr) gene of P.falciparum W1derlie resistance to 
pyrimethamine. Dhfr alleles with one (1 08N) or 
two (1 08N plus 51 I or 108N plus 59R) muta-
tions result in increased parasite clearance 
times. Infections bearing triple-mutant dhfr 
(108N, 51l, and 59R) have high treatment fail-
ure rates, and quadruple-mutant dhfr alleles 
(l08N, 51l, 59R, and 164L) render parasites 
untreatable (1). Parasites with one to three mu-
tations occur in Afiica, whereas all four muta-
tions are common in southeast Asia (2) and 
South America (3). Triple-mutant alleles are 
replacing other alleles in Afiica (4). 
It is generally assumed that pyrimethamine 
resistance has evolved mUltiple times (1), be-
cause it is selectable in the laboratory, has a 
simple genetic basis, and appears rapidly after 
SP introduction. However, analysis of micro-
satellites that flank dhfr in Afiican parasites 
sampled from sites 4000 Ian apart demonstrate 
just three independent origins of double mu-
tants and a single origin of the triple mutant (4). 
Similarly, dhfr alleles with two to four muta-
tions have a single evolutionary origin across 
five southeast Asian countries (2). 
Genotyping of eight microsatellite markers 
flanking dhfr in both southeast Asian and Afiican 
parasites shows that the triple-mutant dhfr allele in 
Africa shares a common origin with dhfr alleles 
bearing two to four mutations in southeast Asia 
(Fig. I). The predominant five-locus microsatellite 
haplotype (- 10 kb to +0.5 kb) associated with 
triple-mutant dhfr in Afiica is identical to that 
associated with dhfr alleles carrying two to four 
mutations in southeast Asia. In contrast, these five 
loci show high levels of variation (mean expected 
heterozygosity = 0.76) around sensitive dhfr al-
leles. Markers situated further from dhfr (- 20 kb 
and > + 6 kb) show higher polymorphism on 
chromosomes that carry resistant dhfr alleles, as 
expected, in a selective sweep (2, 5). However, the 
predominant alleles are the same on resistant chro-
mosomes from both continents. In contrast, Afri-
can double-mutant dhfr alleles have dissimilar 
flanking alleles, indicating independent origins 
(4). Because all southeast Asian dhfr alleles car-
rying > I mutation have a single origin, the sim-
plest explanation is that triple-mutant dhfr alleles 
spreading in Africa originated in southeast Asia. 
Alleles at the major CQ-resistance locus pfcrt 
also have a common origin in African and Asian 
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Fig. 1. dhfr alleles and flanking microsateUites of parasites from Africa and Thailand. The figure comprises data 
from 12 Thai parasites with two to four resistance mutations, 24 African parasites with triple-mutant alleles, 
and 18 African parasites with sensitive dhfr alleles. The four-letter codes describe amino acids present at 
positions 51. 59, 108, and 164 in the predicted dhfr protein (10). Amino acids conferring resistance are 
underlined, and dhfr alleles are shaded yellow, orange, red, and black in order of increasing resistance. 
Sensitive alleles are shaded turquoise. Allele lengths are shown for eight microsatelUtes positioned at -0.1, 
-4.4, -5.3, -10, and -20 kb upstream and +0.5, +6, and + 10 kb downstream of dhfr. Dots and yellow 
shading indicate identical allele size to the predominant resistant haplotype (shown at right). 
parasites (5, 6). CQ-resistant pfcrt alleles and 
triple-mutant dhfr alleles may have arrived in Af-
rica in the same parasite genome. Pyrimethamine 
resistance was widespread in Asia when CQ re-
sistance was first recorded in Africa (7). lmport of 
southeast Asian parasites has thus led to the de-
mise of the two affordable drugs that have been 
the mainstay of malaria treatment in Afiica. 
Why did the triple-mutant allele not arise in-
dependently in Afiica? Asswning a mutation rate 
of 10- 9 per base per generation, we would expect 
10 to 1000 independent origins of triple-mutant 
parasites in every infection (1010- 12 parasites) 
containing double-mutant dhfr alleles. The impli-
cation is that complex compensatory mutations 
are required to restore parasite fitness. 
Every year 30,000 malaria cases are import-
ed into industrialized countries (8). The num-
bers of cases imported into Africa is unknown 
but likely to be substantial. Given that 67% of 
parasites sampled in Thailand, Cambodia, and 
Myanmar carry the I64L mutation in dhfr (2), 
as well as high levels ofmefloquine and quinine 
resistance, it is only a matter of time before 
these invade and establish in Africa. We sug-
gest that careful thought should be given to 
preventing further import of resistant parasites. 
perhaps by screening and treatment of passen-
gers traveling from southeast Asia or South 
America to Africa. Widespread introduction of 
artemisinin-based combination therapy (9) 
could also help to minimize the foci from which 
resistant parasites can spread. Importantly, 
these data demonstrate that antimalarial drug 
resistance is an international problem requiring 
a coordinated international response. 
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